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Abstract 
The work presented in this thesis employed multiphoton microscopy of tissue autofluorescence to 
investigate spectrally and fluorescence lifetime resolved images obtained from normal skin and 
cutaneous malignancies. This was achieved by adapting a commercially available CE-marked 
multiphoton tomograph (DermaInspect®) to allow fluorescence lifetime imaging (FLIM) 
simultaneously in four spectral channels and corresponding steady-state hyperspectral images using 
a prism-based spectrometer to be acquired. 
The images generated were analysed through the manual identification of morphological criteria 
and through manual and automatic segmentation of individual cells within FLIM images followed by 
automated morphological and spectroscopic analysis. 
The analysis of FLIM images acquired from normal skin ex vivo and in vivo identified subpopulations 
of cells based on their autofluorescence characteristics and allowed intra- and interpatient variations 
to be assessed. The mean cellular lifetime was found to decrease between 691-1286 picoseconds 
(ps) with depth, increase between 199-550 ps with age and a statistically significant decrease 
between 286-1436 ps with skin phototype (I-IV) was found, depending on spectral channel. 
The manual identification of morphological features from BCC images acquired ex vivo allowed the 
correct diagnosis to be made with a sensitivity/specificity of 79%/93%. Cellular fluorescence 
lifetimes were statistically significantly longer by between 19.9-39.8% compared to normal skin. A 
linear discriminant analysis combining both spectroscopic and morphological cellular parameters 
allowed BCCs to be discriminated from normal skin with an AUC of 0.83. 
Manually identified morphological features were able to distinguish dysplastic naevi from 
melanomas with a sensitivity and specificity of 75% and 81% respectively from ex vivo FLIM images. 
However, no contrast in cellular fluorescence lifetime was observed. 
A motorised stage has also allowed multispectral FLIM image mosaics of depth resolved images from 
unsectioned skin to be presented for the first time. 
In conclusion tissue autofluorescence and FLIM detect clinically useful differences in the skin. 
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Chapter 1. Introduction to the skin 
1.1 Introduction 
The research presented in the thesis investigates the use of multiphoton microscopy to image the 
skin non-invasively. Both normal skin and skin cancer have been investigated. This chapter therefore 
provides a brief introduction to three topics – the structure and function of normal human skin; the 
most common malignancies that occur in the skin i.e. basal cell carcinoma, squamous cell carcinoma 
and melanoma; and finally a brief synopsis of the major non-invasive imaging modalities that have 
been applied to the skin. 
1.2 Normal Skin 
The skin is the largest organ system in the human body and has many functions. Its primary function 
is to act as a physical, chemical and biological barrier to exogenous substances and organisms. It is 
also involved in thermoregulation, sensation and calcium/vitamin D homeostasis. It is composed of 
three main layers – the epidermis, dermis and subcutis.  
 
Figure 1.1 An annotated H&E stained section of the epidermis and dermis of normal skin 
The epidermis is the most superficial layer of the skin and is structured into a number of distinct 
layers defined by their histological appearance, see figure 1.1. Keratinocytes account for 95% of the 
cells within this layer. The epidermis is separated from the dermis by the basement membrane and 
varies in thickness depending on age and body site (typically 60-100 µm (Sandby-Moller, Poulsen et 
al. 2003)). This multilayered membrane acts as a mechanical and functional barrier between the two 
layers. It serves many functions including orientating the proliferative basal keratinocytes’ direction 
of growth and anchoring the basal layer of the epidermis to the papillary dermis.  Both congenital 
and acquired defects in this layer give rise to many blistering skin disorders (Fassihi, Wong et al. 
2006). 
Reticular Dermis
Papillary Dermis
Stratum Granulosum
Basal Layer
Cellular Epidermis
(~50-80 µm)
Stratum Corneum (~10-20 µm)
Stratum Spinosum
Layers within the epidermisLayers of the skin
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After dividing in the basal layer, keratinocytes migrate towards the skin surface with an 
accompanying change in cellular morphology and function. The cells lose the ability to divide, 
undergo programmed cell death and change their expression of intracellular keratins in a process 
called terminal differentiation and apoptosis (Fuchs 2008) as they mature. The keratinocytes in the 
basal layer are cuboidal in shape, small in size and have a large nuclear to cytoplasm ratio. As cells 
progress to the Stratum Spinosum and Stratum Granulosum they become flatter in shape, 
progressively lose their nuclei and intracellular organelles and accumulate dense keratohyalin 
granules within them. The most superficial epidermal layer, the Stratum Corneum consists of 
compacted, water resistant, richly keratinised layers of dead keratinocytes termed corneocytes. 
Melanocytes are usually found alongside keratinocytes in the basal layer of the epidermis and in the 
papillary dermis. Their primary role is to synthesize and distribute melanin to the surrounding 
keratinocytes, thus protecting their nuclei from UV photodamage by absorbing light in the UV 
spectral range. Most melanocytes are found individually at regular intervals in the basal layer and 
provide melanin for on average 36 keratinocytes, collectively termed a epidermal melanin unit.  
The term melanocytic naevus or mole is used for benign proliferations of melanocytes. The location 
of these within the skin allow them to be classified as junctional naevi (along the basal layer), dermal 
naevi (in the papillary dermis), or compound naevi (containing both junctional and dermal 
components).  
Langerhans cells are present within the Stratum Spinosum of the epidermis but are poorly visible by 
Hematoxylin and Eosin (H&E) staining of fixed, sectioned tissue, (the most common stain used to 
evaluate skin samples). They are dendritic in morphology with numerous protrusions extending 
between keratinocytes. They are specialised cells that can ingest particulate matter around them 
and have an immune- surveillance role within the skin. 
Finally Merkel cells are involved in sensory perception and are situated in the basal layer near 
associated sensory nerve endings. They can’t be visualised using the H&E stain and require specific 
immunostaining to be seen histologically. 
Regional variation can be found in normal skin depending on body site e.g. thicker S.Corneum is 
found on the palms and soles. Changes also accompany malignancy, such as migration of malignant 
cells across the basement membrane and the destruction of normal epidermal/dermal architecture. 
The dermis lies beneath the basement membrane and provides physical support and nutrients for 
the epidermis above. The superficial dermis is called the papillary dermis and is defined by 
protrusions of the dermis, called dermal papillae, interdigitating with the epidermis. The reticular 
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dermis lies below this layer and can be distinguished by a change in the orientation of the collagen 
fibres within it.  
Structures found within the dermis include the pilosebaceous unit (hair and sebaceous gland), 
nerves, sweat glands, sensory receptors and the vasculature. The vasculature is arranged into a 
superficial plexus that lies in the papillary dermis and a communicating deep plexus, found deeper in 
the dermis. The structural support of the dermis is provided by a matrix of proteoglycan 
macromolecules, type I and III collagen and elastin. The collagen provides strength and accounts for 
on average 56% of the dry weight of the dermis (Lovell, Smolenski et al. 1987) whilst elastin provides 
the elastic recoil of the skin and accounts for 2-4% of the dry weight (Kielty, Sherratt et al. 2002; 
Burns, Breathnach et al. 2010). 
The lower reticular dermis has more densely packed collagen and provides more mechanical 
strength and elasticity to the skin than the papillary dermis.  
The subcutis lies beneath the dermis. It consists of loose connective tissue and attaches the skin to 
the underlying musculoskeletal system. Adipocytes account for the majority of the cells in this layer 
and contain approximately 80% of the body’s fat (Burns, Breathnach et al. 2010). Although the 
adipocytes main function is for insulation and mechanical cushioning, they also have an endocrine 
function. 
1.3 Skin Cancer 
The incidence of all types of skin cancer in the western world is rising (Diepgen and Mahler 2002). 
The most prevalent skin cancers are basal cell carcinoma and squamous cell carcinoma, which are 
often referred to as non-melanoma skin cancer (NMSC), and malignant melanoma. In the UK 
malignant melanoma has risen most  in incidence over the last decade compared to NMSC 
(CancerResearchUK 2010). 
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1.3.1 Basal Cell Carcinoma 
 
Figure 1.2 a-c) Different clinical presentations of BCCs a) nodular b) superficial c) pigmented. d-f) Histological 
images of BCCs stained with H&E showing clusters of BCC cells within the epidermis and dermis.  
Basal cell carcinoma (BCC) has high prevalence in the western world (Diepgen and Mahler 2002; 
Demers, Nugent et al. 2005). It is the most common skin malignancy in Caucasian populations with a 
rising incidence in all age groups (Christenson, Borrowman et al. 2005; Staples, Elwood et al. 2006). 
The incidence is estimated at between 105-128 per 100,00 in the UK (Holme, Malinovszky et al. 
2000). They arise through cumulative exposure to the sun (Kricker, Armstrong et al. 1995) and 
therefore typically occur in sun exposed sites, such as the face and mainly occur in fair skinned 
individuals. 
Its name derives from the histological resemblance of the malignant cells to those found in the basal 
cell layer of the epidermis. These tumours have a low metastatic potential and thus their mortality is 
very low. They can, however cause significant morbidity from local tissue destruction if lesions are 
not diagnosed and treated. The incidence of recurrent primary tumours in patients with a BCC is also 
high, with an estimated risk of developing a second tumour within 3 years of 44% (Marcil and Stern 
2000). 
A number of clinical/histological subtypes exist, see figure 1.2. Nodular BCCs are most prevalent and 
have a distinctive pearlescent texture, telangectasia (small blood vessels) with rolled edges 
developing in larger lesions. Histologically malignant cells are grouped into well-defined clusters with 
characteristic stroma between.  The treatment of choice for cure in most patients is surgical 
a) b) c)
d) e) f)
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excision. However excellent results are still gained by radiotherapy for patients not suitable for 
surgery (Telfer, Colver et al. 2008). 
Morphoeic and infiltrative BCCs are poorly defined clinically and histologically. They therefore 
require wider surgical margins to ensure complete excision (Wolf and Zitelli 1987) and have a higher 
recurrence rate than nodular BCCs. Mohs micrographic surgery is a tissue sparing technique that can 
be used in this context. It entails removing the tumour progressively. Frozen sections of the fresh 
tissue can be prepared quickly (in comparison to fixed sections) and are reviewed during the surgical 
procedure. Small amounts of tissue are removed progressively until surgical clearance of the tumour 
margin is gained. In this way, the amount of normal tissue removed and the incidence of 
incompletely excised tumour is minimised.  Unfortunately the technique is time consuming, labour 
intensive and expensive and therefore tends to be reserved for recurrent tumours or those in 
cosmetically sensitive sites.  
1.3.2 Squamous Cell Carcinoma 
 
Figure 1.3 (a) Clinical image of SCC (b) histological image of moderately differentiated SCC stained with H&E illustrating 
keratin deposits within the dermis (black arrow) within the tumour (c) histological image of poorly differentiated SCC 
stained with H&E illustrating strands of epithelial cells invading the dermis(black arrow) (Images courtesy of Dr A Robson, 
St Johns Institute of Dermatology, London). 
The incidence of squamous cell carcinoma (SCC) in the UK has been estimated at 25.5 per 100,000 
(Holme, Malinovszky et al. 2000) with an increase in incidence with age greater than BCCs. (Diepgen 
and Mahler 2002). 
This malignancy arises from keratinocytes and most often occurs in cells that have undergone 
photodamage induced by chronic, cumulative sun exposure (Armstrong and Kricker 2001). SCCs can 
also arise from sites of chronic infection, inflammation or previous radiotherapy.  
The premalignant lesion, actinic keratosis is a UV induced intraepidermal neoplasia and can lead to 
SCCs. The prevalence is as high as 25% in Caucasian populations above the age of 60, with up to 10% 
a) b) c)
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transforming into an invasive SCC (De Berker, McGregor et al. 2007). Once invasive, SCCs have the 
potential to metastasize, with mortality dependent on tumour characteristics. 
There is great variation in the clinical appearance of lesions that typically appear as raised areas of 
red skin with surface scale, see figure 1.3. This can make the distinction between actinic keratosis 
from early SCCs difficult.  
Histologically, key indicators for the risk of local recurrence or metastatic spread are depth of 
invasion of the tumour and cellular differentiation (well, moderate or poor). Poorly differentiated 
tumours greater than 6mm in depth carry the greatest risk of recurrence. The standard treatment is 
surgery for these tumours. However, radiotherapy can be used in selected situations. (Motley, 
Kersey et al. 2002). 
1.3.3 Melanoma 
 
Figure 1.4 a) Clinical image of a benign Junctional Naevus b) Clinical image of a Melanoma c) Histological image of the 
melanoma seen in (b) stained with H&E. Arrows indicate melanoma cells spreading to the epidermis and invading the 
dermis. 
Melanoma is a malignancy arising from melanocytes. Since melanocytes are not exclusively found in 
the skin, primary melanomas can arise within other organs. Cutaneous melanoma accounts for 4% of 
cancers in the UK with approximately 10,400 new cases diagnosed annually (CancerResearchUK 
2010). It is however responsible for 80% of skin cancer related deaths (Miller and Mihm 2006). Its 
incidence increases with age and has quadrupled over the last thirty years. It is currently the 3rd most 
common cancer in the 15-39 age group in the UK (CancerResearchUK 2010). An individual’s risk is 
influenced by family history, skin phototype (a measure of the skin’s ability to tan and easy of 
burning), sun exposure (Elwood and Jopson 1997) and having atypical naevi syndromes. 
Melanoma is suspected by a change in size, shape or colour of a mole accompanied by a supporting 
history, see figure 1.4. However these changes are not specific for malignant change and it can only 
be confirmed histologically by the presence of cytologically malignant melanocytes invading the 
a) b) c)
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dermis i.e. crossing the epidermal basement membrane. As most clinically suspicious moles for 
melanoma are not histologically confirmed as malignant, a large number of non-malignant naevi are 
excised, even with the aid of dermatoscopy (Argenziano, Cerroni et al. 2012). This is potentially 
unnecessary, invasive, scarring to the patient and has a financial cost. 
 A number of histological variants of melanoma are recognised. The most common is superficial 
spreading malignant melanoma. Nodular, lentigo maligna (found on chronically sun exposed skin) 
and acral lentiginous melanomas (occuring on palms and soles) are less common. Despite the use of 
histological criteria, it can remain difficult to classify some melanocytic proliferations as benign or 
malignant e.g. Spitz naevi are lesions that appear in childhood and are often histologically 
indistinguishable from malignant melanoma. However, they behave in a clinically benign manner. 
The primary treatment for melanoma remains surgery. The prognosis of patients correlates well with 
the Breslow thickness of the lesion at excision, defined as the maximum depth of tumour invasion 
from the stratum granulosum layer of the epidermis. Increased Breslow thickness increases the 
incidence of metastatic disease which is poorly responsive to chemotherapy or radiotherapy. Early 
diagnosis is therefore critical. Melanoma patients with a Breslow thickness of less than 1mm have a 
5 year survival of 95-100%. In contrast, a thickness of 2.1-4mm has a 60-75% survival rate at 5 years 
(Roberts, Anstey et al. 2002).  
1.4 Non-invasive imaging 
Financial and clinical pressures have led to the development of a number of non-invasive imaging 
modalities. Improvements to non-invasive diagnostic techniques have the potential to diagnose skin 
cancers earlier and more accurately, allow direct monitoring of the effects of treatment and avoid 
unnecessary over-treatment. These improvements in patient care could be matched by significant 
financial savings. 
Also, accurate non-invasive assessment of the depth of tumour invasion would be useful in planning 
surgical excision margins. For example the standard practice for the treatment of melanoma is to 
excise the tumour, determine the depth of invasion of the tumour histologically, then resect a 
further margin of tissue based on that depth. An accurate initial assessment would remove the need 
for a second surgical procedure. Similarly, the wide surgical margins currently used for surgical 
excision of infiltrative BCCs could be reduced in many cases. 
Finally, non-invasive imaging could play a role in monitoring response to topical chemotherapy 
agents. For example 5-fluorouracil can be used to treat superficial BCCs and actinic keratosis. 
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Current practice relies on clinical assessment alone to determine adequate response to therapy. This 
is commonly impaired in the short term by the degree of inflammation induced by the treatment. 
1.4.1 Dermatoscopy 
 
Figure 1.5 a) Dermatoscope (www.heine.com). b,c) Typical dermatoscopic images of melanomas with corresponding 
macroscopic image inset . 
Dermatoscopy is a technique that magnifies the skin and allows visualisation of structures to the 
depth of the papillary dermis. Dermatoscopes illuminate the skin around a central lens and are held 
either over the surface or in direct contact with the skin, see figure 1.5. Classical dermatoscopy uses 
a fluid interface (usually alcohol gel or oil) to interface between the instrument and the skin. The 
fluid eliminates reflected light and renders the stratum corneum transparent, allowing the structures 
beneath to be more clearly visible. Although dermatoscopy can be applied to all dermatoses, its 
primary role is in the assessment of solid lesions, particularly melanocytic lesions. It provides greater 
morphological information and increases clinical diagnostic sensitivity compared with clinical 
examination alone (Kittler, Pehamberger et al. 2002). 
A number of diagnostic algorithms using dermatoscopy have been validated for the diagnosis of 
melanoma. These include the ABCD system (asymmetry, boarder irregularity, colour, diameter) 
(Nachbar, Stolz et al. 1994), pattern analysis (Argenziano, Soyer et al. 2003), 7 point score (Dal Pozzo, 
Benelli et al. 1999) and the Menzies method (Menzies, Ingvar et al. 1996). All have been shown to 
have a high sensitivity (range 83-86%) and specificity (range 70-83%) for identifying melanomas from 
other pigmented lesions (7 point score, Menzies method) or from pigmented melanocytic lesions 
(ABCD system, pattern analysis). Although these algorithms have allowed more melanomas to be 
diagnosed at the bedside, they are most valuable for their negative predictive power i.e. to exclude 
melanoma and thus have reduced the rate of unnecessary biopsies. Computer algorithms have also 
been written to stratify dermatoscopic images by likelihood of malignancy, with varying success 
(Rubegni, Burroni et al. 2002; Rajpara, Botello et al. 2009). 
Despite the widespread use of dermatoscopy in clinical practice, the number of naevi excised for 
every melanoma still range from 8.7 to 29.4 between dermatology centres (Argenziano, Cerroni et 
(a) (b) (c)
 35 
 
al. 2012). This creates potentially unnecessary procedures, cost and disfiguring scars for patients and 
creates a clinical and financial need for better non-invasive modalities to be developed. 
1.4.2 High Frequency Ultrasound 
 
Figure 1.6 a) HFUS image of a melanoma taken at 20MHz and b) corresponding histology stained with H&E. Key-E entry 
echo, T tumour, K stratum corneum/derims B blood, S subcutis, F fascia. Reproduced from (Marghoob, Swindle et al. 2003) 
Ultrasound imaging uses the echoes from reflected sound waves from interfaces between tissue 
types to reconstruct a 2 dimensional vertically sectioned image, see figure 1.6. The optimal 
ultrasound frequency balances the depth of penetration (deepest at low frequencies) with the 
resolution (highest at high frequencies). Traditional ultrasound equipment for medical imaging 
operates at 7.5 MHz which has inadequate resolution for skin imaging. High frequency ultrasound 
(HFUS) between 20 MHz to 1 GHz has been more successful when imaging skin, allowing axial image 
resolutions between 200µm and 16µm to be achieved respectively. They have been used to assess 
various aspects of normal skin and pathology e.g skin thickness (Alexander et al. 1979), vascular 
disorders (Betti et al. 1990), dermatological diseases (Gupta et al. 196; Machet et al. 2006) and skin 
tumours (Gupta et al. 1996). 
Desai et al. showed good correlation between tumour margins of superficial and nodular BCCs 
between HFUS at 20 MHz and histology. However, they were unable to detect margins from 
infiltrative or morphoeic BCCs (Desai, Desai et al. 2007). 
Their use for reliably differentiating between benign melanocytic nevi and melanomas diagnostically 
has not been possible to date using 20MHz (Harland et al. 2000). Hayashi et al. however showed that 
the depth of tumour invasion of melanomas assessed using HFUS at 30 MHz correlated sufficiently 
well with histology  to allow accurate classification of lesions into the correct AJCC/UICC staging 
category i.e. ≤1mm or >1.01mm depth (T1, T2). (Hayashi, Koga et al. 2009). Gambichler et al. too 
a) b)
a) b) 
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showed that the measured tumour depth was shown to correlate well to the histologically measured 
depth to within 33.9 µm for 20 MHz, increasing to 16 µm for 100MHz frequencies for melanomas 
under 1mm in depth (Gambichler, Moussa et al. 2007). For melanomas between 0.4-7.6 mm, 
moderate agreement was found in thickness between HFUS and histology with a mean thickness 
(±SD) of 1.96±2.15 mm and 1.95±2.62 mm respectively. This degree of accuracy was sufficient to 
predict the correct re-excision margins in 26/31 subjects investigated (84%, 95% CI 66-95)(Machet, 
Belot et al. 2009) .  
In summary the contrast and resolution of this modality is lower than reflectance confocal light 
microscopy and optical coherence tomography and it has been found to be best suited for providing 
dimensional rather than diagnostic information. Most recently, HFUS has been combined/directly 
compared with optical imaging modalities to combine the strengths of each modality e.g. optical 
coherence tomography (Mogensen et al. 2009) and multiphoton microscopy (König & Speicher 
2010). 
1.4.3 Optical Coherence Tomography 
Optical Coherence Tomography (OCT) is the optical analogue to ultrasound. It uses a high bandwidth 
light source (typically infrared) and collects the back scattered light that arises between tissue 
interfaces with differing refractive indexes. It uses interferometry to compare the scattered light to 
light reflected from a second, known path length to calculate the tissue depth of these interfaces 
between tissue layers. It has a poorer resolution than reflectance confocal light microscopy (3-20μm 
laterally and axially) but has a greater depth of penetration of 1-2mm (Mogensen, Thrane et al. 
2009), see figure 1.7. 
 
Figure 1.7 (a) OCT device for skin imaging - Vivosight, Michelson Diagnostics Ltd. (b)H&E stained histological section of a 
nodular BCC and (c) corresponding OCT image taken in vivo. Reprinted from J. Dermatological Science  45(3),p170 
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Gamichler, Orlikov et al. In vivo optical coherence tomography of basal cell carcinoma. Copyright (2007), with permission 
from Elsevier. (Gambichler, Orlikov et al. 2007). 
An early study using OCT to diagnose NMSC was by Mogensen et al. (Mogensen, Joergensen et al. 
2009). They used a self-built system with illumination centred at 1,318 nm, a bandwidth of 66 nm, an 
axial resolution of 8 µm and lateral resolution 24 µm. 115 images of lesions clinically diagnosed as 
NMSC and imaged in vivo were compared with 105 images from peri-lesional normal skin.  
Histologically these lesions included 64 BCCs, 1 baso-squamous carcinoma, 39 actinic keratosis, 2 
malignant melanomas and 9 benign lesions. Blinded observers were able to distinguish these lesions 
correctly with a sensitivity ranging from 58-94 % and specificity between 43-96 %. A drawback of 
OCT found in the study was that only 59% of the OCT images taken were of sufficient 
quality/completeness for analysis and their inability to distinguish actinic keratosis from BCCs. 
Mogensen et al. also compared the accuracy of tumour thickness assessment of NMSC using both 
OCT and 20 MHz HFUS compared to histology (Mogensen, Nurnberg et al. 2009). They examined 34 
lesions that were <2 mm in depth (actinic keratosis and BCCs). Both methods overestimated lesion 
thickness compared with histology but OCT was more precise than HFUS (difference of 0.392 mm 
vs.0.713 mm). These results were reproduced by Hinz et al. (Hinz, Ehler et al. 2012) who also found 
OCT could determine the tumour depth more accurately than 20 MHz HFUS compared to histology 
(median difference 0.13 vs 0.3 mm). Both groups commented that peri-tumour inflammation made 
tumour depth assessment more difficult and led to an overestimate of tumour depth (Mogensen, 
Nürnberg et al. 2011). 
Coleman et al. also used OCT to measure tumour margins in NMSC (Coleman, Richardson et al. 
2012). They analysed OCT images taken in vivo from a 5 mm central area from 18 BCCs (4 superficial, 
12 nodular and 2 infiltrative) and 5 SCCs (4 in situ, 1 invasive). They used the VivoSight® (MDL Ltd, 
Orpington, UK) with light centred at 1305 nm wavelength, resolution of <7.5 µm laterally and 
<10 µm axially, and a maximum imaging depth of 1.5 mm. They found that tumours <1 mm in depth, 
such as superficial BCCs, correlated better with histology (0.17±0.3 mm) than tumours >1 mm in 
depth (-0.54±1.14 mm), which were underestimated in depth by OCT. This was in contrast to the 
findings by Mogensen et al. (outlined above). They also noted that hyperkeratosis in SCCs caused 
increased shadowing and made OCT images more difficult to interpret. In this study the difficulty 
acquiring usable OCT images in vivo was also highlighted. Although 78 patients were recruited, only 
23 (29.5%) image stacks were suitable for analysis. 
This same group also assessed the VivoSight® OCT system’s ability to diagnose remaining tumour 
within freshly excised tissue sections, taken during Mohs micrographic surgery compared with 
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frozen section histological (Cunha, Richardson et al. 2011).  75 sections from BCCs were assessed 
from 38 patients. They found that images were of insufficient quality or sections were incomplete in 
48/75 (64%) sections. In the remaining sections, concordance was poor with only 4/26 and 23/49 
OCT images able to confidently diagnose a histological section as positive or negative for tumour 
respectively. This gave a sensitivity of 19%, and specificity of 56%. 
Most recently Boone et al. found that a high definition OCT device (Skintell®; Agfa Healthcare, , 
Belgium) was able to identify features defining each histological sub-type of BCCs in vivo from 
images taken from  21 patients (Boone, Norrenberg et al. 2012). The device also imaged in the infra-
red spectrum but had a lateral and axial resolution of 3 µm, an maximum imaging depth of 570 µm 
and a field of view of 1.8x 1.5 mm. 
Although OCT has been used widely for the investigation of retinal and choroidal pathology, 
including naevi and melanomas (Say, Shah et al. 2011), its application in cutaneous melanoma has 
been limited. Two groups have tried to detect morphological changes associated with melanoma 
(Giorgi, Stante et al. 2005; Gambichler, Regeniter et al. 2007). However the assessment of tumour 
depth and diagnostic accuracy has not been validated for pigmented lesions yet. Hinz et al. 
compared the depth of 26 melanocytic lesions measured by OCT and 20 MHz HFUS to histology 
(Hinz, Ehler et al. 2011). They found a median lesion thickness of 0.31 mm (range 0.10–0.77 mm) 
with OCT compared to of 0.25 mm (range 0.06–1.5 mm) measured by histopathology, with a 
correlation coefficient of r=0.734. This was superior to HFUS, which had a correlation coefficient of 
0.390. 
In summary OCT has been shown to distinguish morphological features of NMSC non-invasively in 
vivo by several groups. It should be noted that many studies compared in vivo depth with measures 
taken from fixed, sectioned histopathological samples. This comparison inherently lead to 
artefactual errors such as shrinkage of the tissue after fixation with formalin and the sampling error 
for depth, as only a fraction of the tissue is sectioned. Despite this, OCT was shown to be accurate 
for assessing tumours <2 mm in depth but was less precise assessing thicker tumours. It has also 
been shown in several studies to be more accurate for tumour margin assessment than 20 MHz 
HFUS. As studies using OCT for melanocytic lesion are limited, its use for their assessment still 
remains unclear.  
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1.4.4 Reflectance Confocal Light Microscopy 
 
Figure 1.8 (a)BCC mosaic taken using RCLM (b) corresponding histology stained with H&E. Reproduced from(Karen, Gareau 
et al. 2009). (d) Commercially available RCLM - Vivoscope® 1500 (www.lucid-tech.com) 
The first report of reflectance confocal laser microscopy (RCLM) used to image skin in vivo was 1995 
(Rajadhyaksha, Grossman et al. 1995). It uses variation in the refractive index within tissue to 
provide contrast. RCLM focuses light to a point in the sample. The scattered and reflected light is 
then collected by a photomultiplier tube detector. To generate a horizontally sectioned image the 
point of focus must be scanned in two dimensions. Scattered/reflected light must pass through a 
point aperture before it reaches the detector which spatially rejects light from outside the focal 
plane. RCLM can provide high resolution, depth resolved images of the epidermis and papillary 
dermis to a cellular resolution, see figure 1.8. The range of RCLM instruments for use in skin, 
manufactured by Lucid® Inc (Rochester,NY) emit light at 830 nm with a maximum power of 35 mW. 
They have a resolution of 0.5-1 μm laterally, 4- 5 μm axially and a depth of penetration of 350 μm, 
with fields of view of 500 x 500 μm usually taken. 
Study Sensitivity % Specificity % 
Nos. of Diagnostic 
Features in Assessment 
Pellacani (2005) 97.3 72.3 6 
Pellacani (2007) 92 69 6 
c
a
b
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Langley (2007) 97.3 83 7 
Gerger (2008) 97.5 99 not  specified 
Table 1.1 Sensitivity and Specificity of RCLM for the diagnosis of melanoma (Pellacani, Cesinaro et al. 2005; Langley, Walsh 
et al. 2007; Pellacani, Guitera et al. 2007; Gerger, Hofmann-Wellenhof et al. 2008). Adapted from (Psaty and Halpern 
2009). 
As melanin has a high refractive index, it appears bright in images taken by RCLM (Rajadhyaksha, 
Grossman et al. 1995). This high contrast has allowed a number of morphological features to be 
defined that distinguish benign from malignant pigmented lesions (Busam, Charles et al. 2001; 
Langley, Rajadhyaksha et al. 2001; Scope, Benvenuto-Andrade et al. 2007). Several studies found 
that these criteria have a high sensitivity and specificity, see Table 1.1. A direct comparison between 
dermatoscopy and RCLM also published by Langley et al. found dermatoscopy to be more sensitive 
than RCLM for the diagnosis of melanoma (97.3% vs 89.2%). However, both modalities were found 
to have a similar specificity (84.1% vs 83%) (Langley, Walsh et al. 2007). 
A group from Modena, Italy found an 87.6% sensitivity and 70.8% specificity for the 7 criteria they 
defined for the diagnosis of melanomas from RCLM images taken in vivo (Guitera, Menzies et al. 
2012). Gerger et al. also examined 162 lesions that included images taken in vivo from (27) 
melanomas and (15) BCCs (Gerger, Koller et al. 2006). They found RCLM could distinguish these 
malignancies with a positive predictive value of 94.22%. 
RCLM has also been used to evaluate BCCs both ex vivo (Gerger, Horn et al. 2005) and in vivo 
(González and Tannous 2002) with promising results. When the 5 in vivo criteria defined by Gonzalez 
et al. were applied retrospectively to confocal images taken in vivo from 152 skin lesion (benign and 
malignant), containing images from 83 BCCs, a sensitivity of 82.9% and specificity of 95.7% was 
obtained when ≥4 criteria were met (Nori, Rius-Diaz et al. 2004). Another set of 8 criteria were 
tested by Guitera et al. by the group in Modena (Guitera, Menzies et al. 2012). They found that their 
criteria gave a 100% sensitivity and 88.5% specificity for the diagnosis of 52 BCCs. 
Work has also been performed to evaluate the accuracy of tumour margin assessment by RCLM. Pan 
et al. have shown that the surgical margins of BCC measured in vivo by RCLM correlated well to the 
margins assessed by frozen section in 12/13 cases (Pan, Lin et al. 2012).  
In summary RCLM has been shown to have a high degree of accuracy and reproducibility for imaging 
both pigmented and non-pigmented skin cancers in vivo. 
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1.4.5 Multiphoton Microscopy 
Multiphoton microscopy (MPM) is an emerging optical imaging technique (Denk, Strickler et al. 
1990) that excites fluorescence from the sample through the simultaneous absorption of two or 
more photons of infrared light. This process requires a high intensity of excitation light and so is 
confined to the tightly focused excitation spot. Images are generated by raster-scanning the 
excitation spot across the specimen in two dimensions. MPM offers a spatial resolution similar to 
histopathology at high power magnification (<1 µm lateral, <2 µm axial resolution, (König and 
Riemann 2003)) and is licenced for clinical use in vivo. 
The skin contains naturally occurring fluorophores that can be imaged using MPM without the need 
for exogenous contrast agents. These include collagen, elastin, melanin, keratins, porphyrins, 
NAD(P)H and flavins. Fluorescence intensity imaging using MPM has been used to study skin 
morphology with subcellular resolution (Masters, So et al. 1997; König, Raphael et al. 2011; Levitt, 
McLaughlin-Drubin et al. 2011). Further discrimination can be gained measuring the fluorescence 
emission spectrum (Palero, de Bruijn et al. 2007; Dimitrow, Riemann et al. 2009) and fluorescence 
lifetime (Cicchi, Sestini et al. 2008; Sanchez, Prow et al. 2010; Benati, Bellini et al. 2011; Seidenari, 
Arginelli et al. 2012), which measures the rate of decay of the fluorescence signal following a short 
pulse of excitation light. Manfredini et al. have found MPM images from BCCs to have a good 
concordance with reflectance confocal light microscopy (Manfredini, Arginelli et al. 2013). A more 
detailed account of MPM, tissue autofluorescence, fluorescence lifetime and fluorescence lifetime 
imaging can be found in chapter 2 (pp43). 
1.4.6 Optoacoutstics 
Optoacoustics (OA) also known as photoacoustics is a relatively new method for biological imaging. 
It combines the contrast and resolution benefits of optical imaging with the depth of penetration of 
ultrasound. During imaging, the tissue is first irradiated by a short pulsed laser beam (optical). The 
energy from the light is absorbed by the tissue and converted to heat. A rapid thermoelastic 
expansion then occurs within the tissue followed by a resulting pressure wave (acoustic) which 
propagates as an ultrasound wave and is detected by a standard ultrasound probe.  
Optoacoustics has been shown to be a promising modality for imaging of the skin. However, to date, 
the published literature remains limited. Early studies have demonstrated that cutaneous 
microvasculature can be imaged with a high resolution by this modality (Favazza, Jassim et al. 2011) 
and glucose could be monitored non-invasively through the skin (Pleitez, Lieblein et al. 2012). 
Grootendorst et al. used optoacoustics in a preliminary study to image freshly excised lymph nodes 
to look for metastatic melanoma (Grootendorst, Jose et al. 2012). The device had a Q-switched 
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Nd:YAG as its laser light source operating at 10 Hz which allowed imaging in the 720-800 nm spectral 
range. It had a lateral resolution of 150 µm and an axial resolution of 1 mm. They were able to 
detect the foci of metastatic disease in 3/6 positive nodes by the increased signal strength. They 
further stated that optical density of melanin would restrict the functional depth of imaging to 5 mm 
into the lymph node. 
A number of OCT devices have been designed that combine OCT with other imaging modalities such 
as OA & OCT (Zhang, Povazay et al. 2011) and OA & fluorescence confocal microscopy (Wang, 
Maslov et al. 2010). 
1.5 Conclusions 
I have described the structure and function of normal skin; the common skin cancers, namely BCCs, 
SCCs and melanoma. Finally, I have outlined the main non-invasive imaging modalities available to 
date, with a focus on their application to skin cancer assessment. The evidence behind the 
modalities described varies greatly between the more mature modalities, such as RCLM and those 
newer modalities, such as optoacoustics.  
Although all imaging modalities are promising, no modality alone has been able to match to 
resolution, depth of penetration and contrast that formalin fixed, sectioned, stained histological 
slides currently offer. As a result devices using multiple imaging modalities are being trialled e.g. 
Zhang et al. have combined OA, that gives better contrast for vasculature, with OCT, that gives 
optical contrast and has a good depth of penetration into the skin (Zhang, Povazay et al. 2011). 
Similarly König et al. have combined HFUS, that has good depth of penetration for skin imaging but 
gives poor resolution, with MPM, which gives cellular resolution images but has a poorer depth of 
penetration (König, Speicher et al. 2010). 
MPM currently provides the highest resolution images of all the modalities described above. This 
modality provides the greatest endogenous contrast (as multiple autofluorophores exist) and the 
only modality that can provide both structural and functional information about the skin. MPM 
would be excellent for the assessment of epidermal and upper dermal disease in vivo. Its depth of 
penetration would restrict the investigation of deeper dermal diseases to using ex vivo samples. 
MPM therefore offers the greatest information and therefore most likely to be useful diagnostically. 
In contrast, other imaging modalities, such as HFUS and OCT have a greater depth of penetration but 
offer lower resolution images. They would therefore be best suited to assess the size of lesions, once 
the diagnosis had already been made. 
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Chapter 2. Fluorescence in the skin 
2.1 Introduction 
This chapter provides an introduction to the principles, techniques and prior knowledge that directly 
relate to the work described in this thesis. The principles of fluorescence and fluorescence lifetime 
and the methods used for their measurement, including multiphoton excitation will be discussed. 
The endogenous fluorophores of the skin are then described in detail followed by an overview of the 
dynamic changes in fluorescence and fluorescence lifetime associated with malignancy. Finally a 
comprehensive literature review of the published literature on skin autofluorescence is given, 
focusing on research using multiphoton microscopy to study skin cancer. 
2.2 Fluorescence 
Fluorescence can arise in tissue autofluorophores, naturally present within the tissue or from 
artificially inserted fluorophores (physically or genetically). It is caused by the absorption of energy 
that promotes electrons from the S0 ground state to higher more energetic electronic states (Sn). 
Between these discrete, relatively stable electronic states, can exist less stable vibrational energy 
states (Vn) (Redmond 2003; Lakowicz 2006). This is illustrated by the Jablonski diagram, shown in 
figure 2.1 
 
Figure 2.1 Jablonski Diagram illustrating the change in singlet energy states of an electron excited by a photon of light and 
the loss of energy as fluorescence. 
When paired electrons in a molecule have balanced opposing spins, they are said to be in the singlet 
state. A drop of energy between singlet electronic energy states, in the form of emitted light, is 
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generally referred to as fluorescence. Following excitation of a molecule to an excited vibrational 
state through absorption of a photon, energy is typically lost by internal conversion to the lowest 
vibrational state (V0) of the excited singlet electronic energy state (Sn). This is typically S1 for most 
compounds. The molecule can then return to the ground singlet state (S0) by radiative (fluorescence) 
or non-radiative relaxation. A drop of energy to different vibrational levels in the ground state leads 
to fluorescence emission of varying wavelength. An excited molecule can undergo inter-system 
crossing, which results in it being in a triplet state. Radiative decay directly from a triplet state in the 
above way is forbidden and must occur via a slower process (lifetimes ~1 µs) known as 
phosphorescence. 
2.3 Multiphoton excitation 
Multiphoton excitation (MPE) typically refers to the simultaneous absorption of two photons instead 
of one, to increase the energy state of the molecule from the ground to a higher electronic state. 
The probability of this event is low and so excitation is usually focused in order to achieve a 
sufficiently high peak power using femtosecond duration pulses in a subfemtolitre volume. The 
fluorescence intensity induced varies quadratically with the excitation power in two photon 
excitation, and to the third power for three photon microscopy. The principle was first described in 
1931 by Göppert-Mayer in her PhD thesis (Göppert-Mayer 1931) but was not applied to microscopy 
until 1990 by Denk et al. (Denk, Strickler et al. 1990). It has a number of advantages over confocal 
microscopy for obtaining optically sectioned images from biological tissue. These include the 
following:- 
1. It is an intrinsically optically sectioning technique because fluorescence is restricted to the focal 
volume. Optically sectioned MPE images can be obtained if the focal spot is scanned across the focal 
plane without the need to reject light from out of focus planes using a pinhole, as is required by 
confocal microscopy. 
2. MPE is therefore a more optically sensitive technique than confocal microscopy when imaging in 
scattering media, as all emitted fluorescence is collected.  
3. NIR excitation light is absorbed and scattered less than UV or visible light and therefore tissue 
penetration is deeper. 
4. NIR photons have lower energy than the UV /visible light used for one photon excitation and is 
therefore less photo-damaging to cells away from the focal plane. 
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In addition to the emission of fluorescence, high intensity NIR illumination of non-centrosymmetric 
molecules (such as collagen) can cause energy to be converted via second harmonic generation 
(SHG) to visible light. This signal occurs near instantaneously and at exactly 1/2 of the excitation light 
wavelength, and is a dominant signal when imaging in the collagen rich dermis. 
2.4 Quantification of fluorescence 
The emitted fluorescence from a fluorophore can be described and quantified using a number of 
parameters – absorption and emission spectra, emission intensity, lifetime and polarisation. Each 
parameter contributes to the fluorescence signature for that fluorophore. 
2.4.1 Fluorescence intensity 
This measures the number of emitted fluorescence photons from a substance. It is proportional to 
the quantum yield of the substance but will also vary with the excitation power used to illuminate 
the sample and the absorption and scattering properties of the sample measured. Although simple 
to measure, reproducible quantitative measurements can be difficult to achieve. 
2.4.2 Fluorescence spectra 
The distribution of electronic and vibrational energy states varies between molecules. Their 
distribution determines the shapes of the absorption and emission spectra. As the vibrational energy 
states remain similar between electronic energy states in some molecules, the absorption and 
emission spectra of a molecule are often mirror images except for the Stokes Shift (shift towards 
longer wavelength of the emitted spectrum). 
The absorption and emission spectra of some molecules are affected by their local environment and 
this dependence can therefore be used to monitor pH, temperature, etc. As absolute measurements 
of fluorescence intensity are challenging due to variation in excitation efficiency, detection 
efficiency, scattering, etc... , ratiometric measures of the intensity taken at two discrete wavelengths 
are often used to cancel out these unknowns. 
2.4.3 Fluorescence polarisation 
Fluorophores with their absorption transition dipole moment parallel to the electric field vector of 
the illuminating light are preferentially excited. Therefore illumination using polarised light coupled 
with polarised detection can be used to monitor changes in the orientation of molecules, their 
binding state, their rotational mobility and the viscosity of their solvent. 
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2.4.4 Fluorescence lifetime 
The fluorescence lifetime is the average length of time an electron remains in its excited state before 
returning to the ground state (Lakowicz 2006). It can be defined as the inverse of the total decay 
rate, which is the sum of the radiative (  ) and non-radiative (    ) decay rates, see equation 2.1. 
  
 
      
        Equation 2.1 
Following excitation with a short pulse of light (such as with MPE), the fluorescence intensity decays 
exponentially with time, as described by the equation in figure 2.2 below. 
 
Figure 2.2 Schematic illustrating the fluorescence intensity decay over time following excitation from a short pulse of light. 
Key: t - time,   ( )- Intensity at time t,   - Intensity at time 0, τ – fluorescence lifetime. 
Biological fluorophores have different lifetimes in different states e.g. oxidised and reduced state, 
protein bound and unbound state, and for different species in tissue where multiple decay 
components are expected within each pixel. It is therefore useful to fit more complex fluorescence 
decay models, such as described by equation 2.2, where each decay constant,    has an initial 
contribution ai to the total fluorescence intensity. 
 ( )  ∑     
(    ⁄ )           Equation 2.2  
As the number of lifetime decay components to be fitted increases, so must the number of photons 
to be collected in order for the model fit parameters to be determined accurately.  Tissue 
fluorophores typically have more species present than the number of lifetime components fitted 
that can reasonably be fitted to real data and so a compromise must be made.  
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A bi-exponential decay model is therefore commonly adopted and the mean fluorescent lifetime 
(τmean) can then be expressed as either a species (amplitude) weighted or a photon (intensity) 
weighted mean of the two lifetime components, see equation 2.3. 
 )               
(          )
(     )
 
 )              
    
      
  
         
       Equation 2.3  
The lifetime is a ratiometric measure and is not dependent on the absolute fluorescence intensity 
making it suitable for comparative assessment between fluorophores and between instruments. A 
fluorophore’s lifetime can be sensitive to its binding state or local environment and therefore can be 
used to monitor intracellular changes non-invasively in biological tissues.  
2.5 Fluorescence lifetime imaging microscopy (FLIM) 
FLIM refers to the acquisition of time resolved, fluorescence images acquired on the time scale of a 
fluorescence decay. Lifetimes are then typically displayed using a false colour map to provide 
spatially resolved lifetime information. The lifetime colour map is often merged with the 
fluorescence intensity image so as to provide both lifetime and intensity information. 
Experimental methods for FLIM can be divided into two categories– frequency domain or time 
domain. Both methods can provide equivalent information but require different equipment and 
analytical methods. 
2.5.1 Frequency Domain 
 
Figure 2.3 A diagram illustrating the changes measured in the excitation light with frequency domain FLIM. Key: A – 
amplitude of excitation light, B – amplitude of emitted light, φ - Phase shift angle  
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Frequency domain FLIM uses sinusoidally modulated excitation and requires the lifetime to be 
comparable to the reciprocal of the modulation frequency (ω) of the excitation wave. The phase 
shift angle (φ) in the frequency OR the reduction in intensity modulation ( =(B/b)/(A/a)) between 
the excitation and emission light (see figure 2.3) can then be used to calculate the lifetime using the 
following equations (2.4) in the case of a single exponential decay. 
         
   (   
    )           Equation 2.4. 
For samples with multiple lifetimes it is necessary to measure the phase shift angle and intensity 
modulation over a range of modulation frequencies (Lakowicz 2006). 
2.5.2 Time Domain 
Time domain FLIM uses a femtosecond, pulsed laser light source and measures the change in 
fluorescence intensity as a function of time following the excitation pulse. The fluorescence lifetime 
is then calculated by performing a fit to the measured decay data. Two techniques are used. 
 
 
Figure 2.4 A schematic illustrating widefield time domain FLIM. Key: GOI – Gated optical intensifier. 
Widefield time domain FLIM gives a high lifetime accuracy in a given acquisition time by acquiring 
the fluorescence intensity from whole field of view as a single image using a gated optical intensifier 
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(GOI) to act as a fast shutter and a CCD camera, see figure 2.4. Sequential images taken with varying 
time delays from the excitation pulse, using a time delay generator attached to the GOI, create time 
gated images. These can then be used to track the decay of the fluorescence in every pixel of the 
image simultaneously and allow a lifetime to be fitted to each pixel. Typical gate widths vary from 
100-1000 ps while the gate separation is chosen to cover the range of the fluorescence decay. 
 
Figure 2.5 A schematic illustrating time correlated single photon counting FLIM. 
Time Correlated Single Photon Counting (TCSPC) is the most common method of time domain FLIM 
and gives the highest lifetime accuracy per detected photon. It is usually implemented on confocal 
or multiphoton scanning microscopes and therefore collects the fluorescence from single pixels at a 
time. As illustrated in figure 2.5, the electrical signals from the pulsed light source and single photons 
detected by the PMT are passed through CFDs. The time difference between them is then converted 
into a voltage by the time to amplitude converter (TAC) and recorded. This technique can only 
detect a single photon per excitation pulse. Therefore, unless the excitation power is sufficiently low, 
further emitted photons are not detected which biases the measured lifetimes towards shorter 
lifetimes. The excitation power is therefore set below this power threshold and so the maximum 
count rate for the equipment is not exceeded over the imaging time period. This is typically set to 
produce a maximum of one single detected photon for every 100 excitation pulses (Lakowicz 2006).  
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As the focal point is scanned across the field of view, a histogram of photon arrival times is 
constructed. The lifetime is then calculated for each pixel by fitting an appropriate decay model to 
the decay histograms. 
2.6 Tissue Autofluorescence 
A number of endogenous molecules in living cells fluorescence. Although their fluorescence tends to 
be weaker in intensity than exogenous fluorophores, their advantage is that information can be 
recorded in biological systems and organisms without the need to administer exogenous labels and 
without the need to consider associated safety issues and pharmokinetics perturbing their 
homeostatic state. The addition of exogenous fluorophores into live cells can alter cell physiology 
and protein expression, sometimes creating uncertainty whether findings truly represent biological 
phenomena or are artefactual. 
Below is an introduction to the main tissue fluorophores found in skin that can be imaged using MPT 
without the need for exogenous contrast agents. These include collagen, elastin, melanin, keratins, 
porphyrins, NAD(P)H and flavins. Figure 2.6 illustrates the absorption spectra of these proteins, 
which is adapted from Wagnieres et al. (Wagnieres, Star et al. 1998). Emission spectra from these 
fluorophores and the spectral channels into which their fluorescence would be collected using the 
modified DermaInspect® used in this project (see chapter 4.4, pp89) can be seen in figure 2.7 
These spectra of complex proteins such as collagen, elastin, melanin and keratin vary between 
published sources because the fluorescence emission spectra and lifetimes will vary on how the 
proteins were prepared and their local environment. Also, NADH and flavins are known to shift their 
emission spectra and change lifetime when bound to enzymes. Therefore, a purified solution may 
have a slightly different fluorescent signature compared to when it has been fixed for histological  
tissue sections or measured in a live biological system. In addition, measurements made directly 
from tissue (in vivo or ex vivo) often contains fluorescence from other fluorophores as pure 
fluorophores rarely exist in isolation. 
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Figure 2.6 Excitation spectra adapted from (Wagnieres, Star et al. 1998) 
 
Figure 2.7- Emission spectra from fluorophores found in the skin. Adapted from (Wagnieres, Star et al. 1998; Palero, de 
Bruijn et al. 2007). Reprinted from Biophysical Journal 93(3): 992-1007.Palero, J. A., H. S. de Bruijn, et al. (2007). Spectrally 
resolved multiphoton imaging of in vivo and excised mouse skin tissues. Pages No. 1002, Copyright (2007), with permission 
from Elsevier. 
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Two studies have measured complete excitation-emission matricies (EEMs) for purified 
fluorophores. DaCosta et al. performed this using single photon excitation (DaCosta, Andersson et al. 
2003), and Yu et al. (Yu, Lee et al. 2012) performed a similar study using multiphoton excitation.  It 
has been shown that the single photon  and two photon excited emission spectra are similar for  
NAD(P)H and flavins  by  Kierdaszuk et al. (Kierdaszuk, Malak et al. 1996) and Huang et al. (Huang, 
Heikal et al. 2002) respectively. However Teuchner et al. demonstrated a red shift in the emission 
spectrum of melanin in solution using two photon excitation compared to single photon excitation 
(Teuchner, Freyer et al. 1999), see figure 2.8 below. 
 
Figure 2.8 Fluorescence spectrum of melanin dissolved in DMSO. Solid curve – single photon excitation at 400 nm. Line 
with dots- two photon excitation at 800 nm. Reproduced from Teuchner et al. (Teuchner, Freyer et al. 1999). 
2.6.1 Keratin 
Keratins are structural proteins in the Intermediate Filament (IF) family and found mostly in the 
epidermis in the skin, hair and nails. The basic structural unit consists of dimers between acidic (Type 
I) and basic (Type II) keratin Intermediate Filaments. These polymerise into fibrils of increasing size. 
The structural and chemical properties depend on which acidic and basic subunits are paired. The 
expression of the intracellular keratins by the keratinocytes alters with migration from the basal 
layer towards the s.corneum in normal skin and in pathological states. For instance Type 14 and 5 
keratin IF are expressed in the basal layer, type 10 and 1 in the s.spinosum and Type 11 and 2 are 
expressed in the s.granulosum. Following terminal differentiation and apoptosis of the 
keratinocytes, the s.corneum has a high concentration of keratin (Fuchs and Cleveland 1998; Fuchs 
2008). It therefore fluoresces brightly in comparison to other intracellular fluorophores in the 
s.corneum. 
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Keratin autofluorescence varies with its local environment. Pena et al. (Pena, Strupler et al. 2005) 
studied the excitation and emission spectra from purified human epidermal keratin (intracellular 
keratins) dissolved in urea and sections of formalin fixed skin using both single and multiphoton 
excitation.  The keratin solution demonstrated a main absorption peak at 277 nm and another at 210 
nm in its absorption spectrum with single photon excitation. The absorption spectrum measured in 
solution using two photon excitation was significantly broader, with a peak at ~700 nm and reducing 
with wavelength to ~950 nm.  
A fluorescence emission peak at 382 nm was found with single photon excitation when excited at 
277 nm and was consistent with that of Kollias et al. who illuminating intact s.corneum with a xenon  
lamp at 295 nm and measured fluorescence in the range of 340-400 nm (Kollias, Zonios et al. 2002). 
Sterenborg et al. also excited healthy skin in vivo using volunteers but at  375 nm excitation 
wavelength from a filtered xenon arc lamp via a fibre optic cable (Sterenborg, Motamedi et al. 1994). 
They found a spectral peak at a longer wavelength than above of 435 nm and concluded that this 
was from keratin from the s.corneum because the fluorescence intensity significantly reduced 
following tape stripping of the skin. 
 
Figure 2.9 Fluorescence emission spectra from keratin solution when excited by TPE at varying wavelengths between 750-
900 nm. Reproduced from Pena et al. (Pena, Strupler et al. 2005) 
Pena et al. used TPE with various excitation wavelengths to study fluorescence from keratin solution 
and measured the emitted fluorescence spectrum, shown in Figure 2.9 (Pena, Strupler et al. 2005). It 
shows that the peak emission shifts towards longer wavelengths as the excitation wavelength is 
increased. At 760 nm excitation wavelength (used with our system) a peak around 475 nm was seen. 
This correlated well with an emission peak at 477 nm measured using the same excitation 
wavelength from the extracellular keratin in the s.corneum from fixed sections of normal skin also by 
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Pena et al. Palero et al. also used human epidermal keratin in solution to record a spectral peak at 
~465 nm using 764 nm excitation (Palero, de Bruijn et al. 2007). 
The lifetime for pure keratin can be fitted using a monoexponential decay model with a lifetime of 
1.4  ns (Ehlers, Riemann et al. 2007). Ehlers et al. also found that hair keratins had more complex 
decays which varied with hair colour. Breunig et al. recorded the lifetime from the s.corneum in vivo 
from human skin using an excitation wavelength of 720 nm. Fluorescence was filtered through a 
BG39 filter (~345–605 nm 50% transmittance) and the lifetime was fitted to a double exponential 
decay model with resulting lifetime components of τ1=200 ps and τ2=2600 ps. 
2.6.2 Collagen 
Collagen is a structural protein that is produced by fibroblasts and found mainly extracellularly in the 
dermis of the skin but can also be found in other connective tissues such as tendons, ligaments and 
cartilage. Currently 28 types of collagens exist which vary in their helical composition and post 
translational modification. Type I and III fibrillary collagen are found in the dermis, type IV and VII 
and XVII collagen can be found around the basement membrane between the epidermis and dermis 
and around blood vessels. Type I fibrillar collagen accounts for ~80% of the dermal collagen and is 
formed from a triple helix of two α1 (I) chains and a single α2 (I) chain in which every third amino acid 
is a glycine. Type III collagen accounts for ~15% and consists of three α1 (III) chains and can increase 
to account for ~25% of dermal collagen with photoaging (Lovell, Smolenski et al. 1987; Brinckmann, 
Açil et al. 1995).  
Lutz et al. have characterised the differences in fluorescence with the collagen subtype using MPT 
(Lutz, Sattler et al. 2012). They excited rat tail derived type I and placental derived type III collagen in 
vitro using a DermaInspect® at 750 nm and collected fluorescence between 400-700 nm. SHG signals 
were collected using 820 nm excitation wavelength and a 410 nm long pass filter. They found that 
both collagen types had similar emission spectra with a peak ~460 nm, see figure 2.10 a. In contrast, 
previous studies of collagen have found an emission peak around 420 nm for type I collagen derived 
from calf skin and 385 nm for placentally derived type III when excited at 337 nm i.e. using single 
photon excitation (Marcu, Cohen et al. 2000).  
The difference in the emission spectra found between the groups may be caused by the source and 
experimental conditions of the samples being measured. For example the placental collagen varied 
in purification method between sources. 
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Figure 2.10 a) Fluorescence Intensity of purified collagen type I and III. b) Fluorescence lifetime mixtures of collagen type I 
and III. Reproduced from Lutz et al. (Lutz, Sattler et al. 2012) 
Lifetimes were fitted by Lutz et al. using a double exponential decay model (Lutz, Sattler et al. 2012). 
A τmean of 2466 ps was found for type I collagen, and ~2400 ps for types II and and IV using collagen 
manufactured by Abcam® (UK) when excited at 750 nm. When collagen type I & III manufactured by 
Sigma-Aldrich® (USA) was tested, a lifetime between 2060-2295 ps was obtained. When varing 
proportions of type I and type III collagen (from Sigma-Aldrich®) were mixed, a linear reduction from 
2295 – 2060 ps in lifetime was found as the proportion of type III collagen was increased, see figure 
2.10b.  
When using MPE collagen can both emit fluorescence and a much stronger signal by second 
harmonic generation (SHG) as it is a non-centrosymmetric molecule. Lutz et al. also found that the 
intensity of the SHG signal reduced with an increasing ratio of collagen Type III:Type I and increased 
collagen crosslinking (Lutz, Sattler et al. 2012). 
The lifetimes calculated for collagen type I and III by Lutz et al. are in broad agreement with those 
found by Marcu et al. Marcu et al. measured a lifetime of  τ1=0.9 ps, τ2=5 ns with a1 of 0.65 when 
excited at 390 nm (τmean=2335 ps) for collagen I and τ1=~1.3 ns, τ2=~6.75 ns with a1 of 0.525 when 
excited at 390 nm (τmean=3880 ps) for type III collagen (Marcu, Cohen et al. 2000).  
The clinical significance of the change in lifetime with ratio of collagen subtypes is uncertain. From 
the data presented by Lutz et al. the 10% change in ratio between collagen subtypes (that could be 
expected with photoaging) would result in a 25 ps change in lifetime and no detectable change in 
the emission spectra. 
2.6.3 Elastin 
Elastic fibres can be found in the extracellular space in the dermis. They consist of about 2-4% of the 
dermis and consist of elastin and elastin associated microfibrils. Together they provide elastic recoil 
and tensile strength to the skin (Kielty, Sherratt et al. 2002; Burns, Breathnach et al. 2010).  
(a)
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The fluorescence properties of elastin have been studied by a number of groups using a number of 
sources. The emission spectra  of Bovine neck ligament elastin was found to have a peak at ~500 nm 
when excited at 764 nm (Palero, de Bruijn et al. 2007). The same group also found the fluorescence 
from dermal elastin from mouse skin in vivo to be similar. Pena et al. measured the fluorescence 
from elastin powder derived from human aorta at 760 nm and recorded an emission spectrum peak 
at ~ 445 nm. (Pena, Strupler et al. 2005). The same group also imaged the dermis of a sample of 
formalin fixed normal skin. When excited at 760 nm, a broad emission spectral peak at 471 nm was 
recorded and attributed to elastin fluorescence with weaker contributions from the fibroblasts and 
collagen. 
Maarek et al. measured the lifetime from elastin derived from bovine neck ligament (Maarek, Marcu 
et al. 2000). They found little difference in its lifetime between its dry and hydrated form when 
excited over a range of wavelengths using single photon excitation. They used a double exponential 
decay model and calculated at τ 1 1.3 ns, τ2 5.7 ns with f1 of 0.63 when exciting at 390 nm for dry 
elastin. This did not change significantly with hydration. From the values in the paper a τmean between 
2.93 and 3.08 ns can be calculated for dry and hydrated elastin respectively for this excitation 
wavelength.  
Several years later, Fang et al. (affiliated with Marcu et al.) calculated a τmean of 2.05 ns for elastin 
derived from human aorta when excited at 380 nm. They measured a similar τ1 1.5 ns, τ2 5.84 ns and 
τmean of 2.11 ns averaged over emission wavelengths 380-520 nm (Fang, Papaioannou et al. 2004). 
2.6.4 Melanin 
Melanin is synthesized by melanocytes in a number of organs including the inner ear, iris of the eye 
and the skin.  Within the epidermis, melanocytes can be found evenly spaced along the basement 
membrane. They can also be aligned adjacent to each other along the basement membrane to form 
junctional naevi or in nests in the dermis to form intradermal naevi. The malignant transformation of 
naevi gives rise to melanoma and has been discussed in Chapter 1.3.3 (pp32). 
The 2 melanin pigments found in the skin are eumelanin which is brown/black in colour and 
pheomelanin which is yellow/red. Both are derived through the oxidation of tyrosine by tyrosinase 
and packaged into intracellular organelles called melanosomes. These are then distributed by the 
melanocytes to their surrounding keratinocytes in the epidermis to confer the nucleus of the cells 
protection against UV light. Both types can be found in benign naevi and melanomas but the ratio of 
eumelanin to pheomelanin can increase in malignancy (Marchesini, Bono et al. 2009). It has been 
difficult to characterise the 2 types of melanin using conventional light or fluorescence microscopy 
because neither are found in their pure form biologically, their absorption spectra are similar and 
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their in vivo structure, which affects their fluorescence characteristics, have not been possible to 
reproduce. Recently however Matthews et al. have  used a non-linear optical pump-probe method 
to distinguish the pigments from fixed, sections from pigmented skin lesions (Matthews, Piletic et al. 
2011). 
The absorption spectrum of synthetic melanin (most similar to eumelanin) reduces with wavelength 
between ~250nm to 800nm. The emission spectrum of synthetic melanin is broad with a spectral 
peak at 550 nm (Teuchner, Freyer et al. 1999; Palero, de Bruijn et al. 2007). Recently, Krasieva et al. 
attempted to distinguish the emission spectra between eumelanin and pheomelanin in their in vivo 
state by imaging black, red and grey hair using MPM spectroscopy (Krasieva, Stringari et al. 2013). 
They assumed that the emission spectrum from grey hair arises from keratin only with the addition 
of eumelanin from black hair and pheomelanin from red hair. They subtracted the keratin spectrum 
and were able to distinguish the emission spectra between the melanin types when excited at 1000 
nm, see figure 2.11. This figure demonstrates a longer emission peak than that found with synthetic 
melanin and with a peak between 615-625 nm for pheomelanin and 640-680 nm for eumelanin. 
 
Figure 2.11 Emission spectra from eumelanin and pheomelanin from hair using MPM spectroscopy. Reproduced from 
(Krasieva, Stringari et al. 2013). 
Dancik et al. further showed that the fluorescence intensity of melanin increased linearly with 
melanin concentration in solution (Dancik, Favre et al. 2013).  
The fluorescence lifetime from melanin has been measured by a number of groups and been 
summarised in the paper by Dancik et al. (Dancik, Favre et al. 2013). A tri-exponential fluorescence 
decay lifetime model was found to provide the best fit with lifetimes components (and 
contributions) of 0.2 (0.56), 1.5 (0.32) , 5.8ns (0.11) (Teuchner, Freyer et al. 1999). This gives a 
calculated τmean of 1.23 ns. 
Eumelanin
Pheomelanin
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In vivo eumelanin forms complex granules intracellularly with aggregates of varying molecular 
weight. Nofsinger et al. confirmed that the absorption spectrum of eumelanin from Sepia officinalis 
was broad, ranging from the UV through the visible wavelength range (see figure 2.12 a) and was 
affected by the molecular weight of the granule aggregates. The emission spectrum was less 
affected by the molecular weight when excited at 375 nm (Nofsinger and Simon 2001). This study 
found an emission peak closer to 450 nm rather than the peak near 550 nm previously reported. 
They suggested that the difference could be explained by the polymerisation and oxidization status 
of the melanin being examined. 
 
Figure 2.12. a) Changes in absorption spectra of eumelanin from S. officinalis with molecular size. b) Changes in emission 
spectra of eumelanin with molecular size when excited at 375 nm. Key: Molecular Weight (MW) >10 000 (solid), 10 
000>MW>3000 (dot), 3000> MW>1000 (short dot) and MW< 1000 (dash). Reproduced from (Nofsinger and Simon 2001). 
This group also fitted the lifetime of eumelanin using a multi-exponential decay lifetime model but 
used four exponential components which they considered related to the molecular size of the 
aggregate (<1000, >10,000 molecular weight). Their calculated lifetime components (and 
contributions) were τ1= 121-144 (0.03-0.05) ps, τ2= 800-960 (0.14-0.15) ps, τ3= 5.03-5.37 ns (0.29-
0.3) and τ4= 11.8-12.8 ns (0.51-0.53). This gives a calculated τmean of 8.06 ns. 
As discussed above, Krasieva et al. separated the emission spectra between the types of melanins 
using hair. They demonstrated a difference in the fluorescence lifetime between eumelanin and 
pheomelanin on phasor plots using phasor FLIM analysis (Krasieva, Stringari et al. 2013) and their 
lifetimes were distinct from those of free and protein bound NADH. 
2.6.5 NAD(P)H 
NADH and NADPH are the reduced forms of two nucleotide molecules involved in redox reactions in 
cellular metabolism. 
a) b)
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NADH is derived from nicotinic acid, is a key co-enzyme in the oxidation of glucose to pyruvate in 
glycolysis and is involved in the Citric acid cycle/electron transport chain (part of cellular oxidative 
respiration) in the mitochondrion during the synthesis of ATP. Within the cell NADH acts primarily as 
a reducing agent and therefore the oxidised state (NAD+) predominates. 
NADPH binds to several enzyme complexes that are diverse in function. For example, it is involved in 
the anabolic synthesis of lipids and cholesterol, conversion of pyruvate to lactate and the generation 
of free radicals in cells of the immune system.  In contrast to NADH, it acts primarily as an electron 
donor in the cell and therefore the reduced state (NADPH) predominates.  
 Although NADH and NAD(P)H serve different functions within the cell, their fluorescence profiles 
(i.e. absorption, emission and lifetimes) are similar. Both NADH and NADPH only fluoresce at ~ 450 
nm in their reduced state and spectroscopically are typically considered together as NAD(P)H. 
However, the fluorescence of NADH dominates. It is found in greater concentrations within the cell 
(x5) and has higher quantum efficiency than NADPH (Avi-Dor, Olson et al. 1962; Wang, Wei et al. 
2009).  
At an excitation wavelength of 760 nm, NAD(P)H has an emission spectral peak between 450-470 nm 
(König and Schneckenburger 1994; Palero, de Bruijn et al. 2007). 
In aqueous solution, a double exponential decay can be fitted with a τ1=0.35 and τ2= 0.76 ns, with a 
τmean of 444 ps (Vishwasrao, Heikal et al. 2005). Skala et al. fitted a double exponential decay to 
NAD(P)H fluorescence measured from cheek epithelium and attributed the short component to free 
NAD(P)H (τ1=0.29) and the long component to protein bound NAD(P)H  (τ2= 2.03 ns (f2=0.37)), with a 
τmean of 934 ps (Skala, Riching et al. 2007).  
Lakowicz et al. was the first group to perform lifetime imaging of NADH. They determined that 
enzyme bound NADH had a longer lifetime than its free form (Lakowicz, Szmacinski et al. 1992). 
When Vishwasrao et al. measured the fluorescence lifetime in hippocampal tissue and fitted it using 
a quadruple exponential decay model, decay components ranging from 155ps to 6.04ns (τmean948ps) 
were calculated. In conjunction with fluorescence anisotropy measurements, the shortest and 3 
longer components were attributed to free and protein bound NADH respectively (Vishwasrao, 
Heikal et al. 2005). 
2.6.6 Flavins 
Flavins are co-enzymes derived from riboflavin and are involved in oxidation/reduction reactions in 
the cell. They act as electron carriers for redox reactions in the Citric Acid Cycle and the electron 
transport chain within the mitochondrion. The most studied fluorescent flavins are the co-enzymes 
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flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). In their oxidised form the 
fluorescence arise from their isoallozazine ring. However their reduced forms are not fluorescent. 
This distinction can be used to monitor changes in intracellular metabolism.  
The flavins have a broad absorption spectrum between 200 and 500 nm with an emission peak at 
525nm (König and Schneckenburger 1994; Palero, de Bruijn et al. 2007).  
Free FMN has been found to have a monoexponential decay lifetime between 4.6 -5.2 ns (König and 
Schneckenburger 1994; Yang, Luo et al. 2003) with protein bound FMN having a faster, 
multiexponential lifetime decay. For example, Yang et al. used four lifetime components to best fit 
the decay for protein (enzyme) bound FMN, which were 8 ps (19%), 50 ps (39%), 250 ps (39%) and 
4.5 ns (3.6%), with a τmean of 281 ps (Yang, Luo et al. 2003). They also fitted protein bound FAD using 
four similar lifetime components, which were 28 ps (25%), 200 ps (52.1%), 460 ps (21.5%) and 3.3 ns 
(1.2%), with a τmean of 250 ps. This lifetime is longer than that determined in 1980 by Nakashima et 
al. They found monomeric and dimers of protein (enzyme) bound FAD to have a mean lifetime of 
130 ps and 40 ps, whilst free FAD had a lifetime of 2.3 ns (Nakashima, Yoshihara et al. 1980). 
2.6.7 Porphyrins 
The porphyrins consist of a family of proteins derived from the tetrapyrrole molecule- porphyrin. 
They are found as intermediate metabolic products during the synthesis of haem. The most 
important ones are protoporphyrin IX, coproporphyrin III, uroporphyrin III and haematoporphyrin IX. 
Once haem is bound to iron in haemoglobin, its fluorescence is quenched and therefore cannot be 
detected. Normally the concentration of these molecules is low and the only detectable 
fluorescence from porphyrins in mammals arise from chlorophyll when a diet rich in plants has been 
ingested and from phototrophic bacteria, such as Propionibacterium acnes, that colonise sebaceous 
glands of the skin. The presence of porphyrins in these bacteria, that aggravate acne vulgaris, can be 
targeted by photodynamic therapy to improve acne. 
In pathology affecting this metabolic pathway, such as congenital enzyme defects (porphyrias) or 
acquired defects or malignancy, porphyrins can be detected in the skin, blood or internal organs. 
Red fluorescence from porphyrins arising  from malignancies was first detected by Policard et al. in 
1924 (Policard 1924). Protoporphyrin IX was later isolated as the main fluorophore found in 
squamous cell carcinomas (Ghadially and Neish 1960). 
Exogenously applied topical precursors to porphyrins, such as 5-aminolevulinic acid are used for 
photodynamic therapy in skin cancers. This photosensitising drug is preferentially taken up by 
rapidly proliferating cells such as malignant cells.  This artificially increases their intracellular 
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concentration of protoporphyrin IX and means that phototherapy can act preferentially on 
malignant tissue. This technique has used been for photodetection of tumour margins but still 
remains an area for research as current studies have had mixed results for the assessment of BCC 
margins (Wetzig, Kendler et al. 2010; Sandberg, Paoli et al. 2011; van der Beek, de Leeuw et al. 
2012). 
The absorption spectrum of porphyrins consists of 4 peaks, the Soret band at 400 nm and four 
smaller Q-bands ranging from 500-630 nm. Its fluorescence emission spectrum peaks between 624-
633 nm, depending on the porphyrin. For example, when excited at 407 nm protoporphyrin IX was 
found to have a fluorescence peak at 633 nm whilst coproporphyrin had its peak at 632 nm (König, 
Flemming et al. 1998).  
The fluorescence lifetime of protoporphyrin IX following incubation with the photosensitiser 
aminolaevulinic acid, measured in vivo from a chick embryo model, was found to have 2 lifetime 
components when excited at 390 nm. A dominant long lifetime component of ~19 ns (a2=0.9) was 
thought to be from the Protophorphyrin IX, whilst the short lifetime component of 5.2 ns (a1=0.1) 
was thought to arise from photoproducts (Schneckenburger, König et al. 1993). This has been used 
by Cubeddu et al. to enhance the lifetime of BCCs compared to normal skin in FLIM images acquired 
in vivo (Cubeddu, Comelli et al. 2002) 
2.6.8 Lipofuscin 
Lipofuscin is an intracellular pigment that has been found in a number of organs of the body, 
including the brain, heart, liver and retina. It consists of an aggregate of granules that can arise from 
the phagocytosis of degraded lipid from organelles. In the skin,  it is most visible in solar lentigenies  
(Berezin 2010) but can also arise as a result of amiodarone drug therapy for cardiac arrhythmias 
(Weedon 2002). 
Lipofuscin has an excitation spectrum between 440-470 nm, with an emission spectrum between 
510-700 nm (Schweitzer, Schenke et al. 2007). This falls within the excitation wavelength range of 
the DermaInspect®, with the emission spectrum expected to fall within the yellow and red spectral 
channels.  
Schweiter et al. have measured the emission spectra and lifetimes from fluorophores found within 
the retina of a healthy volunteer (Schweitzer, Schenke et al. 2007). They used an excitation 
wavelength of 468 nm and fluorescence was collected between 510-700nm and fitted using a tri-
exponential decay model. τ1= 190ps was attributed to the pigmented retinal epithelium (dominated 
by lipofuscin), τ2=750 ps to the neural retinal and τ3 = 3550 ps to connective tissue and the lens. 
 62 
 
2.6.9 Amino Acids 
Only tryptophan, tyrosine and phenylalanine autofluoresce with emission wavelengths above the 
ultraviolet range (>300 nm). Tryptophan emits its fluorescence in the range 340-380 nm. It has 2 
lifetime components of ~0.5 ns and ~3 ns, although the longer lifetime component becomes 8.7 ns in 
alkaline environments (Ross and Jameson 2008).  
Both phenylalanine and tyrosine have poor quantum yields and therefore are often swamped by the 
signal from tryptophan. 
2.7 Dynamic Changes of Cellular Autofluorescence 
2.7.1 Changes with Metabolism 
As outlined above, the intracellular fluorophores NAD(P)H and flavins are co-enzymes involved in 
oxidation/reduction reactions in the citric acid cycle and electron transport chain, part of cellular 
oxidative respiration. The proportion of each co-enzyme in the oxidised or reduced state therefore 
can be used as an indirect measure of the redox state i.e. the metabolic state of a cell. As the 
fluorescence of NAD(P)H and flavins are confined to their reduced or oxidised state respectively, 
measuring their fluorescence emission allows the opportunity to gain an insight into the metabolic 
state of cells non-invasively and in vivo. In 1979, Chance et al. defined the Redox Ratio as FAD / 
(NAD(P)H +FAD). He suggested that this ratio was a more reliable indicator of cellular metabolism 
than measuring the absolute amounts individually  (Chance, Schoener et al. 1979). A reduced ratio 
indicated an increased metabolic state and vice versa.  Since this time NADH fluorescence 
individually and the redox ratio have been studied extensively and are reviewed elsewhere 
(Mayevsky and Rogatsky 2007; Wang, Wei et al. 2009).  
It has also be found that changes in the fluorescence lifetimes of NAD(P)H, arising from changes in 
the ratio of free to bound protein, could also be used to assess intracellular hypoxia, cell necrosis 
and malignancy. For example, Vishwasrao et al. measured the lifetime of NADH from slices of brain 
tissue and fitted its decay using four components. When using chemically induced hypoxia, they 
found a decrease in proportion of the longer lifetime components of NADH (reflecting decrease 
protein binding) and a shortening of all lifetime components (resulting in a reduced τmean from 948 to 
780 ps)(Vishwasrao, Heikal et al. 2005). Wang et al. used HeLa and 143B osteosarcoma cell lines in 
vitro to determine differences in lifetime between induced cell apoptosis (using staurosporine) and 
induced cell necrosis (using hydrogen peroxide). They found an increase in lifetime from 1.3 to 3.5 ns 
at the start of apoptosis but no increase when cell necrosis was induced (Wang, Gukassyan et al. 
2008).  
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2.7.2 Changes with Malignancy 
Changes in intracellular autofluorescence are also associated with the metabolic changes that occur 
with malignant transformation of cells. Under normal conditions non-dividing, differentiated cells 
use aerobic glycolysis and oxidative phosphorylation to synthesis ATP in the presence of oxygen for 
their energy requirements. In the absence of sufficient extracellular oxygen anaerobic glycolysis is 
used instead to generate ATP. However this process is less efficient for the production of ATP, 
generating 2 vs 36 molecules of ATP per glucose molecule.  
Warburg et al. noticed that proliferative tissues, including tumour cells, favour anaerobic glycolysis 
to generate ATP, despite the presence of sufficient oxygen (Warburg, Wind et al. 1927; Warburg 
1956). The exact reasons for this “Warburg Effect” are still speculative but  may arise from cancer 
cells favouring the accumulation of nutrients into the cell in anticipation of cell division over efficient  
energy production (Vander Heiden, Cantley et al. 2009).  This switch to anaerobic glycolysis is 
thought to occur in malignant cells before characteristic morphological/histological changes are seen 
and therefore presents the opportunity to detect malignant transformation early. 
An important paper linking the change in metabolism associated with malignancy to changes in 
cellular autofluorescence was published by Skala et al. in the Journal of Biomedical Optics. They 
measured the fluorescence lifetimes from epithelial cells in a hamster cheek pouch in vivo. The 
lifetimes were fitted using a double exponential decay model and τ1 and τ2 were calculated as 0.29 
and 2.03 ns in normal epithelium and attributed to the free and protein bound states of NADH 
respectively (Skala, Riching et al. 2007). Chemically induced dysplasia/ in situ carcinoma was 
associated with a decrease in τ2 (from 2.03 to 1.83 ns) caused by a decrease in protein bound 
NADH:free NADH ratio, and hence a reduced contribution (α2). This therefore reduced the mean 
lifetime. They then inhibited aerobic glycolysis in vitro using a breast cancer cell line (MCF-10A) and 
replicated the shortening of τ2. From this they suggested that the decrease in protein bound NADH 
was associated with the switch from oxidative glycolysis/phosphorylation to anaerobic glycolysis for 
ATP production in dysplastic cells.  
Skala et al. published a 2nd paper in PNAS in 2007. In this they reported an increase in the variability 
in the redox ratio with dysplasia.  In high grade dysplasia, they also found an increase in τ1 for 
protein bound FAD but a decrease in its contribution (Skala, Riching et al. 2007). 
Lin et al. examined the changes in extracellular fluorescence associated with BCCs using formalin 
fixed sections of tissue (Lin, Jee et al. 2006). They correlated the remodelling of the extracellular 
matrix surrounding the tumour with a reduced SHG signal from collagen, in comparison to normal 
skin. 
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2.8 Conclusions 
In conclusion, this chapter has introduced the principles of fluorescence and the main methods for 
fluorescence lifetimes imaging are then briefly outlined. The following section describes the main 
fluorophores to be found in the skin and details their fluorescence characteristics. Finally the 
changes in fluorescence and fluorescence lifetime described with alterations in cellular in 
metabolism and malignancy are outlined. 
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Chapter 3. Literature Review of tissue autofluorescence lifetime 
spectroscopy and imaging. 
3.1 Introduction 
As described in Chapter 2.6 (pp50), the skin contains a number of endogenous fluorophores 
including extracellular structural proteins such as keratin, collagen and elastin and intracellular 
functional molecules, such as NAD(P)H, flavins and melanin. These provide opportunities to use 
autofluorescence lifetime to investigate contrast in both normal skin and changes caused by disease. 
Fluorescence lifetime measurements of human skin have been carried out using a wide range of 
instruments, from non-imaging fibre-optic probe-based point measurements using single photon 
excitation through to multiphoton microscopy and tomography providing sub-cellular resolution 
images.  
This chapter aims to review the current literature concerning fluorescence and fluorescence lifetime 
measurements of skin, with a focus towards investigations of skin cancer and the use of multiphoton 
microscopy (MPM). It is important to consider this field in the context of the extensive work on 
steady-state and spectrally resolved measurements of autofluorescence of human skin. A number of 
studies have shown that the autofluorescence characteristics of neoplastic skin differ from those of 
normal tissue. Detailed reviews of this existing work are discussed in several reviews, e.g. (Richards-
Kortum and SevickMuraca 1996; Wagnieres, Star et al. 1998; Ramanujam 2000; Zeng and MacAulay 
2003).  
The chapter is organised by the type of instrumentation used and the type of disease studied. The 
initial sections cover results employing single photon excitation, while sections 3.4 (pp69) onwards 
consider multiphoton imaging. 
3.2 Fibre optic point-based probes 
3.2.1 Spectroscopy  
Most of the studies cited in this section have discriminated between normal and neoplastic tissue by 
detecting differences in the measured steady-state fluorescence intensities or spectra using a point-
based spectrometer. 
Using point-based measurements in vivo, Lohmann et al. (Lohmann and Paul 1988) reported an 
increase in 366 nm excited autofluorescence intensity from the edges of melanomas with a strong 
peak at 475 nm not present in benign naevi in a study of 82 patients. Later work using the same 
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instrument was still able to contrast benign naevi from dysplastic naevi/melanomas using fresh 
frozen samples (n=147), but could not contrast dysplastic naevi from melanomas (Lohmann, Nilles et 
al. 1991). Chwirot et al. used a digital imaging approach with the same excitation wavelength and 
collecting autofluorescence at 475 nm. They used the perilesional and lesional fluorescence intensity 
to distinguish melanomas from common/dysplastic naevi (Chwirot, Chwirot et al. 1998). When this 
technique was used to screen melanomas in a multicentre trial, they found a sensitivity of 82.7% in 
detecting the 56 melanomas from 7228 pigmented lesions, and specificity of 24% for discriminating 
common/dysplastic naevi in the 568 cases in which histology was taken (Chwirot, Chwirot et al. 
2001). 
A number of groups have applied point spectroscopy of autofluorescence in basal cell carcinomas 
(BCCs) with broadband near-ultraviolet excitation (350-375nm).  Both Na et al. and Brancaleon et al. 
have reported that the autofluorescence intensity from BCCs at these excitation wavelengths is 
significantly lower than that from normal skin (Brancaleon, Durkin et al. 2001; Na, Stender et al. 
2001). It has been suggested that this may be due to the degradation of dermal collagen by BCC 
tumour matrix metalloproteinases, resulting in reduced collagen fluorescence from the upper 
dermis (Brancaleon, Durkin et al. 2001).  Conversely, Sterenborg et al. demonstrated no significant 
differences between the autofluorescence from BCCs and normal skin (Sterenborg, Motamedi et al. 
1994). Other groups have successfully used longer (410-440nm) (Panjehpour, Julius et al. 2002; Zeng 
and MacAulay 2003) or shorter (295nm) (Brancaleon, Durkin et al. 2001) wavelengths of excitation 
light to differentiate BCCs from normal skin. 
The group of Tunnel et al. (Rajaram, Aramil et al. 2010) have applied an instrument combining 
diffuse reflectance spectroscopy and fluorescence spectroscopy to the study of non-melanoma skin 
cancers. The diffuse reflectance spectroscopy provided information on blood volume fraction, 
oxygen saturation, blood vessel size, tissue micro-architecture and melanin content and the 
fluorescence spectroscopy used excitation at 337 nm and 445 nm to provide native fluorophore 
contributions of NADH, collagen and FAD. This instrument was used to study non-melanoma skin 
cancer in 48 lesions from 40 patients and demonstrated differentiation of basal cell carcinomas from 
normal skin with a sensitivity and specificity of 94% and 89% respectively (Rajaram, Reichenberg et 
al. 2010). 
Although fluorescence intensity measures were used to distinguish normal from neoplastic skin in 
the studies described above, fluorescence intensity measurements are sensitive to fluctuations in 
excitation intensity, tissue scattering and absorption and are difficult to quantify and compare 
between samples. The spectrally-resolved measurements provided additional information in these 
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studies, but fluorescence emission spectra of many tissue fluorophores are broad and overlap 
significantly (Cubeddu, Pifferi et al. 1999).  
3.2.2 Fluorescence lifetime  
Autofluorescence lifetime measurements provide a further opportunity to contrast different tissue 
fluorophores for different disease states, beyond those provided by fluorescence intensity and 
spectral measures. The following studies have primarily measured fluorescence lifetimes from 
normal skin, skin from diabetics and from BCCs.  
Pitts and Mycek developed a fibre-optic point-probe device able to collect spectrally and temporally 
resolved fluorescence decays and this instrument was applied to measurements of human skin 
autofluorescence in 2001 (Pitts and Mycek 2001). The forearm from a healthy volunteer was excited 
using light from a pulsed nitrogen laser at 337 nm with a repetition rate of 10 Hz and fluorescence 
was collected above 460 nm. Fluorescence decays were fitted using a double exponential decay 
model, which yielded decay components τ,τ and τ2 of 0.938 ns and 5.3 ns respectively from the skin 
surface, which were thought to be compatible with the expected fluorescence decay of collagen. 
In 2006 Katika et al. (Katika, Pilon et al. 2006) used a pulsed LED excitation source at 375 nm and 
collected the fluorescence decays using time correlated single photon counting (TCSPC) in 4 emission 
bands between 442-496 nm. Their aim was to compare differences in the fluorescence lifetime with 
age, sex and skin type. The skin from both palms was recorded from 35 volunteers and various body 
sites were examined in one patient. A tri-exponential decay model was used to analyse the data and 
decay components at 0.4, 2.7 and 9.7 ns were observed with the 442 nm emission filter. Whilst the 
two shorter fluorescence decay components were thought to be due to NAD(P)H, the longest 
component was postulated to arise from advanced glycation end-products, which are described in 
the following paragraph. The authors found no correlation of the fluorescence lifetime with skin 
type, gender or age. 
Advanced glycation end products (AGEs) are the final product of chemical reactions between sugars, 
proteins, lipids and nucleic acids. Although these accumulate naturally with age, the rate increases in 
diabetics. Some AGEs, such as pentosidine, fluoresce and therefore there is the potential that 
fluorescence spectroscopy can be used for non-invasive monitoring of diabetics.  
Blackwell et al. (Blackwell, Katika et al. 2008) used the same fibre-optic probe instrument described 
by Katika et al. above to collect time-resolved fluorescence decays in vivo from the skin with the aim 
to screen for type 2 diabetes. Data was collected from the palms of 38 type 2 diabetic and 37 non 
diabetic patients in vivo and a triple exponential decay model was employed for the fluorescence 
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decay analysis. In normal skin, the decay component lifetimes of 0.5, 2.6 and 9.2 ns were calculated. 
The shorter two decay components were thought consistent with that of protein bound and free 
NADH respectively. No statistical differences in lifetime with age, gender, skin type or between the 
two patient populations were observed. They also made a comparison of the fluorescence decay 
from 18 diabetic patients with foot ulcers (a marker for microvascular disease) versus age-matched 
healthy controls. They showed a change in 1 (477 ps to 510 ps, p = 0.038) and both fractional 
components f1 (0.769 to 0.761, p = 0.012) and f2
 (0.196 to 0.217, p = 0.002). The authors speculated 
that the change was related to differences in the metabolic rate of the tissues, rather than the 
presence of AGEs. 
In 2007 De Beule et al. (De Beule, Dunsby et al. 2007) presented another point-based probe for 
measuring time (4096 time bins)  and spectrally resolved (16 spectral channels) fluorescence decays 
in skin. This instrument was used to measure the fluorescence from freshly excised lesions. Lesions 
were excited at both 355 nm and 435 nm using pulsed laser diodes and fluorescence decays were 
collected using TCSPC and were fitted using a double exponential decay model. The fluorescence 
lifetimes collected using 355 nm excitation showed little contrast between benign and malignant 
skin. However, excitation at 435 nm of basal cell carcinomas (BCCs) yielded a mean fluorescence 
lifetime (τmean) of 2.44 ns vs. 2.96 ns measured for surrounding uninvolved skin. Six samples allowed 
paired lesional and peri-lesional measurements, which showed a decrease in τmean of 620 ps for BCCs 
(p<0.03) using 435 nm excitation. Further spectrally resolved lifetime histograms for SCCs, naevi, 
melanomas and seborrhoeic keratosis were presented but there were insufficient patient numbers 
to support further statistical analysis.  
Thompson et al. (Thompson, Coda et al. 2012) applied similar equipment as De Beule et al. (except 
for the second laser wavelength being changed from 435 nm to 445nm) to measure the fluorescence 
from a number of lesions on the skin in vivo, including 10 BCCs. Consistent with the data collected by 
De Beule et al. from ex vivo samples, excitation at 355 nm did not show a consistent change in 
lifetime between normal skin and BCC. However, once again, when excited at 445 nm, they found 
that the spectrally averaged, intensity weighted τmean were consistently shorter for BCCs than paired 
peri-lesional normal skin (2240 ± 480 ps BCC vs 3130 ± 413 ps normal). This shift of 886 ps was 
statistically significant (p = 0.002) and greater than the average variability found in the surrounding 
normal skin of 175 ps. 
3.3 Wide-field FLIM of skin  
The studies described below have used wide-field FLIM to measure fluorescence images from the 
surface of the skin i.e. spatially resolved fluorescence lifetimes but not depth resolved. This allowed 
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variation in fluorescence lifetimes to be correlated with the clinical appearance of the skin and 
margins of a tumour. 
Galletly et al. (Galletly, McGinty et al. 2008) published work evaluating 25 freshly excised BCCs and 
their margins by collecting FLIM images from the tissue surface. Tissue was excited at 355 nm using a 
frequency tripled mode locked Nd:YVO4 laser with a repetition rate of 80 MHz and fluorescence was 
collected at wavelengths >375 nm and >445 nm using a wide-field time-gated FLIM system. Each 
pixel was defined manually as lesional or peri-lesional normal skin using the reflectance white light 
image and a single exponential decay was fitted to the data. Unlike many previous studies, e.g. 
(Brancaleon, Durkin et al. 2001), no consistent changes were seen in fluorescence intensity between 
normal and lesional skin. A significant difference was found in the fluorescence lifetime between 
BCCs and normal perilesional skin (means of 1.4 ns vs. 1.6 ns respectively, p<0.001). This contrasts to 
the studies discussed above by De Beule et al. (De Beule, Dunsby et al. 2007) and Thompson et al. 
(Thompson, Coda et al. 2012) who found no significant change in autofluorescence lifetime at this 
excitation wavelength. This may be explained by the differences in excitation/collection geometry 
between fibre-optic point-probe and wide-field imaging systems and the differences in detection of 
the wavelength bands employed.  
Wide-field FLIM has also been applied to skin following treatment with photosensitisers. In 1999, 
Cubeddu et al. (Cubeddu, Pifferi et al. 1999) and in 2000 Anderson-Engles et al. (Andersson-Engels, 
Canti et al. 2000) published studies investigating the potential to increase the contrast of 
fluorescence from BCC/SCCs by applying aminolevulinic acid (ALA) topically, which is a precursor to 
the fluorescent protoporphyrin IX and preferentially accumulates in cancerous tissue compared to 
normal tissue.  FLIM of the skin surface was implemented with excitation from a pulsed dye laser 
operating at 405 nm that provided sub-1 ns pulses. Subsequently an in vivo study of 48 lesions in 34 
patients (benign and malignant, mainly BCC) reported that, following application of ALA, tumours 
were found to have a longer lifetime of 18 ns compared to normal skin of 10 ns (Cubeddu, Comelli et 
al. 2002).  
3.4 Multiphoton imaging of normal skin 
The first publication of multiphoton imaging of human skin in vivo was published in 1997 by Masters 
et al. (Masters, So et al. 1997). This work contrasted autofluorescence spectra and lifetimes from 
images taken from two depths in the skin (0-50 μm and 100-150 μm), exciting fluorescence at 
730 nm and 960 nm using a tunable femtosecond pulsed Ti:Sapphire laser. An emission peak at 445-
460 nm consistent with that of NAD(P)H was found to dominate images at both depths when excited 
at 730 nm. When exciting at 960 nm, a spectral peak centred at 520 nm consistent with the emission 
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spectrum of flavins was found. Another peak at 450 nm was also found but its origin was not 
identified. Mean fluorescence lifetimes were calculated for each pixel using frequency domain FLIM 
and values ranging from 0.5 to 3 ns were observed. 
König et al. (Konig 2000; Konig, Wollina et al. 2002; König and Riemann 2003) developed a 
multiphoton tomograph (DermaInspect®, JenLab GmbH) capable of measuring both fluorescence 
intensity and lifetimes in optically sectioned images of skin both ex vivo and in vivo. A tunable 
modelocked Ti:Sapphire laser was used to excite the tissue and imaging with submicron lateral 
spatial resolution and TCSPC FLIM with 250 ps temporal resolution was implemented. In this initial 
work, ex vivo samples from a variety of dermatoses including psoriasis, naevi, a melanoma and 
fungal infection were studied and the forearms of two volunteers were also examined in vivo. The 
fluorescence decays acquired at each pixel were fitted to a double exponential decay model and the 
τmean of cellular autofluorescence was found to be in the range of 1.8-2.4 ns. The DermaInspect® 
instrument was subsequently CE marked for clinical use in vivo and currently remains the only 
commercially available multiphoton imaging device licenced for in vivo imaging of the skin. 
Koehler et al. (Koehler, Vogel et al. 2010) used the DermaInspect® to study epidermal thickness. 
Image depth stacks were acquired from the dorsal forearm and the dorsum of the hand in 30 
volunteers. Skin was excited at 800 nm and 2 spectral channels with filters were used to collect the 
SHG using a 400 nm band pass filter and the second channel collecting autofluorescence between 
410-490 nm. They described an objective method of distinguishing the levels in the skin using the 
number of photon counts per image of the autofluorescence and SHG signals. Using the peak in SHG 
signal to signify the papillary dermis, they used ~9000 images to calculate the epidermal thickness 
from the acquired image depth stacks. The dorsum of the hand was found to have thicker total 
epidermis, cellular epidermis and stratum corneum and higher depths of the papillary dermis than 
the forearm. No thickness differences were found with age. No significant variation was observed in 
the undulations of the dermo-epidermo junction with age.  
The same authors (Koehler, Zimmermann et al. 2011) also present a study of 30 patients with 
normal skin, discussing tissue morphology and quantifying three parameters for two different body 
sites (dorsal forearm and dorsum of the hand) in three age groups (young, mid-aged and old). The 
parameters investigated were the number of papillae per square millimetre, (in the stratum 
granulosum) the mean number of keratinocytes per unit area and the mean nuclear area. The total 
number of papillae was found to be significantly decreased in the old group compared with the 
young and keratinocytes were found to be smaller from the dorsum of the hand compared with the 
dorsal forearm. They also defined MPT features for distinguishing the layers in the epidermis (see 
 71 
 
figure 3.1). They defined the s.granulosum as consisting of relatively large cells with a dark nucleus 
and a granular cytoplasm with a strong fluorescence signal. The dark inter-cellular spaces in this 
layer appeared wider compared with the s.spinosum. The s.spinosum has small cells and the 
cytoplasm is more homogenous than the s.granulosum. The basal layer appears as a lattice of 
densely packed small, round, homogenously fluorescing cells, resulting in a ‘cobblestone’ pattern. 
The bright cytoplasmic fluorescence is from melanin and the lack of a visible nucleus in some cells is 
caused by the vertical orientation of the basal cells because of the basal position of the nucleus 
within the cell. In some sections, the cobblestone pattern is interrupted by round structures which 
correspond to the apices of the dermal papillae. 
 
Figure 3.1. MPT images taken from different layers in the epidermis of normal skin. Reproduced from Koehler et 
al.(Koehler, Zimmermann et al. 2011) 
3.4.1 Spectrally resolved MPM 
This section includes studies that use MPM to acquire depth resolved images from the skin that are 
spectrally resolved. 
Early spectrally resolved multiphoton imaging of the dermal layer of ex vivo human skin was carried 
out by Buehler et al. (Buehler, Kim et al. 2005) using a 16 channel multi-anode photomultiplier tube. 
It allowed the emission spectra from collagen-rich and elastin-rich regions of the image to be 
compared. 
Laiho et al. (Laiho, Pelet et al. 2005) imaged 5 samples of normal skin that had been stored at -3C 
before use. Each sample was excited at 730, 780 and 830 nm using a tunable modelocked 
Ti:Sapphire laser and the fluorescence was detected in 10 spectral channels between 375 nm and 
600 nm using a filter wheel. The spatially and spectrally resolved images were collected at 5 µm 
intervals in depth throughout the sample. The spatially integrated emission spectrum from the 
whole sample correlated well with those taken from 4 specific depths. Within the emission spectra 
obtained from exciting the skin at 3 wavelengths they identified consistent peaks at 475 nm and 550 
nm which were thought to be consistent with NAD(P)H and melanin respectively. Fluorescence 
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lifetime measurements were also undertaken using TCSPC (64 time bins) for which the decay profile 
from each pixel was fitted to a double exponential decay model.  This allowed second harmonic 
generation (SHG) in collagen to be distinguished from elastin autofluorescence in images taken from 
the dermis. 
Pena et al. (Pena, Strupler et al. 2005) investigated autofluorescence from keratin using single- and 
two-photon microscopy and spectroscopy. They presented multiphoton imaging of autofluorescence 
and SHG from fixed sectioned normal human skin excited at 860 nm and their spectral analysis of 
autofluorescence indicated that keratin and elastin spectra are similar (with spectral peaks at 
477 nm and 471 nm respectively when excited at 760 nm). 
Chen et al. (Chen, Zhuo et al. 2006) performed multiphoton imaging with a modelocked Ti:Sapphire 
laser excitation source and a 32 channel hyperspectral detector. Emission spectra of both epidermis 
and dermis were recorded using two-photon excitation wavelengths in the range 790-830 nm. They 
observed that the spectral peak for the epidermis shifted towards longer wavelengths and the 
fluorescence intensity decreased with excitation wavelength. They also found the maximum SHG 
signal from dermis was obtained using 800 nm excitation. Zhuo et al. (Zhuo, Chen et al. 2006) used 
the same instrument to study spectrally resolved images of dermis of fresh frozen human skin and 
were able to identify dermal components such as collagen and elastin with high spatial and spectral 
contrast. 
The group of Gerritsen presented spectrally resolved multiphoton imaging of mouse skin in vivo 
using a prism-based spectrometer readout by a high speed EMCCD camera providing 100 spectral 
channels over the range 350-600 nm (Palero, de Bruijn et al. 2006; Palero, Latouche et al. 2008). 
Images were acquired using an excitation wavelength of 760 nm and images were converted into a 
RGB scale for real-colour visualisation. The authors performed a detailed analysis of the spectral 
signatures of mouse skin (Palero, de Bruijn et al. 2007) and determined the relative contributions 
and emission spectra of keratin, melanin, NAD(P)H, flavins, collagen and elastin. Subsequent work 
included a study of the effect of ischemia on the emission spectrum of NAD(P)H (Palero, Bader et al. 
2011) and of the two-photon excited emission spectra of human skin in vivo (Bader, Pena et al. 
2011). The images of normal skin from 2 people with different skin types clearly demonstrated the 
high spatial resolution of the system and its ability to distinguish collagen, elastin, NAD(P)H/FAD and 
melanin based on spectra alone. 
Subsequently, a prism-based spectrometer incorporating a fibre-bundle spot-to-line converter was 
incorporated into a DermaInspect®-based instrument and used to acquire spectrally resolved images 
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of human skin ex vivo from a suspected nodular BCC with excitation at 760 nm and 840 nm (Talbot, 
Patalay et al. 2011). 
Breunig et al. (Breunig, Studier et al. 2010) used the DermaInspect® to characterise the influence of 
the excitation wavelength on the fluorescence emission intensity from various depths within normal 
skin in vivo. As found by Chen et al. above, intracellular autofluorescence reduces whilst collagen 
SHG signal increases in intensity as the excitation wavelength was increased from 720 – 880 nm and 
the authors discussed the optimum excitation wavelength for each of the fluorescent species 
investigated. They concluded that the spectral contribution of each fluorophore changed with 
excitation wavelength, which contributed to the differences in fluorescence intensity seen. They also 
found a corresponding change in the calculated fluorescence lifetimes for a field of view in the 
papillary dermis with excitation wavelength resulting from this change in contribution. 
3.4.2 Lifetime resolved MPM 
The studies outlined below focus on lifetime resolved images from normal skin. In addition, the 
study discussed immediately above by Breunig et al. investigated both spectrally and lifetime 
resolved images.  
Sugata et al. (Sugata, Sakai et al. 2010) applied the DermaInspect® to evaluate the fluorescence 
lifetime of melanin within normal skin in vivo and compared it to melanin found in the hair bulb and 
from melanocytic 3D cell cultures. Ultrafast excitation pulses at 760 and 800 nm were employed and 
fluorescence decays collected using TCSPC were fitted to a double exponential decay model. 
Fluorescence lifetimes in the basal epidermal layer of 1 = 132 ps and 2 = 1762 ps were obtained 
using 760 nm excitation. The authors concluded that, for all samples, the short 1 component was 
dominated by melanin fluorescence and while the longer 2 component mainly represented other 
fluorophores. The authors then fixed the lifetimes of the two decay components (to 120 and 
1100 ps) in the fitting software and used the resulting ratio maps of the amplitude of the short and 
long fluorescence decay components (a1/a2) to produce maps of melanin concentration.  
Benati et al. (Benati, Bellini et al. 2011) have published a comprehensive in vivo study of the 
fluorescence lifetimes from normal skin using  multiphoton imaging. 49 patients in total from 2 age 
groups had images taken from different body sites and depths. A DermaInspect® was used with 
760 nm excitation and fluorescence decays were collected using TCSPC and fitted using a single 
exponential decay model to estimate the mean fluorescence lifetime. The fluorescence lifetimes in 
the skin were found to vary with body site, to increase with age and shorten with tissue depth. The 
shorter lifetimes lower in the skin were partially attributable to the higher melanin content in the 
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basal layers of the skin. A more detailed summary of this paper can be found in discussion sections 
of Chapter 6.5 (pp146) & 6.6 (pp155) 
In 2011, Sanchez et al. (Sanchez, Prow et al. 2010) outlined the effect of excision, temperature and 
the use of culture media on the autofluorescence from NAD(P)H in freshly excised human skin. A 
detailed discussion of this paper and that of Palero et al. whom also examined the effects of 
ischaemia on mouse skin using spectrally resolved images (Palero, Bader et al. 2011), can be found in 
the Chapter 5.2.1 (pp115). 
A number of further studies of diseased tissue have studied normal tissue as part of the 
investigation. Therefore, to avoid repetition, these papers are discussed in sections below covering 
diseased tissue. 
3.4.3 MPM of skin to study the effects of aging 
The SHG signal to autofluorescence (AF) aging index of dermis (SAAID) has been defined as  
SAAID = (SHG-AF)/(SHG+AF), which provides a useful numerical index to assess the age of skin using 
multiphoton imaging (Lin, Wu et al. 2005). Lin et al. (Lin, Wu et al. 2005) investigated 3 samples of 
vertically sectioned, formalin fixed sections of facial skin from patient of differing ages. Multiphoton 
images were obtained exciting the tissue at 760 nm and collecting the fluorescence from areas in the 
superficial dermis at 380 nm for SHG and >435 nm for autofluorescence. The SAAID was found to 
decrease with age to -0.93 in a 70 year old patient and correlated with an increase in elastin in the 
dermis in the form of solar elastosis and decrease in SHG signal from collagen causing an increase in 
the collagen:elastin ratio.  
Koehler et al. (Koehler, König et al. 2006) looked at the skin from the inside forearm from 18 
volunteers in vivo. The skin was excited at 820 nm with the SHG collected at 410 nm and 
autofluorescence collected above 470 nm. Five fields of view were acquired from each patient from 
the upper dermis and the SAAID was calculated for each pixel. The results showed that SAAID 
generally reduced with age (linear regression R2=0.57) but there was large inter-patient variability. 
This drop was greater for women (R2=0.89) compared with men (R2=0.68). In subsequent work, the 
same group (Koehler, Hahn et al. 2008) assessed quantitatively the dermal matrix composition and 
showed characteristic changes with aging. In methodology identical to their 2006 study, 18 
volunteers had the inside of their forearm imaged using the DermaInspect® and 5 images were 
acquired from the upper dermis. The dermis was evaluated using a multiphoton imaging-based 
dermis morphology score (MDMS). Images were evaluated for 8 parameters in the following 
categories – fibre spread and fibre aspect, network pattern and image homogeneity (SHG images 
only), clot formation (autofluorescence images only). A single MDMS score was calculated, which 
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correlated strongly (linear regression R2=-0.9) with age, less strongly with SAAID (R2=0.66) and did 
not show gender specific differences.  
In 2009 Koehler et al. looked at the skin of 60 healthy volunteers including the young, old and 
women using tanning salons (Koehler, Preller et al. 2009). The skin elasticity was measured using 
both mechanical methods and SAAID. The skin was excited at 800 nm from the volar and dorsal 
aspect of the forearm and SHG was collected at 400 nm and fluorescence collected from 410-
490 nm. 16 regions at approximately 180 µm below the stratum granulosum were measured and 
averaged for each patient. The authors found that older patients had lower SAAID scores. Sun 
exposed areas had a lower SAAID (significant in old men, old women and young women using 
tanning but not in young men and young women). Mechanical measurements of skin elasticity 
(cutometry) indicated loss of elasticity with age and a higher elasticity on the outside forearm than 
the inside was found in all groups. The procedures used in this study reduced the intra- and inter-
patient variability compared to the 2006 and 2008 studies and this study confirmed that SAAID 
decreased with age in a larger sample size. The authors found a lower SAAID in sun exposed dorsal 
forearm compared to the sun-protected volar forearm in the old and in young women using tanning 
salons, but were not able to detect any damage done by tanning beds.  
Kaatz et al. examined the influence of depth and epidermal thickness on the SAAID index (Kaatz, 
Sturm et al. 2010). The forearms of 30 healthy volunteers divided into 3 age groups were examined 
in vivo. Skin was excited at 800 nm using a DermaInspect® and SHG was collected at 400 nm and 
autofluorescence at 410-490 nm. The fluorescence intensities from the images were then analysed 
based on changes in the autofluorescence and SHG intensity with depth. The maximum penetration 
depth was found to be 130-180 µm based on the plateau in the autofluorescence and SHG 
intensities below this depth and the authors determined the papillary dermis was reached at 
91±16 µm. The position of the basal layer and the presence of solar elastosis in older patients could 
be seen through small peaks in the plots of tissue autofluorescence intensities as a function of 
depth. A sharper decline in the SHG signal after the dermis was reached was found in the elderly 
compared to the young. The SHG peak in the upper dermis was due to the high content of fibrillar 
collagen (types I and III). The most significant differences between ages were found in the SAAID 
index when a constant depth below the surface was assessed (below the SHG peak and above the 
penetration depth) e.g. 150 µm. 
Koehler et al. looked at the variation of tissue autofluorescence lifetimes using TCSPC from the 
dermis with age, sex and body site (Koehler, Preller et al. 2011). They used the DermaInspect® to 
excite both the medial and lateral forearms of 47 volunteers at 800 nm wavelength. 
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Autofluorescence was collected from 16 fields of view using a 450±40 band pass filter. Due to the 
low photon counts per pixel, fluorescence was summed for each image at each time point and bi-
exponential decays were fitted to the data to find τ1 and τ2. They found the mean of τ1 to be 
between 700-1000 ps and τ2 to be between 3475 – 3600 ps. They found no variation between the 
sexes and no consistent variation with body site. They did however find that the fluorescence 
lifetimes in the dermis increased with age, which is consistent with the findings by Benati et al. of 
the changes in fluorescence lifetime of the epidermis with age (Benati, Bellini et al. 2011). They 
attributed this change to the replacement of collagen and elastin in the dermis with the 
accumulation of solar elastosis. 
Puschmann et al. attempted to refine the SAAID index to quantify aging of the skin and described 
the elastin to collagen ratio (ELCOR) (Puschmann, Rahn et al. 2012). They used the DermaInspect® to 
acquire images from normal skin in vivo from 45 women to assess aging and 12 to assess 
photodamage. The skin was excited at 820 nm and collected at 410 nm for collagen SHG, and excited 
at 750 nm and collected between 548±150 nm for elastin autofluorescence. Although both methods 
measure SHG to determine dermal collagen, the ELCOR uses a manually defined mask to remove 
autofluorescence from other dermal structures before calculating the ratio. This index showed a 
progressive statistically significant increase with age and a statistically significant increase for sun-
exposed (temple) body sites compared to photo-protected sites (upper arm). In contrast the 
sensitivity of the SAAID index was only sufficient to detect a statistically significant difference 
between the young/middle aged groups and the elderly age groups’ skin. 
3.5 MPM in non-melanoma skin cancer 
In one of the first studies of skin cancer using multiphoton imaging (Lin, Jee et al. 2006) 
autofluorescence intensity images were collected from 9 fixed, sectioned slices from BCCs. Serially 
acquired images were montaged together to generate an autofluorescence image covering a large 
area crossing tumour margins and this was presented with an exact correlative histopathological 
image. The SHG from dermal collagen was spectrally filtered from the emitted fluorescence and the 
authors used an index of multiphoton-excited autofluorescence to SHG (MFSI, equivalent to the 
negative of the SAAID index, see section 3.4.3) to distinguish cancer cells/stroma from normal 
dermis in BCCs. The authors found that the MFSI ratio was greatest within the tumour, lower in 
cancer stroma and lowest in normal dermal stroma and could be used to identify the tumour. 
Paoli et al (2008) published a study of the morphological features observed in multiphoton-excited 
autofluorescence intensity images. 14 freshly excised specimens of non-melanoma skin cancer – 
including squamous cell carcinoma in situ, superficial BCCs and nodular BCCs – were imaged using 
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780 nm excitation. They looked for the presence of 8 features in squamous cell carcinoma in situ 
(bowenoid dysplasia, multinucleated cells, widened intercellular spaces, hyperkeratosis, keratin 
pearls, dyskeratosis, loss of cell polarity and speckled perinuclear fluorescence) and 5 features in 
superficial BCCs (hyperkeratosis, thickened subcorneal epidermis, elongated cells and nuclei 
polarisation, peripheral palisading and speckled perinuclear fluorescence). Their study confirmed 
that many of the established histopathological features could be seen using the en face multiphoton 
imaging although image features characteristic of disease were only found in one of three nodular 
BCCs due to the limited penetration depth.  
The group of Pavone has applied en face multiphoton imaging and FLIM to assess freshly excised 
BCCs (Cicchi, Massi et al. 2007; Cicchi, Sestini et al. 2008; De Giorgi, Massi et al. 2009). Using 
autofluorescence excitation at 740 nm and SHG imaging at 840 nm, they presented examples of the 
morphological features seen in multiphoton imaging images of BCCs and compared them directly to 
correlative histology. The SAAID index (see section 3.4.3) was used to distinguish BCC tumours 
(negative index), stromal interface (marginally positive index) and the dermis (negative index). The 
autofluorescence emission spectrum of 4 BCCs was studied and found to be shifted towards the blue 
for BCC compared to normal skin (shift in fluorescence to <525 nm) with this shift being greatest for 
depths in the range 30-50 µm. They also studied fluorescence lifetime histograms obtained from 
FLIM images acquired at different depths and found the fluorescence lifetime to be longer for BCC 
compared to normal skin tissue for most depths with a peak difference of +91 ps at 30 µm depth. 
Our group, Patalay et al. (Patalay, Talbot et al. 2011) evaluated BCCs ex vivo using a DermaInspect® 
to acquired FLIM data in two emission spectral channels (300-500 nm & 500-640 nm) prior to the 
investigation described in this thesis. Whole excised, fresh tissue samples were imaged using 
excitation at 760 nm. Each cell in every image was identified manually and all pixels within each 
region of interest (ROI) summed to provide a single fluorescence decay per cell. This approach 
increased the number of photons available in order to fit a double exponential decay model to the 
data. In total, fluorescence decays from 615 cells from 3 nodular BCCs and 566 cells from 4 naevi 
were defined and fitted. The mean fluorescence lifetimes for naevi vs nBCC were calculated as 2516 
vs 2786 ps (<500 nm channel) and 1334 vs 2085 ps (>500 nm channel). Shorter fluorescence 
lifetimes were observed in both spectral channels for naevi and this was attributed to the increased 
melanin content in the naevi. Fitting fluorescence decays on a cell-by-cell basis allowed populations 
of naevi cells to be contrasted with nBCC via their lifetime and it was suggested that the variation in 
the melanin content in cells could be responsible for the lifetime histograms obtained. This study 
also indicated a large inter-patient variability in fluorescence lifetimes of skin lesions.  
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Seidenari et al. (Seidenari, Arginelli et al. 2013) investigated a range of morphological image 
descriptors – building on those identified by Paoli et al. (Paoli, Smedh et al. 2008) – with the aim to 
optimise the differentiation of BCC from normal skin using multiphoton imaging . Initially, training 
image stacks acquired at 10 depths from one field of view per sample were acquired ex vivo, imaging 
24 BCCs and 24 samples of normal skin. These multiphoton imaging stacks were used to identify 9 
morphological criteria/descriptors. Figure 3.2(a,b) illustrate the 3 epidermal descriptors and (c)-(h) 
illustrate the remaining dermal descriptors. 
In the main study, image stacks from a further 66 BCCs, 66 other lesions (23 nevi, 8 melanomas, 17 
skin tumours and 18 other skin lesions) and 66 normal regions of skin were acquired. The resulting 
images were then assessed by three independent observers who assessed each sample for the 
presence or absence of each descriptor. The mean number of descriptors per lesion was 2.64 for 
BCCs, 0.17 in other lesions and 0 for normal skin. The presence of ‘Aligned elongated cells’ was 
found in 73% of BCCs but in only 5% of other lesions. An overall sensitivity/specificity of 95/89% was 
achieved when using the presence of one or more BCC descriptor(s) as the diagnostic criterion, 
whereas 83/95% was obtained when using the presence of two or more descriptors. These results 
indicate the potential utility of multiphoton imaging as a diagnostic tool.  
Figure 3.2.Morphological criteria/descriptors for defining BCCs from MPT images defined by Seidenari et al. (a) detached 
cells with increased intercellular spaces (b) cells with irregular contours & random arrangement of cells (c) Elongated cells 
aligned along a single axis (d) cells aligned in two directions.(e) Palisading i.e. cells at the periphery of a BCC nest aligning 
perpendicularly to the surrounding dermis. (f) BCC nodule (asterix) surrounded by fibres (arrow) (g) sheets of cells 
intermingled with fibres. (h)BCCs cells are not seen when excited at 800 nm causing the appearance of ‘phantom cells’. 
Images (a)-(g) Excited at 760 nm, (h) excited at 800 nm. Reproduced from Seidenari et al. (Seidenari, Arginelli et al. 2013). 
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Seidenari et al. extended this approach to the combination of multiphoton intensity imaging and 
FLIM for the diagnosis of BCC, distinguishing them from a range of other skin lesions (Seidenari, 
Arginelli et al. 2012). A preliminary study of 35 BCCs and 35 healthy skin samples were imaged and 
morphological descriptors were identified using the resulting FLIM images. In the main study 63 
BCCs, 66 other skin lesions (24 nevi, 8 melanomas, 15 inflammatory lesions and 19 skin tumours) and 
63 samples of healthy skin were imaged and the presence or absence of each descriptor assessed by 
three independent observers. 15 FLIM images were acquired at different depths for each sample 
using an excitation wavelength of 760 nm. Cells with a longer fluorescence lifetime were always 
observed for BCCs and this descriptor provided the highest sensitivity/specificity (100/70%) of all of 
the descriptors investigated. The mean fluorescence lifetime values, calculated on three 
representative cells in the lower layers of each of the 98 (preliminary and main study samples 
combined) healthy skin lesions and each of the 98 BCC lesions were found to be 1012 ps and 1475 ps 
respectively (a significant difference at p < 0.001)i.e. longer and  in agreement with earlier work on a 
smaller number of samples (Cicchi, Sestini et al. 2008). The mean number of BCC descriptors per 
lesion was higher in BCC (3.86 ± 1.45) compared to miscellaneous lesions (0.54 ± 0.86). The presence 
of at least one BCC descriptor was observed in all BCCs but only in 36% of other skin samples. An 
overall sensitivity for the diagnosis of BCC from other lesions and healthy skin of 97% was achieved 
when the diagnostic criterion was chosen to be the presence of two or more descriptors and this 
produced no false positives, either in other lesions or healthy skin. A specificity of 100% was 
obtained when considering the presence of five descriptors or more.  
Seidenari’s group then compared the morphological features seen in images from 16 BCCs acquired 
in vivo using reflectance confocal light microscopy to MPT FLIM images from the same lesion 
acquired ex vivo using the DermaInspect®(Manfredini, Arginelli et al. 2013). They concluded that 
there was a good concordance of morphological features between both modalities but found 
limitations in their ability to compare images directly due to the difference in field of view size 
between them. 
3.6 Multiphoton spectroscopy and imaging of pigmented lesions 
Teuchner et al. presented emission spectra and fluorescence lifetime measurements of synthetic 
melanin and melanin in ex vivo specimens of normal human skin (Teuchner, Freyer et al. 1999) 
reporting a complex fluorescence decay profile with a dominant short decay component at about 
200 ps. Melanin excitation can also occur via a stepwise multiphoton excitation (Teuchner, Freyer et 
al. 1999), which allows for preferential excitation of melanin, particularly when using longer 
(nanosecond) NIR excitation pulses (Eichhorn, Wessler et al. 2009). In subsequent work, Teuchner et 
al. (Teuchner, Ehlert et al. 2000) studied the emission spectra of normal skin, naevi and melanoma 
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and noted a shift in the peak of the fluorescence emission spectrum of the melanoma sample 
(~550 nm) compared to naevi (~520 nm) and normal skin (~500 nm). The same group observed the 
same trends in a larger study of 10 specimens in each of the three lesion types (Hoffmann, Stucker et 
al. 2001).  
Eichhorn et al. (Eichhorn, Wessler et al. 2009) exploited selective excitation of melanin using 2.5 ns 
excitation pulses at a wavelength of 810 nm to study the fluorescence emission spectra of melanin in 
formalin fixed paraffin embedded samples. A total of 27 lesions were studied, including 9 malignant 
melanomas. For common and junctional naevi, spectral emission peaks of ~480 and ~490 nm were 
observed respectively. For malignant melanoma, the autofluorescence was characterised by a peak 
at ~600 nm. A dysplastic compound naevus exhibited both peaks. Similar spectra were observed for 
a fresh unfixed specimen of malignant melanoma. These results were confirmed in a more detailed 
subsequent study by Leupold et al.(Leupold, Scholz et al. 2011), where the authors measured the 
emission spectra of 167 cases of naevi and melanomas. Melanoma gave a characteristic emission 
peak at 640 nm with common melanocytic naevi presenting a peak at 590 nm. This difference was 
thought to be due to changes in the ratio of eumelanin to pheomelanin. For each sample the 
emission spectrum was acquired for an array of 129 positions on the surface of the specimen that 
were spaced laterally in steps of 50 µm. The fluorescence signal at each point was compared in two 
bands (483-520 nm and 585-620 nm) in order to classify the measurement as benign or malignant. 
Overall, this study reported a sensitivity, specificity and diagnostic accuracy of 94, 80 and 83% 
respectively for distinguishing malignant melanoma from naevi.  
Ehlers et al. (Ehlers, Riemann et al. 2007) used a DermaInspect® to investigate the fluorescence 
lifetime of human hair, which is rich in melanin. Fluorescence lifetime analysis of hair of different 
colours revealed differences in the lifetime between blond (0.4, 2.2ns) and black hair (0.2, 1.3ns) and 
these lifetimes were compared to pure melanin and melanin measured in vivo from a mole. When a 
fast multichannel plate photomultiplier tube providing a 24 ps response time was used to detect the 
fluorescence decays, eumelanin in black hair (0.03, 0.8ns) could be distinguished from pheomelanin 
in red/blonde hair (0.34, 2.3ns) and white hair (0.3, 2.1ns).  
Cicchi et al. (Cicchi, Sestini et al. 2008; De Giorgi, Massi et al. 2009) applied spectrally resolved 
multiphoton imaging and FLIM to study 2 melanoma specimens with excitation at 740 nm. 
Melanomas were found to have a shorter fluorescence lifetime than normal skin and BCCs but were 
not compared to other pigmented lesions. Spectral analysis showed a reduction in fluorescence 
intensity below 520 nm for melanoma compared to normal skin. However, the shift towards longer 
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emission wavelengths for melanoma compared to normal skin reported by Teuchner et al. 
(Teuchner, Ehlert et al. 2000) was not seen.  
Dimitrow et al. applied the DermaInspect® to study pigmented lesions. In their first study (Dimitrow, 
Ziemer et al. 2009), they initially studied 15 ex vivo specimens (healthy skin, melanocytic lesions and 
melanoma) using multiphoton imaging with excitation at 760 nm and identified 6 morphological 
features to distinguish melanomas from naevi. A further 83 lesions (42 both in and ex vivo, 11 only in 
vivo and 30 only ex vivo) were then imaged and the data assessed by four independent observers for 
the occurrence of each feature. The feature of ‘large intercellular distance’ provided the greatest 
sensitivity of 80% and ‘dendritic cells’ provided the greatest specificity of 96% (when considering all 
lesions). Binary logistic regression showed that the features of ‘architectural disarray’, ‘poorly 
defined keratinocyte cell borders’, ‘pleomorphic cells’, and ‘dendritic cells’ should also be included in 
diagnostic decisions, which yielded an overall diagnostic accuracy of 85/97% for analysis of images 
acquired in/ex vivo. MPT images of these features have been reproduced in figure 3.3 below. 
 
Figure 3.3. MPT features seen in melanomas (a) Ascending highly fluorescent melanocytes (white arrows) appear within 
the upper epidermal layers. (b) Large intercellular distance and poorly defined keratinocyte cell borders. (c,d) Cell 
fragments, pleomorphic cells (asterisk) and dendritic structures (white arrows) in the s.spinosum. Scale bar: 40 mm. 
Reprinted by permission from Macmillan Publishers Ltd: Journal of Investigative Dermatology 129(7): 1752-1758.Copyright 
(2009), (Dimitrow, Ziemer et al. 2009). 
In a second study (Dimitrow, Riemann et al. 2009) Dimitrow et al. examined 13 naevi and 10 
melanomas, mostly from ex vivo samples. In this study they found that multiphoton excitation at 
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800 nm enhanced many of the morphological features in the intensity images associated with 
melanoma, compared to excitation at 760 nm. Fluorescence lifetimes were calculated for a total of 
84 manually selected pixels of the cytoplasm from either keratinocytes or melanocytes and a bi-
exponential decay model was fitted to the data. The authors found that both the short/long decay 
components were shorter for melanocytes than keratinocytes (140/1076 ps vs. 445/2269 ps 
respectively) and that melanocytes had a more dominant short lifetime component than 
keratinocytes (93%/7% and 76%/24% respectively). The differences in the fluorescence decay 
parameters between the two cell populations were attributed to a dominant NAD(P)H fluorescence 
in keratinocytes and a dominant melanin fluorescence in melanocytes. The observed fluorescence 
lifetimes were able to distinguish keratinocytes from melanocytes but not naevi from melanomas. 
The authors also investigated the fluorescence emission spectrum of 4 lesions (two of normal skin, 
one naevus and one melanoma) and found a peak at 550 nm occurring in the melanoma sample, but 
not the naevus or normal skin. This peak was more pronounced when exciting at 800 nm compared 
to 760 nm. 
Arginelli et al. performed a comparison of MPT FLIM images acquired ex vivo from 51 melanocytic 
naevi and compared them to 51 miscellaneous lesions with the aim to define diagnostic 
morphological features for melanocytic naevi (Arginelli, Manfredini et al. 2012). The miscellaneous 
lesions consisted of a wide variety of lesions including pigmented and non-pigmented diagnoses e.g. 
BCCs, SCCs, dermatofibroma, actinic keratosis and seborrhoeic keratosis. Initially images taken from 
16 naevi ex vivo were used to define a number of morphological features. Their presence was then 
assessed blinded on the images acquired ex vivo from the 102 lesions. They determined that ‘small 
short-lifetime cells’ in the upper and lower epidermal layers, ‘edged papillae’, ‘junctional nests of 
short-lifetime cells’ and ‘dermal cell clusters’ as 5 sensitive and specific descriptors for diagnosing 
benign naevi, see figure 3.4. They also confirmed the presence of the descriptors for benign naevi 
defined by Dimitrow et al. of monomorphic cells with regular histo-architecture, evenly distributed 
keratinocytes, well defined cell borders and rarely seen dendritic cells (Dimitrow, Ziemer et al. 2009). 
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Figure 3.4. MPT FLIM images taken from benign naevi illustrating morphological descriptors for naevi defined by Arginelli 
et al. (a) Small cells with short lifetimes in the upper epidermis; acquired at 760 nm excitation wavelength. (b) Small cells 
with short lifetimes in the lower epidermis; acquired at 760 nm excitation wavelength. (c) ‘edged papillae’ constituted by  a 
rim of short lifetime cells surrounding an oval space with collagen fibres; acquired at 800 nm excitation wavelength. 
(d)Junctional nest of short lifetime cells at the dermo-epidermal junction. acquired at 760 nm excitation wavelength. 
(e)’Dermal cell clusters’ in the papillary dermis; acquired at 820 nm excitation wavelength. Reproduced from (Arginelli, 
Manfredini et al. 2012). 
3.7 Multiphoton imaging of other skin diseases 
3.7.1 Actinic keratosis 
Keohler et al. (Koehler, Zimmermann et al. 2011) performed an in vivo study using the 
DermaInspect® to compare normal skin from 30 patients with actinic keratosis (AK) from 27 patients. 
The skin was excited at 760 nm and 820 nm for autofluorescence intensity (470 nm long-pass filter) 
and SHG imaging respectively. The authors observed wider inter-cellular spaces and the presence of 
a fluorescence perinuclear rim for AK. A number of cellular size parameters were compared, but only 
the nuclear to keratinocyte size ratio was deemed significantly different with AK. They also found an 
increase in the SAAID index with AK. In addition they observed increased thicknesses of the total and 
viable epidermis consistent with epidermal acanthosis seen histologically. 
3.7.2 Atopic dermatitis 
Huck et al. (Huck, Gorzelanny et al. 2010) presented results comparing the changes in 
autofluorescence intensity images and lifetimes seen with the inflammatory dermatosis ‘atopic 
dermatitis’ compared with normal skin in vivo using a DermaInspect® with an excitation wavelength 
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of 710 nm. In three patients with control, mild and severe atopic dermatitis, they found that the 
peak mean lifetime lengthened from ~1150 to ~1300 to ~1500 ps respectively. In addition, non-
lesional skin in atopic dermatitis patients was found to have a longer mean lifetime than patients 
with normal skin (Huck, Gorzelanny et al. 2011).  
3.7.3 Psoriasis 
Pavone’s group, based in Florence have used MPM to acquire images from the skin from patients 
with psoriasis in vivo (Kapsokalyvas, Cicchi et al. 2011; Kapsokalyvas, Cicchi et al. 2011). They noted 
an abnormal epidermis, smaller cells than normal in the s.spinosum and were able to detect the 
longer and larger dermal papilla, which is histologically characteristic of the disease. 
In a review paper Roberts et al. also present FLIM images from the skin from patients with psoriasis 
but do not perform any analysis on them (Roberts, Dancik et al. 2011) 
3.7.4 Scleroderma 
Lu et al. (Lu, Chen et al. 2009) studied sclerodermatous skin ex vivo using frozen vertically sectioned 
tissue. Three samples from scleroderma patients and two from normal skin were imaged with 
multiphoton excitation at 810 nm, with SHG detected between 393-414 nm and autofluorescence 
between 430-650 nm. Intensity images from the dermis were analysed and general morphological 
differences were discussed. The net orientation of collagen bundles was assessed via the fast Fourier 
transform of the images and found to be higher in scleroderma compared to normal skin. In 
addition, the spacing of collagen fibrils and the epidermal thickness was found to be reduced in 
scleroderma. The SHG/autofluorescence ratio (similar to the SAAID index) was found to be increased 
in the lower dermis in scleroderma patients.  
3.7.5 Scarring 
Scarring of the skin occurs after full thickness epidermal injury and repair of the skin by the 
fibroblasts in the dermis. In some individuals this process becomes overactive and leads to the 
formation of raised hypertrophic scars or, if larger, keloid scars.  
In 2004, Brewer compared multiphoton excited image depth stacks of an excised keloid scar with 
normal skin (Brewer, Yeh et al. 2004). In 2008 Cicchi et al. (Cicchi, Sestini et al. 2008) acquired 5 
images for each of four different regions in one keloid specimen, showing that regions of fibroblastic 
proliferation and keloid demonstrated a strongly positive SAAID index compared to normal tissue.   
Chen et al. (Chen, Chen et al. 2009) applied multiphoton imaging with 32 spectral channel detection 
to acquire multispectral image depth stacks from 5 hypertrophic scars and 1 sample of normal skin 
in frozen sectioned tissue excited at 850 nm. They recorded the SHG between 414-436 nm and 
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elastin autofluorescence between 457-714 nm, and presented the morphological features of the 
collagen and elastin fibres in normal and scar tissue. Their further work examined frozen sections 
from 5 freshly excised keloids. Tissue sections were excited at 810 nm and SHG was collected 
between 398-409 nm and elastin autofluorescence between 430-697 nm. In this paper they 
quantified the increase in collagen throughout the entire dermis of a keloid compared to normal skin 
and also measured an increase in elastin confined to the deep dermis (Chen, Zhuo et al. 2011). 
Zhu et al. constructed mosaics of MPM images to assess scar margins from 15 normal scars on the 
abdomen of various ages using freshly frozen, sectioned samples of the scars (Zhu, Zhuo et al. 2011). 
The tissue was excited at 810 nm and fluorescence collected at 405 nm for collagen SHG and 430-
697 nm for elastin autofluorescence. They were able to delineate scar margins based on the change 
in collagen and elastin morphology and signal. They also found a significant negative correlation with 
scar age/patient age and collagen/elastin content in the scar. i.e. the increased collagen and elastin 
found in fresh scars reduced with time. The sample was too small to conclude if this difference was 
caused by patient’s age or the age of the scar. 
3.8 Combining MPM with other modalities 
MPM has for the first time allowed sub-cellular resolution depth resolved images to be acquired 
from skin in vivo. One deficiency of this modality is its limited depth of penetration in comparison to 
other non-invasive imaging modalities (which have poorer image resolutions). In recent years 
imaging with combined modalities has been reported with the aim to allow them to be used 
synergistically in the future. For example, MPM has been combined/compared with optical 
coherence tomography (König, Speicher et al. 2009), high frequency ultrasound (König, Speicher et 
al. 2010), reflectance confocal laser microscopy (Koehler, Speicher et al. 2011; Ulrich, Klemp et al. 
2013) and epi-coherent anti-Stokes Raman scattering (CARS) (Breunig, Bückle et al. 2011) which 
images intercellular lipids and water. 
3.9 Conclusions 
Autofluorescence provides a rich range of contrast parameters for studying diseased human skin. 
These fluorescence signals have been investigated using a range of instrumentation including single-
point fibre probes, wide-field imaging with single photon excitation and multiphoton imaging. 
Autofluorescence intensity can be complemented by measurements using multiple excitation 
wavelengths, multiple emission detection bands and measurements of fluorescence lifetime. This 
chapter aimed to summarise the key papers studying autofluorescence in the skin, focusing on 
multiphoton microscopy of both normal skin and skin malignancies. 
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Chapter 4. Materials, Methods & Analysis 
4.1 Introduction 
This chapter describes the details of patient recruitment and associated ethics approval, the 
instrumentation and its development, the imaging protocols, and the methods used for image 
analysis. 
4.2 Patients 
Patients were recruited from those attending the Dermatology Department at the Hammersmith 
Hospital site of Imperial College Healthcare NHS Trust.  
Patients with the following criteria were excluded: age 18 years or less, in state custody, carrying a 
blood borne infection, having a photosensitive skin disorder, currently pregnant. In addition, 
patients unlikely to tolerate in vivo imaging were excluded from in vivo imaging. In vivo imaging of 
the skin not scheduled for excision were excluded from transplant patients to avoid any possible 
increased risk of genetic damage from the laser light source. Once recruited, all patients gave their 
written informed consent to participate in the study. 
Patients with lesions clinically diagnosed as BCCs, naevi or melanomas were recruited for in vivo and 
ex vivo imaging from the skin cancer clinic. Patients attending non-cancer dermatology clinics were 
recruited for in vivo imaging of normal skin and SCCs in the pilot phase. 
All patients were allocated a pseudo-anonymised identification number that identified the images 
and could be used to access the diagnostic histological slides without identifying the patient when 
lesions were excised. This was generated by either The Human Biomaterials Resource Centre of 
Imperial College Healthcare NHS Trust (Tissue Bank) or the clinical research team.  
Once eligibility and pseudo-anonymisation had occurred, a minimum data set from each patient was 
collected, either from the medical records, clinical examination or verbally from the patient. Details 
included patient demographics, presence of a family history of melanoma, past history of skin 
cancer, if an organ transplant recipient, whether currently immunosuppressed, skin phototype, 
presence of solar lentigenies as a marker of actinic damage (none, few, numerous), number of 
melanocytic naevi (<50, 50-100, 100+) and current medication. In addition details regarding the site 
of imaging and clinical diagnosis for lesions were recorded.  
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Figure 4.1 (a) G10 Cannon Camera shown with dermatoscopic attachment. (b) DermliteFOTO® dermatoscopic lens 
detached from camera.  (c) DermliteFOTO® ring light attachment for macroscopic imaging. 
Finally a Cannon® G10 camera was used with a DermliteFOTO® macroscopic or dermatoscopic 
attachment to photograph the lesion, see figure 4.1.  
The excitation wavelength, magnification, imaging depth, acquisition time (using the image save 
time) and a unique daily ID number was recorded for all FLIM images. The excision time for ex vivo 
samples was also recorded.  
4.3 Ethics approval 
4.3.1 ex vivo imaging 
Application Title: Autofluorescence spectroscopy and fluorescence lifetime imaging (FLIM) of human 
tissues. (REC reference number: 09/H0706/28). 
National Research Ethics Committee (NREC) approval was sought to acquire and image fresh ex vivo 
tissue using FLIM by Imperial College London. Provisional approval was granted on 16/3/2009 by the 
Riverside REC office. Local hospital trust approval from Imperial College Healthcare NHS Trust (LREC) 
was granted (project reference STAG1025) on 26/6/2009. 
An amendment was requested to the study protocol including changes to the Chief Investigator’s 
primary workplace (Professor G Stamp), amendment of the consent form for photography, changes 
to allow pseudo-anonymisation to be performed by clinical researches when necessary, the addition 
of Charing Cross Hospital (Imperial College Healthcare NHS Trust) and The Royal Marsden Hospital as 
recruitment sites, and changes to allow imaging using ultrasound and optoacoustic modalities in 
addition to FLIM. This was approved on 14/3/2011 by the LREC committee. 
A further site specific approval was granted by the Research & Development office and LREC 
committee of The Royal Marsden Hospital on 10/8/2011 (CCR3610). 
a) c)b)
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4.3.2 in vivo imaging 
Application Title: 09/H0706/83.‘Multimodal skin inspection with hybrid acoustic and optical 
spectroscopic imaging: SKINSPECTION A (REC reference number: 09/H0706/83) 
NREC approval was sought by Imperial College London to image skin in vivo using FLIM. This 
application was provisionally approved on 22/1/2010 by the Riverside REC office. Local hospital trust 
approval from Imperial College Healthcare NHS Trust (LREC) was granted (project reference 
CHUA1039) on 08/3/2010. 
A substantial amendment was submitted to allow modification and consolidation of consent forms, 
to allow peudo-anonmisation by clinical researchers when necessary and to add Charing Hospital 
(Imperial College Healthcare NHS Trust) as a recruitment site.  This was approved by the LREC 
committee on 14/3/2011. 
4.4 Instrumentation 
 
Figure 4.2. An annotated imaged of the modified DermaInspect® 
The work in this thesis used a modified DermaInspect® instrument. The fluorescence detection 
module was adapted to allow fluorescence lifetime imges to be collected in four spectral channels 
and a spectrometer module was constructed to allow hyperspectral images to be acquired. The 
DermaInspect® (JenLab GmbH) is a CE marked, Class 1M femtosecond laser scanning system that 
allows non-invasive optical imaging, see figure 4.2. It incorporates a mode-locked 80 MHz 
Titanium:Sapphire laser (MaiTai, Spectra Physics®, CA, USA) equipped with a prism-based chirp 
compensation unit (DeepSee™ module, Spectra Physics®) generating femtosecond pulses with pulse 
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length <100fs, average power 1.3W, TEM00, Noise <0.15% as its excitation light source. The laser has 
a tuning range between 710-920 nm with excitation power attenuated to a maximum of 50 mW at 
the sample (measured at 800 nm) by a step motor driven half-wave plate and polarising beam 
splitter system (software controlled). The excitation beam passes through two galvoscanners, 
allowing scanning in the x-y plane, before passing through a 40x/1.4NA oil immersion objective.  The 
objective has a working depth of 200 µm in the z plane, with a lateral resolution of 0.7 µm and axial 
resolution of 1.5-2 µm for a maximum field of view of 350 x 350 µm2.  
Sliders, situated on the detector module casing allow the beam path for the emitted fluorescence to 
be directed either to the internal MPT fluorescence intensity PMT (BG39 filter & Hammamatsu 
H7732 PMT, Hamamatsu Photonics K.K., Japan), the FLIM detector module or the spectrometer. 
4.4.1 FLIM detector module 
 
Figure 4.3 (a) A schematic of the original design of the 4 spectral channel FLIM detector unit. (b) A photograph of the 
completed unit with the module casing removed. Key –White line -The beam path. Colour of PMT outline- spectral range as 
per the schematic.  
The FLIM detector module (see figure 4.3) was designed by Dr Clifford Talbot and had an optical 
transmission efficiency of 85% across 200 µm in the x-y plane. The figure 4.3(a) illustrates the 
excitation beam (in red) directed to the skin. The two photon fluorescence emitted from the skin 
passes through the excitation short pass dichroic filter (position 1), allowing fluorescence below 640 
nm wavelength to pass to the FLIM detector module in the original configuration. The beam is then 
focused and spit into 4 spectral channels through a number of further filters and dichroic mirrors. 
The fluorescence is then collected by 4 Hammamatsu H7422P-40 PMTs (with peak quantum 
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efficiency of 40%)  defining the spectral channels as blue (360-425 nm), green (425-515 nm), yellow 
(515-620 nm) and red (620-640 nm). Fluorescence decays are collected by time correlated single 
photon counting (TCSPC) using an SPC-830 module (Becker & Hickl, GmbH). The PMTs were 
controlled using a DCC-100 module (Becker Hickl) and wide band amplifiers with overload detection 
(Becker Hickl part number HFAC-26dB) were placed after each PMT. Routing of the timing signals 
from the four channels was achieved using a HRT-411 module (Becker Hickl). The spectral cut-off of 
the dichroic in position 1 was changed to 655 nm for the modified design and is discussed below in 
section 4.5.1, pp91. 
4.4.2 Spectrometer Module 
 
Figure 4.4. Schematic of the prism based spectrometer unit. The inset diagram illustrates the mapping of the fibres in the 
fibre bundle collecting the fluorescence of position (A) to those that relay it to the spectrometer at position (B). 
 
Figure 4.5 An annotated photograph of the prism-based spectrometer. The inset shows a detailed image of the spot end of 
the spot-to-line fibre bundle. 
A prism based spectrometer that was designed and constructed by Dr Clifford Talbot allowed steady 
state fluorescence emission spectra to be collected from the plane of focus by the DermaInspect®, 
see Figures 4.4-4.5. The emitted fluorescence collected by the objective was initially relayed by two 
lenses onto spot-to-line fibre bundle (FiberTec Optica, Canada). This system had a geometric 
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transmission efficiency of 100% up to a calculated geometrical radial distance of 0.18mm from the 
centre of the field of view. The fibre bundle had an active area of 63% of the fibre spot end and was 
coupled into the prism based spectrometer, which used a LucaEM R (Andor™, Northern Ireland) 
EMCCD as the detector. The EMCCD camera had a detection spectral range between 360-877 nm 
with a quantum efficiency of between 40-65% in the range 380 – 655 nm. The EMCCD was 
configured to record the fluorescence signal into 50 spectral bins over this range. The start/stop 
signal and pixel clock from the DermaInspect® could be routed to the spectrometer, allowing a 
spectrum to be acquired from a pixel, line or frame of the imaged FOV. Image acquisition was 
performed using a user interface written in LabView™ 7.1 (National Instruments®,USA). Initially this 
was executed on a standalone laptop PC but was ultimately installed on the PC running the 
DermaInspect® control software. 
When acquiring a spectrum from each pixel, the spectral image resolution was limited by the 
acquisition rate of the EMCCD camera. The image resolution was either 32x256 or 41x256 pixels in 
size and acquired over 49.9 seconds. 
4.5 System Development 
4.5.1 Spectral Channels of FLIM module 
Minor modifications were made to the system during the study to improve the spectral separation 
between channels and to broaden the red channel’s detection bandwidth from 620-640 to 620-
655 nm. To achieve this, the 640 nm DCSP (Chroma Technology Corp., Vermont, USA; position 1, 
figure 4.3) was replaced with a 670 nm DCSP, the BG39 filter (position 2, figure 4.3) was replaced 
with a 680 nm short pass filter and a number of band pass filters were inserted, see table 4.1. 
Installation date Position Manufacturer’s Description 
before 7/6/2010   As Above 
07/06/2010 2 BG39 to 680 SPF 
1-7/10/2010 6 (Blue) Short pass 440nm 
  1 640 DCSP to 670 DCSP 
25/05/2011 8 (Red) Band pass 601-657 nm 
01/07/2011 7 (Yellow) Band pass 506-594 nm 
  9 (Green) Band pass 420-520 nm 
 Table 4.1 Chronological list of the modification of the spectral filters made between then original design of the FLIM 
detector module and its final design. Position references to figure 4.3 
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As the spectral range of the optical filters inferred from the name given by the manufacturers had 
slight differences to their actual spectral ranges, a comparison of the listed spectral range and the 
50% transmission spectral range of the filters used is given in table 4.2. Once the spectral 
sensitivities of the PMTs were accounted for, the overall detector efficiency for each channel 
following is illustrated in figure 4.6 for both before and after the modifications. Following the failure 
of a PMT, the red spectral channel was missing from FLIM images acquired between 27/7/11 and 
6/10/11 and therefore data was collected for just three spectral channels over this time. 
Channel Spectral range stated in 
Manufacture’s filter description 
50% transmission 
spectral range 
Blue 360-425 nm 370-429 nm 
Green 425-515 nm 430-515 nm 
Yellow 515-620 nm 517-600 nm 
Red 620-655 nm 617-655 nm 
Table 4.2 A comparison of the listed spectral range of filters used and their 50% transmission range. 
Figure 4.6 Wavelength range of detection for fluorescence for each spectral channel (a) in the original design and (b) 
following all modifications. 
FLIM images were either 128 x128 pixels before the integration of TCSPC FIFO (first-in first-out) 
acquisition mode (occurred on 15/8/2011) or 256x256 pixels after, with all acquired over 25.5 
seconds. 
The changes to the dichroic filter in position 1 (figure 4.3) to increase the spectral range of the red 
channel, consequently meant that a greater spectral contribution came from the channel after the 
change. The remaining filter changes had a minimal effect on this parameter. The calculated lifetime 
parameters were independent from these changes as a calibrated spectral response of the system 
was made daily using a blue fluorescence slide as a reference (Chroma Technology Corporation, 
USA). 
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4.5.2 Articulated Arm 
 
Figure 4.7 Photograph of the articulated arm with annotations of the two planes of rotation that can be made. 
The fixed objective and its proximity to the edge of the optical bench significantly restricted the 
range of body sites that could be imaged in vivo. This was because of a number of reasons :- 
- The physical restriction caused by the size and position of the optics. 
- Insufficient comfort for the patient. 
- Inability of microscope objective of the DermaInspect® to angle to the contour of a patient. 
As a consequence imaging in vivo was effectively restricted to lesions on the extremities for most 
cases. On 25/5/2011 an articulated arm (JenLab GmbH) was installed to allow greater flexibility in 
positioning the objective, see figure 4.7.  It could rotate in the horizontal plane about the detector 
module, and the objective head could rotate around the end of the arm, which allowed a greater 
range of body sites to be imaged. 
4.5.3 Detector Overload Protection 
Two safety mechanisms were incorporated into the system to protect the PMTs from potentially 
damaging high light levels caused by accidental exposed to room light or bright fluorescence. These 
electronic mechanisms were an internal overload trigger in the PMT and another inside the external 
amplifier. Images containing bright fluorescent spots (usually of from keratin or melanin) would 
trigger an overload circuit, resulting in a failed attempt to acquire a FLIM image.  The internal 
overload circuit was very sensitive and typically triggered first. Unwanted triggering of either 
overload circuit increased the number of failed attempts to acquire a complete FLIM image and 
prolonged the time taken to obtain a complete image stack from a patient. This was especially 
noticeable when imaging lesions in vivo. As a result, over the period of July to September 2010, the 
internal PMT overload trigger was removed from all 4 detectors. This left the external overload 
trigger which was more tolerant of single bright pixels within an image. 
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4.5.4 Motorised Stage 
 
Figure 4.8 (a) An image of the DermaInspect® with the motorised stage and articulated arm attached. (b) An image from 
above the motorised stage illustrating the position of the microscope objective in relation to the stage. (c) A side image of 
the position of the microscope objective, tissue sample within a petri dish and motorised stage. 
A motorised microscope stage (Scan IM 120 x 80, Märzhäuser Wetzlar Gmbh, Germany) , mounted 
on a custom built frame, attached to the DermaInspect® trolley was used for the sequential 
acquisition of data from several adjacent fields of view from ex vivo samples to create mosaic 
images, see Chapter 7.3.6. Course positioning of the sample in the z plane was made using a 
micrometer screw (figure 4.10f) in addition to the computer controlled piezo positioner controlled 
through the DermaInspect® acquisition software.  The stage could be positioned in the horizontal 
tissue plane with a smallest step size of < 0.1 µm using a joystick or keyboard using software written 
in LabView™ running on a standalone laptop PC. The stage is illustrated in figure 4.8. 
4.6 Tissue Imaging 
4.6.1 Pre-Imaging Tissue Preparation 
 
Figure 4.9 Illustration of how to attach the coupling ring to the skin and the microscope objective of the DermaInspect®. 
Adapted from the DermaInspect User Manual (JenLab 2009). 
a) c)b)
X-Y positioning screws
DermaInspect® microscope objective
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Once an area of skin was selected to be imaged in vivo, it was moistened with a drop of water. A 
coupling ring, with a size 0 (thickness 80-120 µm) and 18 mm diameter cover slip (Assistent®, 
Glaswarenfabrik Karl Hecht GmbH & Co KG,Germany) was then attached to the skin using double 
sided adhesive. Finally, a drop of Immersol ™ 518 F DIN 58.884 (Carl Zeiss Ltd., Germany) was placed 
on upper surface of the cover slip. The patient was then moved to magnetically couple the metal 
ring surrounding the DermaInspect® microscope objective (see figure 4.9). 
 
Figure 4.10 (a) Inverted glass bottomed petri dish used to image ex vivo samples. (b) Metallic coupling rings. Left- used for 
in vivo imaging. Right- coverslip groove removed to allow attachment to petri dish for ex vivo imaging. (c) Transparent 
plastic ring placed over metal coupling ring to indicate the centre of FOV that will be imaged. (d,e) Stage with clips to 
prevent lateral movement of the petri dish/sample during imaging. (f) Sample in petri dish mounted on stage ready to 
image. 
Freshly excised ex vivo tissue was rinsed with Hanks Balanced Salt Solution buffer (HBSS) without 
phenol red, calcium or magnesium (Gibco®, Invitrogen™, CA, USA), its surface moistened with the 
buffer solution and placed on damp gauze in an inverted glass bottomed petri dish containing either 
a size 0 (thickness 80-130 µm) or size 1.5 (thickness 160-190 µm) cover slip (Matek®, USA), figure 
4.10a. Once the lid (containing the cover slip) was replaced, a coupling ring (designed for ex vivo 
use), was adhered to the cover slip surface, so that the FOV of interest would align with the centre of 
the coupling ring and therefore the objective of the DermaInspect®, see figure 4.10b. This was aided 
by the use of a transparent plastic ring with a 1mm central hole (figure 4.10c) which indicated the 
centre of the coupling ring. A metallic plate was designed to accommodate the petri dish under the 
objective and prevent its movement during imaging which could be used with the motorised stage if 
necessary, for imaging ex vivo samples (figure 4.10d-f).  
b)a) c)
e)d) f)
Positioning Screws
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The objective could be adjusted to remain centred within the coupling ring by adjusting the positions 
of two screws shown in figure 4.10f, thereby ensuring that the image was taken from the centre of 
the FOV defined by the plastic ring. 
Ex vivo samples imaged using the motorised stage to create mosaics required lateral movements of 
the petri dish in relation to the objective. Therefore, although the dish was fixed to the stage, it was 
not fixed to the objective using the coupling ring, as outlined above. Instead, a drop of the 
Immersol™ was placed on the surface of the cover slip, the objective was focused and the dish was 
allowed to move under the objective lens as controlled by the motorised stage. 
4.6.2 FLIM Imaging Protocol 
All FLIM images were acquired with the room lights off and the computer screen covered to 
minimise the background light. 
Once the patient/tissue sample was in place, the s.corneum layer was visualised using the 
fluorescent intensity MPT detector by adjusting the depth of focus using the piezo driven objective 
positioner. Initially, the excitation power was restricted to < 12 mW for this layer (as per the 
DermaInspect® manual). 
If required, imaging parameters such as excitation wavelength, magnification, x-y adjustment of the 
objective position were adjusted. The tissue depth reading on the control software was then reset to 
0 µm in preparation for imaging the s.corneum layer. 
The fluorescence beam path was then set to direct fluorescence to the FLIM detector module. The 
excitation power was adjusted to optimise the signal strength for the current imaging depth before a 
FLIM image was acquired (with the computer screen covered to further reduce the background 
light). Once acquired, the image was saved immediately and the objective was repositioned using 
the piezo positioner to image a different depth. Images were taken at approximately 10 µm depth 
intervals in the sample until the dermis was reached. The excitation power was adjusted for each 
image depth. Although most images were acquired using an excitation wavelength of 760 nm, paired 
images at two different wavelengths were taken for some samples. 
FLIM images were acquired over 25.5 seconds. Images were initially acquired using 128 x 128 pixel 
resolution. From 15/8/2011 (from patient ID 4108) acquisition using FIFO FLIM mode was 
successfully implemented and allowed for images with an improved 256 x 256 pixel resolution. Most 
FLIM images were 107 µm x 107 µm2 in size; however a range of sizes between 56 µm x 56µm2 and 
271 µm x 271 µm2 were used. Fluorescence decays were collected with 256 time bins over 12.5 ns. 
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Should the emitted fluorescence from a pixel exceed the detector overload protection threshold, an 
audible warning was produced, the detectors would cut out and require resetting before the image 
could be re-acquired at a lower excitation power. 
At the start of each session, two calibration fluorescence decay measurements were taken. One 
from a blue fluorescent slide (Chroma Technology Corp. USA) with a known lifetime of 0.9 ns for use 
as a lifetime standard and another from gold nanorods with an ultrafast response for use as an 
instrument response function (IRF), see section 4.10.1, pp103. 
A time limit of 3 hours from surgical excision was set for imaging ex vivo samples for imaging i.e. 
before sample fixation in formalin for subsequent histology. This limit was chosen to maintain the 
tissue close to its in vivo state whilst still allowing sufficient time for imaging. Previously published 
studies vary considerably in this regard. For example, many do not define the length of time imaging 
was performed post excision (König and Riemann 2003; Dimitrow, Riemann et al. 2009; Dimitrow, 
Ziemer et al. 2009). In those that have, Benati et al. limited imaging to 45 minutes (Benati, Bellini et 
al. 2011), whilst some had imaging protocols extending from 3 to 6 hours post excision (Cicchi, 
Sestini et al. 2008; Ericson, Simonsson et al. 2008; Paoli, Smedh et al. 2008; De Giorgi, Massi et al. 
2009).  
In our studies a few samples were imaged longer than 3 hours to allow larger montaged mosaic 
images to be acquired. In these cases, images taken after this time limit were used for illustration of 
the image mosaic only and not for the lifetime analysis of the data. 
It was difficult for patients to remain sufficiently still during the entire acquisition time of an image in 
vivo for a number of reasons including the difficulty in maintaining many body sites correctly and the 
long duration of imaging (25 seconds). This caused many images to have significant movement 
artefacts. Improvement was seen after the addition of the articulated arm. However, despite its 
addition, many patients were unable to remain comfortable during imaging. The most successful 
images acquired in vivo were from patients seated in a chair with their arm resting on a couch. 
Further changes such as reducing the acquisition time were not found to make a significant 
difference. 
4.6.3 Spectrometer Imaging Protocol 
Hyperspectral images were always taken following FLIM image acquisition as they required greater 
excitation powers to acquire reasonable images. Typically, after a FLIM image was acquired and 
saved, the fluorescence and necessary electronic signals were directed to the spectrometer. Due to 
limitations in the frame rate of the spectrometer camera, images were acquired over 49.9 seconds 
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at either 32x256 or 41x256 pixel resolution. A background image, (using zero excitation power) was 
acquired in most cases for each individual FOV.  
4.7 Histology 
 
Figure 4.11 Images of sample 4126 recording the stages of the protocol. (a) Macroscopic image of a BCC taken in vivo. (b) 
Dermatoscopic image of BCC taken in vivo (c) Image of freshly excised BCC. (d) Image of sample attached to metallic 
coupling ring with plastic ring placed over to indicate the centre of the FOV/area of BCC to be imaged. (e) BCC after fixation 
with formalin. (f) Ink tattoo to indicate the area of BCC imaged, based on photograph d. (g) BCC cut into 5 sections prior to 
embedding, microtome sectioning and staining. (h) Photograph of stained vertically sectioned slides used to make the 
histological diagnosis. 
Following imaging, ex vivo samples were placed in an aqueous solution of 10% formalin for fixation 
for at least 12 hours. Sectioning of the fixed tissue, prior to embedding was performed by myself or a 
histopathology technician. Following embedding, microtome sections were generated, mounted and 
stained with Haematoxylin & Eosin (H&E). The diagnosis of all ex vivo samples were confirmed 
histologically by a consultant pathologist. Figure 4.11 a-h shows a single lesion photographed at all 
the stages of the imaging and histological processing. 
4.8 Image Co-registration 
Dermatoscopic, FLIM and histological images are all viewed at scales of different orders of 
magnitude and orientation. Dermatoscopic and FLIM images are viewed en face, whilst histological 
slides are cut in vertical sections. These differences in scale and orientation created challenges when 
aligning the FLIM FOV with a specific skin surface feature and when correlating the FLIM images with 
histological structures. It was therefore important to develop a method to co-register the different 
types of images. A plastic ring, as described above and seen in figure 4.10 d, was found to be the 
best method to align the surface features of the lesion with the area being imaged. This method was 
tested and found to allow imaging to within 1x1 mm2 of the defined spot.  
a) c)b) d)
f)e) h)g)
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The following procedure was used for co-registration of features seen in the FLIM images and 
sectioned slides. For samples that were cut-up by myself, the area imaged (as correlated with the 
photographs taken during imaging) was marked on the surface of the tissue by scoring superficially, 
perpendicular to the sectioning plane and tattooing with permanent ink. Histological sections were 
then aligned as accurately as possible using this tattoo.  This is demonstrated in figure 4.11 f-g. For 
the majority of samples either the ink tattoo or the superficial score could be seen in the sectioned 
slides. When these markers could not be seen on the sectioned slides under the microscope, the 
slides from the sections nearest the area imaged (e.g. the 3rd and 4th sections in figure 4.11 g) were 
used as the closest correlate. 
Prior to this method, a number of techniques were tried and were found to be less successful. These 
included marking the tissue with ink prior to imaging & collecting a reflected white light image of the 
sample through the DermaInspect® objective in order to orientate the position of the FOV within the 
sample. These methods were unsuccessful because the ink would often run over the surface of the 
tissue and/or it was very difficult to find the pre-marked spot, once the sample was under the 
DermaInspect®. The white light image was unsuccessful because of the difficulty in acquiring a 
focused image. 
4.9 Experiences with the Modified DermaInspect® 
4.9.1 DermaInspect® Characteristics 
 
Figure 4.12 Graph of emitted power from the excitation laser of the DermaInspect® with software set to the maximum 
power of 50 mW. 
Figure 4.12 plots the peak power output of the DermaInspect ® against excitation wavelength. It 
shows that the peak power of the instrument has been set to 50 mW which can only be achieved at 
800 nm. The pulse length of the excited light is ~150 fs without the articulated arm. Breunig et al. 
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have shown that the pulse duration is maintained at ~150 fs in the image plane when the arm is 
attached (Breunig, Studier et al. 2010) over most wavelengths. 
4.9.2 Detector Cross Talk 
    % signal recorded 
    Blue Green Yellow Red 
Activated Blue   0 0.000891 0 
Detector Green 0   0.023234 0 
  Yellow 0 0   0 
  Red 0 0 0.00049   
Table 4.3 shows the % of electrical crosstalk between the PMT detectors when the gold nanorod slide is excited and each 
detector it activated in turn with the photon count measured in all. 
The electrical cross talk was assessed by measuring the luminescence decay in all 4 spectral channels 
when the gold nanorod IRF slide was excited at 760 nm. A reading was performed for each PMT 
activated in turn. Table 4.3 shows that the % electrical crosstalk between the detectors is <0.05%. 
The optical cross talk can be seen by the transmission curves previously shown in figure 4.6. 
4.9.3 Clinical Experience 
This section describes experiences using the DermaInspect® to acquire clinical images. 
Figure 4.13 Fluorescence intensity & false colour FLIM images for each spectral channel are shown of an image taken at 
110 µm depth of the basal layer of normal skin (ID 4117 fov3).  
In the first instance, figure 4.13 is a typical image taken with the 4 spectral channels from normal 
skin and shows fluorescence intensity and FLIM images. All images have been taken from the same 
field of view of normal skin. It illustrates the increased contrast benefits of acquiring fluorescence 
lifetimes in more than one spectral channel. Figures 4.13a-d show that contrast between different 
structures can be seen in the fluorescence intensity images recorded in the 4 spectral channels that 
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is not visible in the calculated total fluorescence intensity image (Figure 4.13e). The second harmonic 
generation (SHG) signal from collagen, seen in the tips of the dermal papilla, dominates the blue 
spectral channel (Figure 4.13a) and can be visually separated from the weaker intracellular 
fluorophores (c.f. Figure 4.13b-d). It is however difficult to visually separate the multiple 
fluorophores contributing to the green, yellow and red channels (Figure 4.13b-d) using the 
fluorescence intensity images alone. The addition of the fluorescence lifetime information (Figures 
4.13f-i) allows NAD(P)H autofluorescence (blue-green on false colour scale), dominant in the green 
spectral channel to be easily distinguished from melanin (short lifetime (Teuchner, Freyer et al. 
1999) red on false colour scale), which is dominant in the red spectral channel. The yellow spectral 
channel includes fluorescence from flavins, NAD(P)H and melanin. The multiple FLIM spectral 
channels also allow SHG from collagen, (with an instantaneous decay) seen in the blue channel, and 
elastin (with a long fluorescence lifetime (König and Schneckenburger 1994)), seen in the 
green/yellow channels, to be distinguished from the same spatial location within the dermal papilla. 
One disadvantage of the method of tissue preparation prior to imaging is that the useful imaging 
depth is reduced by the distance between the bottom surface of the cover slip and the s.corneum. 
For example, this can significantly affect the ability to image the epidermis when the surface of the 
tissue is not flat. Despite this, images with a good signal to noise ratio were obtainable to a tissue 
depth of 100 – 150 µm in the majority of cases. However, this restriction excluded imaging of 
lesions/normal skin that had significant hyperkeratosis (thick s.corneum), including many actinic 
keratosis and cutaneous squamous cell carcinomas. In these cases, only images from the s.corneum 
were possible. 
A difficulty in developing the DermaInspect® was that software changes were difficult and costly to 
approve, as the CE marking of the device could not be compromised. It prevented the integration of 
all the software into a single user friendly interface. Instead, the following software tools were used 
to acquire the images presented in this thesis: JenLab GmbH software controlled the excitation 
parameters; Mai Tai laser software controlled the laser excitation wavelength; SPCM (Becker & 
Hickl) was used for FLIM acquisition; Spectometer control/acquisition software (Andor™) controlled 
the spectrometer; and in house software (written in LabVIEW®) was used to control the motorised 
stage.  Some integration was instituted through AutoIT, an automating and scripting language for 
windows GUIs. For the future, improved software integration for image acquisition would reduce the 
risk of errors and allow images to be acquired in vivo more easily. 
Over the project, the incremental changes made to the DermaInspect® improved the clinical 
experience both for the patient and the clinician. Initially, limited automation of the control software 
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using AutoIT (Jonathan Bennett & AutoIt Consulting Ltd), as described above, improved efficiency. 
This included code to automatically reset the PMTs once the overload protection was triggered and, 
code to co-ordinate the JenLab GmbH and Becker Hickl software to allow automatic image 
acquisition and automatic saving & standardised image file names. Much time was also saved by 
raising the internal PMT overload protection threshold, which reduced the likelihood that the 
overload trigger was tripped.  
Finally the addition of the articulated arm had a significant impact on the number of body sites that 
could be imaged in vivo. Furthermore, as patients were no longer required to physically strain to be 
imaged, the extremities could be imaged for longer periods of time and less movement artefact was 
seen in the images acquired. 
4.10 Analysis 
4.10.1 Instrument Response Function 
 
Figure 4.14 (a) A plot of the recorded SHG signal from Urea Crystals above and below 500 nm. (b) A plot of the measured 
luminescence of the signal from gold nanorods in each spectral channel. (c) A plot comparing the signals measured 
between urea crystals and gold nanorods using the DermaInspect®. (d) A electron microscope image of the gold nanorods 
used. Image courtesy of Fulvio Ratto. Inst. di Fisica Applicata, Consiglio Nazionale delle Ricerche, Fiorentino, Italy. 
In order to accurately fit acquired fluorescence decay data, it is necessary to convolue the 
fluorescence decay model with an instrument response function (IRF).This process adjusts the model 
for the artefactual effects caused by the instrument itself. For this purpose, an IRF was collected by 
exciting a substance with a very short luminescence prior to each imaging session and allowed the 
fluorescence decay model to be adjusted as the system was modified over time. 
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For the preliminary studies using a modified DermaInspect® and 2 emission spectral channels 
(Patalay, Talbot et al. 2011), the IRF was measured by excited urea crystals to generate an SHG 
signal. This had the disadvantage that the SHG signal was only emitted at ½ the excitation 
wavelength and therefore was only detectable in a single spectral channel, see figure 4.14a. 
Since that time, the method of collecting an IRF in multiple spectral channels by exploiting the 
broadband ultrafast luminescence (< 50fs) from gold nanorods was described  by Talbot et al. 
(Talbot, Patalay et al. 2011). Gold nanorod luminescence provides a similar IRF to that emitted by 
urea crystals, as can be seen in figure 4.14c, and due to the broadband nature of their emission, they 
were better suited to providing an IRF in this multispectral system, see figure 4.14b.  
4.10.2 Fluorescence Decay Models 
In MPT of live biological tissue, the number of photons collected per pixel is limited because of 
restrictions on imaging duration and maximum allowed excitation power.  This in turn restricts the 
complexity of the decay models that can be used to fit the data. Two fluorescence decay models 
were used for the work presented in this thesis – a single exponential decay model for generating 
FLIM images and a double exponential decay model for the FLIM analysis. 
Fluorescence images were acquired at either 128 x 128 pixels or 256 x 256 pixels resolution, over 12 
ns into 256 time bins. 
4.10.3 Single Exponential Decay Model 
 
Figure 4.15 (a) Fluorescence intensity image (b) Colour map of the fluorescence lifetime calculated for each pixel (c) A 
merged fluorescence intensity and lifetime image taken from the green spectral channel (ID 4210 image 2). 
For the purposes of displaying an image, a single exponential decay model was used to fit the 
fluorescence decay at each pixel of the images in each spectral channel, as insufficient photons were 
collected to calculate a more complex decay reliably. This was performed using fitting software 
written in C++ and Matlab® (R2010b, The Mathworks Inc., USA) by Sean Warren and with a user 
interface written by Dr Clifford Talbot.  
2000 ps
200 psa) c)b)
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For 128x128 resolution images the decay data was smoothed spatially using a 3x3 kernel prior to 
fitting each pixel. The fitting model accounted for effects of incomplete decays and the IRF obtained 
from gold nanorods was used with a temporal offset fixed to zero. The resulting FLIM map was then 
merged with the fluorescence intensity image. 
Initially the 256x256 resolution images were binned to 128x128 prior to fitting. The FLIM image was 
then merged with the 128x128 resolution intensity image and upscaled using linear interpolation to 
256x256 pixels again (see figure 4.15c). The final method used was to spatially smooth 256x256 
resolution images using a 5x5 kernel without binning prior to fitting. The fitted FLIM image was then 
merged with the intensity image. This image could then be upscaled as necessary, depending on the 
monitor size and resolution to 384x384. This final method was chosen to allow FLIM images similar 
in resolution to that used in SPCImage (Becker & Hickl, GmbH) to be generated. 
The intensity merged FLIM images were then used to assess the morphological features in the 
samples. 
4.10.4 Manual Regions of Interest (ROI) segmentation 
 
Figure 4.16 (a) Fluorescence intensity image (b) Intensity image with overlay indicating the manually defined ROIs 
corresponding to each cell in the image. 
To allowing a more complex decay model to be used, images were segmented to combine the 
fluorescence from multiple pixels and increase the number of photons available for fitting.  The 
photons were binned spatially for the area corresponding to each cell within each image into regions 
of interest (ROI), see figure 4.16. 
ROI were defined manually using software written in Labview™ 7.1 by Dr Chris Dunsby, Dr Sunil 
Kumar and Dr Clifford Talbot. A threshold of 1000 photons in the total cell fluorescence decay was 
deemed sufficient to reliably fit a double exponential decay model for the lifetime analysis. Decay 
curves from a single spectral channel containing fewer than 1000 photons were therefore excluded 
from the analysis.  
a) b)
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Although smoothing was used to increase the number of photons available to fit the single 
exponential decays used to generate the merged FLIM images, it was not used here. A disadvantage 
of smoothing is that it is performed over the entire image indiscriminately, counting light from both 
intracellular and extracellular regions and, for our data, would still have insufficient photons to fit a 
more complex decay model.  
The use of ROI-integrated decays allowed sufficient photons to fit a double exponential decay model 
and the calculated lifetimes to reflect intracellular fluorophores only. This allowed each lifetime to 
be biologically meaningful by corresponding to a single cell. It further enabled analysis of different 
cell populations within a sample and comparison between different samples and disease states to be 
performed. 
 
Figure 4.17 (a) A fluorescence intensity image with a pixel (red) and cell (green) highlighted. (b) Plot of the fluorescence 
decay curves of the pixel and cell shown in (a). (c) The fluorescence  emission spectrum from the pixel shown in (a). (d) The 
fluorescence emission spectrum from the cell shown in (a). 
Figure 4.17a shows a single pixel (red) within a cell (outlined in green) in a fluorescence intensity 
image. Figure 4.17b shows the resulting decays from the single pixel and cell ROI. Figure 4.17c-d 
demonstrates this same improvement with the emission spectra gained from the spectrometer from 
the same FOV. 
4.10.5 Double Exponential Decay Model 
For the fluorescence decay analysis, it was desirable to employ a more complex decay model than a 
single exponential decay. A double exponential decay model was chosen as it provided a reasonable 
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fit to the data and allowed information to be gleaned regarding the complex nature of the 
underlying fluorescence decay, which is considerably more complex. The skin autofluorescence 
originates from multiple fluorescent species, each of which are themselves likely to exhibit complex 
decay profiles. For example, free NADH in solution is known to have a double exponential decay and 
the fluorescence lifetimes of both components can change when they bind to proteins.  
Furthermore, there are a large number of potential protein binding partners and therefore more 
than 4 decay components are required for intracellular NADH alone (Vishwasrao, Heikal et al. 2005). 
Similarly, melanin is known to have at least 3 fluorescence decay components (Teuchner, Freyer et 
al. 1999).  
Given the limited number of detected photons available, only two decay components were chosen 
to fit to the fluorescence signal from each ROI. Therefore, the short and long fluorescence decay 
components (τ1 and τ2) serve to summarise the changes occurring in a complex biological system 
exhibiting a multi-exponential decay. 
The measured fluorescence decay per ROI for each channel was calculated by spatially summing the 
photons. This was then fitted to a double exponential model using non-linear least squares 
minimization (Levenberg-Marquardt method). Software was written in Matlab® by Dr Yuriy 
Alexandrov. Figure 4.18 illustrates a typical lifetime fitted to a double exponential decay model (the 
cell ROI signal highlighted in green in figure 4.17a). 
 
Figure 4.18 Illustration of a fluorescence decay fitted using a double exponential decay model with the residuals of the fit 
shown below. 
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The double exponential decay model used is described in Patalay et al. (Patalay, Talbot et al. 2012) 
and briefly below and was implemented using Matlab®.  It accounted for incomplete exponential 
decays, background noise and detector after-pulsing. It was then convolved with the measured IRF  
to calculate a predicted fluorescence (Lakowicz 1999;P103), which was then used to fit to the 
measured data for each time point. 
Prior to convolution, the IRF was pre-processed by subtracting the horizontal long-time asymptote 
or ‘pedestal’ and normalised to the unit area.  The main contributing factors to this pedestal were a 
small signal-independent contribution from background noise (stray light, electronic noise and 
cosmic rays) and a much larger signal-dependent contribution from after-pulsing (caused by a 
delayed response of the PMT to a small fraction of preceding laser pulses) (Becker 2005 ;P233). 
    ∑
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        Equation 4.1 
The ‘data-weighted’ definition of the fitting error function 2  was used as it was found to be less 
biased when fitting a double exponential decay model, equation 4.1, see also (Lakowicz 1999 ;P119). 
Here, tk is the time delay of the k
th bin (Nbins = 256 for our system), Ipredicted is the predicted 
fluorescence and Imeasured is the recorded fluorescence signal at each time delay. The fluorescence 
lifetime parameters fitted were 1, 2, and the f1 (fractional component of τ1).  f2 was calculated as 1- 
f1. The fitting was implemented using the Matlab® “lsqnonlin” function to find the four fitting 
parameters ]min[arg},,,{ 2211  fittedtot fI . Individual decays with fewer than 1000 photons per ROI 
per channel were discarded. 
4.10.6 Fluorescence Decay Quantifiers 
The following section lists the parameters that were calculated from the fluorescence decays.  
a) The total fluorescence signal was calculated by first correcting for the PMT background and 
after-pulsing effects, and then calibrating against the signal acquired daily from a reference 
fluorophore with a known fluorescence emission spectrum (blue fluorescent slide from 
Chroma Technology Corp., Vermont, USA). 
b) The relative fluorescence (RF) in each channel was calculated for each ROI using the total 
fluorescence (F) in each channel using the equation 4.2 below where the relative 
fluorescence and total fluorescence from each spectral channel in indicated by the subscript 
letter. 
rygb
b
b
FFFF
F
RF

       Equation 4.2
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c) τ1 is the short lifetime component.    is the short lifetime component contribution. τ2 is the 
long lifetime component.    is the long lifetime component contribution. τmean is calculated 
using the equation 4.3 below 
 τmean =            (    )         Equation 4.3 
 
d) The coefficient of variation (CV) was defined as the ratio of standard deviation of ROI pixels’ 
intensities to their mean. In order to exclude the contribution of the Poisson pixel noise to 
CV values, the corrected formula was applied, where VarROI and EROI are the estimates of the 
variance and expectation (average) of the intensity of ROI pixels, respectively. See equation 
4.4 
  2/12 )(/1)(/)( IEIEIVarCV ROIROIROI      Equation 4.4 
4.10.7 Cellular Morphological Quantifiers 
Parameter Description 
Perimeter Perimeter of ROI’s boundary (µm) 
Major Axis Length The length of major axis of the effective ellipse (µm) 
Minor Axis Length The length of minor axis of the effective ellipse (µm) 
Gyration Radius A linear measure of distance of a point on the ROI from the 
centre, an indirect measure of effective linear size (µm) 
Area Area of ROI (µm2) 
Shape Factor Perimeter2/(4πArea). A measure of how circular an object is 
(equals 1 for a circle and >1 for any other figure) 
Solidity Ratio of cell area to the area of a convex hull. A measure of 
negative curvature. Equals maximum of 1 for a shape with no 
concave parts e.g. a circle or square 
Flattening Factor Ratio of minor to major axis. A measure of flatness. 
Table 4.4 Description of the cellular morphological quantifiers that were measured and calculated for the analysis. 
The cellular morphology quantifiers were based on cell ROI geometry and are defined in table 4.4 
above. A standard Matlab® morphometry routine “regionprops” was applied to obtain several 
geometric features such as Solidity and Major and Minor Axis Lengths. The dimensional geometric 
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parameters (e.g. area and distance measured in microns) were calculated taking into account image 
magnification. 
 
Figure 4.19 (a) Fluorescence Intensity image with ROI overlaid. (b-d) Adjacency graphs generated using 3 methods to define 
the nearest neighbour ROIs. 
Another group of morphology features was designed to study properties of groups of neighbouring 
cells.  These methods first define local neighbourhood relations via adjacency graphs in the image 
between a ‘central’ cell and its neighbouring cells. The Delaunay triangulation, Gabriel and Sphere of 
Influence (SOI) graphs (Bivand, Pebesma et al. 2008;P245) were constructed for this purpose for 
each field of view, see figure 4.19 .  
Parameter Description 
Cell Density The effective number of ROIs per µm2 
Cell Confluency Relative area occupied in the image by a ROI and its neighbouring 
ROIs. Indirect measure of the area of cytoplasm present and 
therefore scales inversely with the amount of extracellular matrix 
present. 
Orientation SD Standard deviation of the angle of the major axis of a ROI and its 
neighbouring ROIs (degrees) 
Number of 
Neighbours 
The number of neighbouring ROIs 
Distance to 
Neighbours 
The average distance to a neighbouring ROI (µm) 
Table 4.5 Description of the descriptors used to evaluate the density and relationship of ROIs/cell between each other. 
The morphological features used to quantify the relationship of each cell with its neighbours are 
listed in table 4.5. Every cell was characterised (for every adjacency graph) by its number of 
Sphere Of Influence Gabriel Delaunay triangulationIntensity image with ROIs
(a) (b) (d)(c)
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neighbours (   ) and average distance to the neighbour(   ). The local cell density and the cell 
confluency were estimated using the area of the effective influence circle as defined below in 
equation 4.5 where dnb is the distance to neighbour. 
         
         Equation 4.5  
The cell density, defined below in equation 4.6 and is calculated using the number of neighbouring 
cells to a central cell and the area of influence, where Ainf is the effective influence circle and nnb is 
the average number of nearest neighbours. It is independent of cell size.  
            
  ∑
 
   ( )
     
   
    
       Equation 4.6  
The calculation for cell confluency (equation 4.7) uses the area of a central cell (Areacell) as a 
reference and calculates the ratio of average cell area of the neighbouring cells to the area of ‘formal 
free space’ for this cell, where Ainf is the effective influence circle and nnb is the average number of 
nearest neighbours. 
                
 
        
(∑     ( )           
      
   )
    
    Equation 4.7  
Therefore, if cells have the same geometrical position but are larger in size, this ratio will be bigger, 
whereas cell density will not. 
4.10.8 Automatic Segmentation 
Manual segmentation of images was very time consuming for the number of images acquired. 
Therefore an algorithm to automatically segment images into ROIs was attempted. Automatic image 
segmentation was performed using size-tuned non-linear top-hat detection which has been 
previously used by Santos et al. (Santos, Zaltsman et al. 2008). This method applied a pixel-wise 
transformation to the image (formula A2.1 in Santos et al.) that enhanced the brightness of a pixel if 
its close vicinity was also bright and its distant vicinity was dim. A user defined threshold was then 
applied to the transformed image. The resulting binary images were then morphologically smoothed 
using the Matlab® ‘imopen’ function and spatially distinct regions identified. These regions were 
then size-sieved using standard Matlab® image processing functions to remove objects smaller than 
35 µm2. The same procedure, including all parameters, was applied uniformly across all images. 
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Figure 4.20 (a) Fluorescence Intensity Image and (b) Intensity image shown in (a) with manually segmented ROIs overlaid. 
(c) Intensity image with automatically segmented ROIs overlaid. 
The automated approach was used to segment the images used for the analysis of normal skin to 
follow the changes in lifetime over time post excision, described in Chapter 5 (pp115). The 
application of the automatic ROI segmentation greatly reduced input from the user but was not 
found to be as accurate as defining individual cells as the manually defined ROIs, typically generating 
many more ROIs. This can be appreciated in figure 4.20c.  As this analysis focused on the average 
changes in the lifetimes of cells over the whole FOV, the difference in the manual and automated 
segmentation was not important as long as each was internally consistent between images. 
4.10.9 Statistics 
The data within most summary tables were compiled using SPSS 18 (SPSS Inc. IL, USA).All the 
spectroscopic, lifetime and morphological parameters and the statistical calculations were 
performed by Dr Yuiry Alexandrov. The Wilcoxon Rank Sum test (Lupton 1993;P119-28) was applied 
to study the difference in distribution and their significance between BCC and normal skin or 
between pigmented lesions groups.  
The discriminative ability of the individual spectroscopic and morphological ROI measurements were 
assessed using 2 parameters which were implemented using Matlab®  
- Receiver Operator Characteristic  Area Under the Curve (AUC,(Mathews 2010;P158)) which 
measures the probability that the source diagnosis of the cell/ROIs would be correctly 
identified. 
- Cohen’s d  statistic (Gravetter and Wallnau 2009;P262) measures the difference between 
the means of two populations e.g. normal skin and BCC ROIs and is a marker for the 
discrimination between them. 
To determine discrimination using multiple parameters, linear discriminant analysis (LDA) was 
performed. To reduce the dimensionality of the data, which included spectroscopic +/- cellular 
a) b) c)
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morphology parameters, a correlation-matrix based principal component analysis (PCA) was 
performed first (Joliffe 2002;P24). The initial 4 principal components were then selected to be used 
in the LDA.  To perform this, the Matlab® functions “cov” was used to get a covariation matrix. This 
was transformed into a correlation matrix before the Matlab® function “pcacov” was used to 
calculate PCA coefficients. The Matlab® function “classify” was then used to perform LDA for each 
ROI using a leave one out approach, to classify which diagnostic group it arose from e.g. either BCC 
or normal skin, or naevi or melanoma. Initially each patient was characterised by the fraction of 
malignant and Normal ROIs determined by LDA. These fractions could then be used to build ROC 
curves from which AUC could be calculated and sensitivities and specificities for a given diagnostic 
threshold to diagnose a patient correctly could be generated. 
This process was applied using manually segmented ROIs, automatically segmented ROIs and for 
unsegmented images. Cellular morphological parameters were removed from the PCA when using 
automatically segmented images, due to its lack of accuracy defining individual cells, and for 
unsegmented images. Unsegmented images were analysed by first spatially integrating the 
fluorescence decay profiles over each field of view, fitting the resulting decays and then calculating 
the mean spectroscopic parameters for each patient.  
Sensitivity and specificity were also calculated for the visual assessment of morphological features 
present in the FLIM images. For the example of BCC vs normal skin, the sensitivity was calculated as 
the number of patients correctly determined to have a BCC using a given threshold number of 
diagnostic features divided by the total number of patients with BCCs. The sensitivity was calculated 
as the number patients correctly determined not to have a BCC using this threshold divided by the 
total number of patients without BCCs. 
4.11 Summary 
This chapter has described the methods, instrumentation and the analytical techniques used to 
obtain the results discussed in this thesis. 
In Section 4.2 the criteria for patient recruitment and the minimum data set collected from each is 
first described. This is followed by  the details of the ethics approvals that were gained in order to 
perform this research. 
Sections 4.4 – 4.5 describe the technical details of the original DermaInspect® and the modifications 
made over time to allow collection of FLIM in 4 spectral channels and of hyperspectral images.  
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Section 4.6 outlines the procedure used to prepare the skin (both in vivo and ex vivo) prior to 
imaging and the imaging protocol for acquiring FLIM and hyperspectral images.  
A discussion can then be found of the methods used to process the tissue histologically to improve 
the co-registration of FLIM images with the dermatoscopic and histological images in section 4.7 and 
4.8. The final section regarding methods (Section 4.9) outlines the characteristics of the 
DermInspect® and our clinical experiences using the device. 
Finally the methods of analysis of the collected fluorescence and fluorescence lifetimes are 
discussed in section 4.10. 
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Chapter 5. An analysis of the effect of surgical excision on tissue 
autofluorescence of normal skin. 
5.1 Aim 
In this chapter, the changes in tissue autofluorescence and lifetime are monitored over a 3 hour time 
period after excision. This is the first time this has been performed using multispectral FLIM and the 
first time over this time period using human skin. The lifetimes from cells acquired in vivo vs. ex vivo 
are then compared directly. 
5.2 Introduction 
Multiphoton tomography (MPT) intensity imaging and multispectral MPT FLIM has been used to 
investigate changes in normal and cancerous skin, both in vivo and ex vivo. In many cases 
investigating skin in vivo is not possible for ethical reasons or practical concerns, e.g. motion 
artefacts and difficulty imaging highly curved surfaces. In these circumstances the use of excised, 
unfixed ex vivo skin is a necessary surrogate for in vivo imaging.  
As soon as skin is excised, it is removed from its homeostatic environment. Hypoxia and hypercapnia 
start to occur immediately which affect the metabolism of the cells in the tissue sample, ultimately 
leading to cell death. The rate at which these changes affect intracellular metabolism (and therefore 
autofluorescence) is dependent on many factors, including cell type and origin and whether normal 
or malignant tissue is used. 
The published studies performed using unfixed, excised skin have varied in the length of time post-
excision imaging was performed.  Some studies had imaging protocols extending from 3 to 6 hours 
post excision (Cicchi, Sestini et al. 2008; Ericson, Simonsson et al. 2008; Paoli, Smedh et al. 2008; De 
Giorgi, Massi et al. 2009), whilst other had no times reported (König and Riemann 2003; Dimitrow, 
Riemann et al. 2009; Dimitrow, Ziemer et al. 2009). 
In this study, freshly excised normal human skin samples were taken and the changes seen in 
autofluorescence and lifetime were measured regularly up to 3 hours post excision. A further 
comparison was then made between normal skin in vivo and ex vivo. 
5.2.1 Previous Literature 
Two studies have been published to date to evaluate the changes in autofluorescence following 
ischaemia/excision of the skin. Sanchez et al. studied the changes in autofluorescence intensity and 
lifetimes of human skin daily over a 7 day time period (Sanchez, Prow et al. 2010).  Palero et al. 
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investigated the changes in autofluorescence emission spectra emitted from mouse skin both in vivo 
and post euthanasia over a 3.3 hour time period (Palero, Bader et al. 2011). These studies will be 
described in detail below. 
5.2.1.1 Sanchez et al. 2010 
Following surgical excision, Sanchez et al. monitored the effect of ischaemic necrosis over time on 
tissue autofluorescence when incubated with/without culture medium and at different 
temperatures (-20 oC, 4 oC , 37 oC and room temperature) daily for 7 days. Up to 3 samples of human 
abdominal skin were tested in each environment and an in vivo control image was also acquired 
from the forearm of one volunteer. Tissue was excited using 740 nm at 25 mW and images of 52 x 52 
µm in size were collected over 13.6 s. The s.spinosum was imaged using cellular morphology to 
assess when the correct depth of imaging was attained. Band pass filters were used to selectively 
collect autofluorescence from NAD(P)H (350-450 nm), keratin (450-515 nm) and FAD (515-620 nm).  
 
Figure 5.1 Change in autofluorescence of ex vivo human skin with time over 7 days relative to baseline. Total mean 
fluorescence intensity (350-620 nm) (a) at room temperature and (b) at 37oC. Mean photon count from the NAD(P)H 
spectral channel (350-450 nm) (c) at room temperature and (d) at 37oC. Key: Solid line – without culture medium. Dotted 
line - with culture medium. Reproduced from Sanchez et al. (Sanchez, Prow et al. 2010). 
They found that without culture medium and storage at room temperature, tissue autofluorescence 
could still be detected after 7 days duration. The presence of culture medium accelerated changes in 
autofluorescence intensity seen over time, whilst reducing the temperature slowed them. The 
autofluorescence intensity for each day was calculated by averaging the photon counts for each 
image in the 3 samples and normalising by the image taken at day 0 from the excised skin. See figure 
5.1 reproduced from the paper. Over the first 24 hours, when the tissue was incubated without 
culture medium (solid black line), the total autofluorescence intensity reduced to ~50% at room 
temperature (panel a) but to less than 25% at 37 oC (panel b). This drop in intensity plateaued over 
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the ensuing 24 hours and ultimately increased to 200% of its initial intensity on day 4 at room 
temperature. Although the same trend was seen at 37 oC, the intensity only recovered to 50% of its 
initial value.  
Without medium, the NAD(P)H channel showed a slight increase in its fluorescence intensity after 24 
hours at room temperature (panel c), and fluctuating around the baseline intensity over the 
remaining 6 days. At 37oC (panel d), the same drop in intensity over time as that seen with total 
intensity (panel b) was found. 
Fluorescence lifetimes for NAD(P)H were calculated for each pixel using a double exponential model 
using SPCImage (Becker & Hickl, GmbH). Some ex vivo samples showed a new lifetime peak at ~ 800 
ps in τ1 at day 0 in addition to the previously seen peak at ~400 ps seen in vivo.  τ2 showed a 
broadening of the peak at ~2500 ps seen in vivo following excision. τmean showed a progressive 
increase from ~1000 ps to 2000 ps with time whilst autofluorescence was still present over the 7 
days period. No information was included in the paper of the time post-excision the images taken on 
day 0. 
5.2.1.2 Palero et al. 2011 
Palero et al. looked at NAD(P)H autofluorescence in the epidermis of mouse skin over 3.3 hours 
(Palero, Bader et al. 2011). They used MPT but recorded spectrally resolved fluorescence images, 
without lifetime information. The abdomens of two mice were imaged in vivo whilst anaesthetised. 
The changes following euthanasia of the mouse was monitored every 3 minutes for 3.3 hours whilst 
the animal was on a temperature-controlled stage. The epidermis was illuminated using an 
excitation wavelength of 765 nm and power of 5 mW. Images of 224 x 224 pixels covering 100 µm x 
100 µm were acquired over a 2 minute period. The spectral resolution was 0.5 nm over 350 – 600 
nm range i.e. sufficient to detect the small shift in the peak spectral emission between protein 
bound (445 nm) and free (460 nm) NAD(P)H, despite their large spectral overlap. Spectral changes 
were examined over a fixed area within the image sets covering approximately 25 cells from the 
s.spinosum. A spectral shift in the peak fluorescence emission wavelength was detected with time. 
An in vivo spectral peak of 456 nm seen at t= -29 minutes moved to 450 nm after 20 minutes, 455 
nm at 80 minutes and 460 nm at 150 minutes. This suggested a shift from protein-bound to free 
NAD(P)H with time. 
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Figure 5.2 The change in relative amplitude of the fluorescence from a sample of mouse skin over time pre/post 
euthanasia. Key: A1 -protein bound NAD(P)H component, A2 - free NAD(P)H component, A3 - flavins (in the figure). 
Reproduced from Palero et al. (Palero, Bader et al. 2011). 
The total fluorescence intensity was seen to increase initially in all wavelengths, peaking at 80 mins 
(x1.7 fold). It then fell to below the initial intensity after 110 mins.  Linear spectral unmixing was 
performed using 3 spectral components to estimate the changes in protein-bound peak (fixed at 448 
nm), free NAD(P)H peak (fixed at 459 nm) and flavins peak (fixed at 528 nm), see figure 5.2. A good 
fit was obtained using this method and showed that flavins (A3 in the figure) had the smallest 
contribution to the emission spectra of ~5% which remained unchanging over time. They found a 
doubling (x113%) in the amplitude of protein bound NAD(P)H component (A1 in the figure) at 50 
mins, which returned to baseline at 100 mins and remained reduced for the duration of the 
experiment (~70%). The free NAD(P)H component (A2 in the figure) also increased with a broad peak 
at ~100mins (85%) which fell slowly to 25% of baseline amplitude. The greatest change in the 
free/bound NAD(P)H ratio was seen at ~50 mins. 
5.3 Method 
5.3.1 Instrumentation 
Lifetime resolved imaging was performed using the instrument previously been described in Chapter 
4.4. FLIM images were acquired by four emission spectral channels defined as blue (360-425 nm), 
green (425-515 nm), yellow (515-620 nm) and red (620- 655nm). All images were acquired at 760 nm 
excitation wavelength. 
Euthanasia protein bound NAD(P)H
free NAD(P)H
flavins
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5.3.2 Tissue samples 
 
Figure 5.3 An exemplar tissue sample used in our study (ID 4210). (a) Image of BCC in vivo. (b) Image of lesion excised. (c) 
Image following removal of peri-lesional normal skin prior to imaging.  
Patients attending the Dermatology Department, Imperial College Healthcare NHS Trust, having 
suspected skin cancers requiring excision, consented to have their tissue imaged. Larger lesions with 
sufficient peri-lesional normal skin for imaging were selected for this study. 5 skin samples were 
collected, with a typical example presented in figure 5.3. Once excised, the peri-lesional normal skin 
was separated and prepared for imaging as previously outlined in Chapter 4.6.1 (pp95). Briefly, it 
was rinsed and moistened using HBSS and mounted on damp gauze in an inverted plastic petri dish 
containing an embedded cover slip. A field of view (FOV) centrally within the sample without 
obvious superficial blemishes was then selected for imaging. All imaging was conducted at room 
temperature. 
5.3.3 Imaging protocol 
Once the tissue was in focus, the s.spinosum layer of the epidermis was identified visually by cellular 
morphology and used for imaging in all samples. This layer is the thickest in the epidermis and 
therefore easiest to remain within in spite of the large degree of tissue movement that occurred in 
some samples during imaging. Images were acquired and saved as outlined previously in Chapter 
4.6.2 (pp97). Initially, the excitation power was optimised in a plane of focus within 5 µm away from 
that used for imaging, to minimise possible photobleaching/ phototoxicity. Once the imaging plane 
of focus was selected, the excitation power was fixed throughout each experiment. Images were 
acquired over 25.5 seconds using excitation powers between 4-10 mW. All images had a field of view 
of 107 x 107 µm2 and were taken with a resolution of 256x256 pixels with pixel size of 0.42 µm (FIFO 
images, zoom=800). Images were acquired until 3 hours post time of excision. 
The time of excision was noted to the closest minute. Thereafter the time was recorded to the 
second using the PC clock on the DermaInspect®. The time post excision of each image taken was 
extracted from the save time of the FLIM image file.  This save time included a delay of less than a 
minute between completion of image acquisition and the time stamp given to the saved file. This 
a) c)b)
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time delay consisted of manually removing the shielding of the PC computer screen, activating the 
automated save macro following the emitted ‘end of imaging’ audible warning and a relatively fixed 
delay for the PC to save the 128 Megabyte image.  The total delay was in the range of 30-60 seconds. 
This delay however was short compared to the time scale of the experiment. 
When this imaging method was trialled, it was found that the tissue relaxed and moved away from 
the objective and therefore down in relation to the fixed depth of view of the microscope. This 
movement was most pronounced initially but continued to occur over the whole imaging period. To 
maintain a static FOV for the experiment, the depth of focus was adjusted as follows.  
As a reference, the first FLIM image acquired was left on screen, adjacent to the imaging acquisition 
window on the DermaInspect® PC desktop. This reference image was compared by eye to every 
subsequent image taken to ensure the FOV remained static. During period of large tissue movement, 
typically within the initial hour, frames of 2.5 seconds were viewed (with no change to the excitation 
power) to confirm no change occurred from the reference FOV and adjust the FOV depth if 
necessary. Scans of 2.5 seconds were used for this purpose to minimising possible photobleaching 
effects to the tissue, before acquiring the actual FLIM image over 25.5 seconds. If the FOV of the 
reference image could not be found due to excessive movement, another reference image was 
taken and used for successive image acquisitions.  
5.3.4 Image analysis 
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Figure 5.4. A series of sequentially taken FLIM images from sample 4210 taken in the yellow channel, numbered in the 
bottom left corner of each image. FLIM images 1,3,7 were discarded due to changes in FOV compared to the remaining 
images. The FLIM scale bar is shown on the right of each image. The image acquisition time given in min:seconds is shown 
centrally under each image. 
FLIM images were generated, fitting each pixel with a single exponential decay model, as described 
in Chapter 4.10.3 (pp104). This allowed images with a difference in their FOV, not identified during 
image acquisition, to be discarded. An exemplar set of acquired images including those discarded 
from further analysis is presented in figure 5.4. 
Due to the large number of images acquired and the variability of manually defining the same region 
of interests (ROIs) over a series of near identical images, an automated image segmentation 
algorithm was used. The segmentation was based on multiscale nonlinear local thresholding (Santos, 
Zaltsman et al. 2008) and is described further in Chapter 4.10.8 (pp111) and illustrated for a number 
of sequentially acquired images in figure 5.5. The fluorescence lifetimes parameters (τ1, τ2, f1, τmean) 
of each ROI in the images were then fitted using a double exponential decay model as described in 
Chapter 4.10.5 (pp106). 
 
Figure 5.5 Set of sequentially acquired images (ID 11, 12, 13) taken in the yellow channel from sample 4117. 1st column 
(a,e,i) - FLIM images with lifetime scale bar on the right of each panel. 2nd column (b,f,j) – fluorescence intensity images. 3rd 
column (c, g,k) – automatically segmented ROIs overlaid on each intensity image. 4th column (g,h,l) – close up of top left 
hand corner of images of automatically segmented ROIs. Images 107 µm x 107 µm, 256x256 pixels. Scale Bar 25 µm. 
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In order to monitor the changes in lifetime between images, the average ROI lifetime parameters 
were calculated for each image. 
5.4 Results 
Tissue   Patient Details     Time  (seconds)     
Sample Lesional Diagnosis Body Site Sex Age 
Skin 
Type 
Initial 
Image 
1st Analysed 
Image 
Last Analysed 
Image 
Images 
Analysed 
4117 Seborrhoeic Keratosis Back m 69 2 994 1354 9950 15 
4120 Melanoma Back m 32 3 1356 2428 10208 14 
4121 Seborrhoeic Keratosis Lower Leg m 75 2 1084 1434 10264 20 
4122 BCC Face m 46 3 688 792 10068 18 
4210 BCC Back m 50 3 868 2075 10881 16 
Table 5.1 Details of the 5 tissue samples and imaging parameters used in the study. 
The origin of the 5 tissue samples and imaging timings are shown in table 5.1. Although all samples 
originated from males, they varied in age (range 32-75 years), body site and lesional diagnosis. 
The time taken to prepare tissue for imaging prevented immediate assessment following excision. 
The first image was taken an average of 16:38 minutes (range 11:28 - 22:36) after excision. Once 
prepared however, tissue movement prevented tracking a stable FOV until an average of 26:56 
minutes (range 13:12 – 40:28) after excision. Once tracked, the average movement of this FOV was 
of 20 µm (range 5 – 33 µm) over the remaining imaging time. The tissue movement before this time 
was greater but could not be recorded. 
Figure 5.6. FLIM images of the stratum spinosum taken from each sample in the study (sample number labelled in the left 
lower corner) taken from the yellow spectral. Images 107 µm x 107 µm, 256x256 pixels channel. Lifetime scale bar shown 
to the right of each panel. Scale Bar 25 µm. 
Exemplar FLIM images of the s.spinosum taken from each sample are illustrated in figure 5.6. 
Although the cells shown in this figure appear to have similar morphology, the FLIM images show 
that their melanin content varies between samples, indicated by its short fluorescence lifetime.  No 
reduction in the signal to noise ratio was noticed in the images over time to suggest loss of cell 
4117 4120 41224121 4210
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integrity and leakage of intracellular fluorophores into the extracellular space. This was assessed by 
visually assessing the images over time but was not quantitatively assessed. 
5.4.1 Fluorescence Intensity 
 
Figure 5.7 Change in average pixel brightness per image over time for each sample and spectral channel. 
The mean pixel brightness was calculated for each time-point imaged by taking the sum of (time-
integrated) counts over ROI pixels and dividing by the total number of ROI pixels. Only ROIs for 
which fluorescence lifetimes were fitted in all 4 channels, were considered.  This is plotted for each 
spectral channel and sample in figure 5.7. The percentage change in the mean pixel brightness over 
all samples between the first and last image analysed were 106%, 105%, 112% and 112% for the 
blue, green, yellow and red spectral channels respectively. This indicates that no significant 
photobleaching was seen. 
5.4.2 Fluorescence Lifetime 
 
  Emission Spectral Channel 
Lifetimes Blue Green Yellow Red 
 τ1 (ps) 120 347 199 160 
 τ2 (ps) 4040 3610 2677 2928 
 f1 0.39 0.38 0.45 0.57 
 τ mean (ps) 2460 2366 1563 1343 
Table 5.2 shows the average τ1, τ2, f1 and τmean over all ROIs and images, by the emission spectral channel.  
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Table 5.2 summarises τ1, τ2, f1 and τmean for all ROIs over all images by emission spectral channel. It 
shows that the lifetime parameters for ROIs are similar in the yellow and red spectral channels in 
comparison to the blue and green channels. A trend for the f1 to increase and τmean to decrease with 
emission wavelength is also seen. 
 
Figure 5.8 The average change in lifetime for all ROIs in each image from baseline over time, for each sample. (a) Blue 
channel (b) Green channel (c) Yellow channel (d) Red channel.  
The deviation of τmean from baseline over time, for each sample and spectral channel is plotted in 
figure 5.8. On visual examination, although there are changes in lifetime over time seen, no clear 
trends could be identified.   
 
Figure 5.9 Dot Plot of average reduction in lifetime over time for each sample (diamonds) with the mean lifetime reduction 
per channel highlighted (dashes). 
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(c) Yellow channel
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To evaluate the τmean over time further, linear regression was used to fit a trend line for each sample 
for each spectral channel. The slope calculated for each sample has been plotted in figure 5.9. It 
shows an average drop of 61, 18, 21 and 75 ps/hour in the blue, green, yellow and red spectral 
channels respectively over all samples. This small but consistent change in all spectral channels 
represents a 5.6%, 1.7%, 3.2% and 8.0% reduction in τmean from the baseline over the time period 
investigated. A summary of the variation in τmean for each spectral channel and the percentage 
change in lifetime broken down by sample and spectral channel is shown in table 5.3. 
 
  Emission Spectral Channel 
 
Blue Green Yellow Red 
Variation in mean lifetime from start(ps) 8 - 338 16 -218 38 - 205 32 - 283 
Sample 4117 (% change)  -13.4 -9.0 -13.4 -13.0 
Sample 4120 (% change)  -0.8 3.4 2.7 -22.6 
Sample 4121 (% change)  -14.8 -1.5 -5.4 -2.8 
Sample 4122 (% change)  0.3 0.6 4.6 4.2 
Sample 4210 (% change)  0.7 -2.2 -4.5 -5.7 
Mean % change from start -5.6 -1.7 -3.2 -8.0 
Table 5.3 Summary of the variation in τmean and percentage change in lifetime over time for each sample and spectral 
channel. 
Table 5.3 shows that the percentage change in lifetime varies between 1.7-8.0% from the start of 
the experiment. However the variation in lifetime over this period is greater. This can be seen in the 
graphs shown in figure 5.8 that track the average lifetimes per FOV in each spectral channel over 
time and by the data in the first row of table 5.3. In an attempt to put this variation in context to the 
normal variation in lifetimes found in the skin, we calculated the variation in τmean between cells 
from images taken from the s.spinosum layer of the skin on a per FOV basis. This allowed the data to 
reflect intrapatient variation in the lifetimes of cells in this skin layer and exclude the variations 
caused by imaging different body sites and an interpatient comparison. Therefore ranges of τmean for 
all the cells imaged from the s.spinosum layer in normal skin on a FOV basis (and therefore patient) 
were calculated by subtracting the cellular τmean at 25
th from the 75th percentile. The spread of 
ranges from all these FOVs are listed in Table 5.4 for each spectral channel. The results shown in this 
table indicates that the maximum variation in lifetime seen following excision of the skin (see row 1 
in table 5.3) is close to the minimum intracellular variation in lifetime seen in this skin layer for 
normal skin. 
 126 
 
Spectral Channel FOVs 
Minimum Lifetime 
Range (ps) 
Maximum Lifetime 
Range (ps) 
Blue 33 159 817 
Green 33 105 779 
Yellow 33 197 1651 
Red 31 84 5171 
Table 5.4 The range in τmean between cells found in the s.spinosum of normal skin. Calculated as the difference between the 
75th and 25th percentile on a per FOV basis.  
It has been previous described in Chapter 2.6.5 (pp58), that intracellular fluorescence from NAD(P)H 
is expected to dominate in the spectral range defined by the green spectral channel. Changes in free 
and protein bound NAD(P)H reflect changes in intracellular metabolism and are thought to be 
described by τ1 and τ2 respectively in this spectral range (Vishwasrao, Heikal et al. 2005).Table 5.3 
has already shown that the change in τmean over all samples averaged 1.7% over time in the green 
channel, suggesting that there may not be a large change in τ1, τ2 or f1. In order to investigate if this 
is the case τ1, τ2 and f1 from the green channel are plotted in figure 5.10. This graph shows an 
average of -0.80%, +0.60% and +4.80% change in τ1, τ2 and f1 respectively between the first and last 
plotted values. Therefore, as suggested by no significant change in τmean, no significant changes over 
time for any of these lifetime parameters was seen in the green channel. 
 
Figure 5.10 Graphs showing the change in ROI average fluorescence lifetime with time for the green spectral channel 
representing NAD(P)H fluorescence, illustrated per sample. (a) τ1 (b) τ2 (c) f1. 
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5.4.3 Lifetimes in vivo vs ex vivo 
 
Figure 5.11 The difference in median τmean per sample per spectral channel for images acquired ex vivo and in vivo. Error 
bars show 25th and 75th percentiles. 
Finally the median τmean from cells from normal skin are compared in images acquired ex vivo (n=8) 
and in vivo (n=19). The median τmean was recalculated per sample (not per cell) in an attempt to 
remove bias in the calculations from some samples having more cells than others. The median τmean 
for the samples were found to be 1886, 2127, 1389 and 1033 ps in the blue, green, yellow and red 
spectral channels respectively for samples imaged in vivo, see figure 5.11 The ex vivo samples were 
found to have a % difference in median τmean of -0.73%, -0.75%,-1.68% and +11.9% in the blue, 
green, yellow and red spectral channels respectively. This difference between ex vivo and in vivo 
measurements was not found to be statistically significant using the Wilcoxon rank sum test (p = 
0.98, 0.70, 0.63 and 0.23 in the blue, green, yellow and red spectral channels respectively).  
5.5 Discussion 
5.5.1 Methods 
In this study the changes that occur in tissue autofluorescence of normal skin over time following 
surgical excision has been investigated. An ideal study design would have allowed precisely the same 
area and depth in the skin to be measured continuously in vivo and following excision. Experience 
using the DermaInspect ® in vivo has shown that image acquisition is very sensitive to movement 
artefacts when attempting to acquire images at a fixed depth with submicron precision over 25.5 
seconds. This difficulty tracking a set FOV in vivo and the difficulty in finding this set FOV ex vivo, 
made this ‘ideal study’ unachievable. In the literature, the images presented by Sanchez et al. show 
that they were not able to use identical FOV for sequential images either (Sanchez, Prow et al. 2010). 
Palero et al. only managed to both maintain a fixed FOV and monitor changes in autofluorescence 
0
500
1000
1500
2000
2500
Blue Green Yellow Red
S
a
m
p
le
 m
e
d
ia
n
 R
O
I/
c
e
ll
 m
e
a
n
 
fl
u
o
re
s
c
e
n
c
e
 l
if
e
ti
m
e
 (
p
s
)
Spectral Channel
Normal Skin (in vivo)
Normal Skin (ex vivo)
 128 
 
emission spectra in vivo and ex vivo in mouse skin by euthanising the mouse during monitoring 
(Palero, Bader et al. 2011).  
The tissue movement that occurred during imaging also prevented the basal layer (which is a single 
cellular layer thick) from being monitored in this way consistently. This is the most metabolically 
active layer in the skin and most likely produced that greatest response following surgical excision. 
One disadvantage of the method used in this study were the delays that occurred between excision 
of the tissue sample, tissue preparation and securing a trackable FOV to image. Although the time 
taken to prepare the samples for imaging did improve with practice to < 5 minutes, tissue movement 
within the petri dish caused a seemly random variation in the time to the first acquired image and 
first tracked image. This prevented any data being collected from any sample before 13 minutes 12 
seconds (seen for sample ID 4122).  
Lateral movements of the tissue within the petri dish were prevented by placing the sample on 
moistened gauze and firmly securing the petri dish under the microscope objective. These measures 
were successful as little lateral movement was seen. However, it is possible that the pressure 
required to close the petri dish lid, so as to ensure the embedded cover slip lay firmly against the 
sample, compressed the tissue. The compression may have acted on both the tissue itself, with the 
loss of extracellular fluid from the cut tissue margins, and supportive underlying gauze leading to a 
vertical shift away from the microscope objective. Another possible contributing cause for the tissue 
contraction is the cooling of the tissue from body temperature to room temperature during the 
investigation. 
The methods used for fixing the FOV to within a micron during imaging are detailed in the methods 
section above. This method was necessary because movement by just a few microns in depth 
affected lifetimes. For example, a 5 µm shift in depth noted between  9060 and 9162 seconds after 
excision in sample ID 4120 caused a change of 29, 3, 2, 2 ps in τ1, a 147, 70, 97, 77 ps in τ2 and 9, 74, 
86, 78  ps in τmean in the blue, green, yellow and red channels respectively. Some of these differences 
can be attributable to the automatic segmentation algorithm, as discussed in the following 
paragraph. However a true difference in the fluorescence lifetime may be accounted for by slight 
changes in quantity of fluorophores fluorescing between the images such as NAD(P)H and melanin. 
This lifetime change is small compared to the variability in lifetimes seen between cells in the 
s.spinosum (as shown in Table 5.4), however any artifactual changes affect the ability to detect small 
‘true’ changes in lifetime. 
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The automatic segmentation algorithm for ROIs was also found to be sensitive to small changes in 
FOV between images. It resulted in slight changes in the defined ROIs between almost identical 
images. This has been illustrated in figure 5.5. It shows 3 consecutively taken images from sample ID 
4117 (image 11, 12 and 13) taken at 5752, 6428 and 6956 seconds. As can be seen from the 
fluorescence intensity images (panels b, f, j), the images are almost identical. Panels d, h and I show 
a close up of the top left hand corner of the automatically segmented images. These pictures clearly 
highlight the differences in the segmentation process between these fluorescence images. These 
differences were not felt to significantly affect the average lifetime parameters per image used in 
the analysis. However, its influence is difficult to quantify and distinguish from changes in lifetimes 
for other reasons e.g. movement, change in cellular metabolism. 
5.5.2 Fluorescence Intensity Changes 
The results from this study have shown that no photobleaching occurred during the imaging process. 
The mean pixel brightness actually increased steadily over the period imaged between 105-112% 
dependent on spectral channel, as can be seen in figure 5.7. In comparison to the experimental set 
up by Sanchez et al., our study would be the equivalent to using no culture medium and at a 
temperature between 37 oC and room temperature (Sanchez, Prow et al. 2010). In contrast to our 
results, they found a drop in fluorescence intensity over the first 24 hours, followed by an increase 
until day 4. As only daily readings were taken, it is impossible to extrapolate what their findings at 3 
hours might have been (the end time for this experiment). Palero et al. did demonstrate a peak in 
total fluorescence intensity at 80 minutes (x1.7 fold from baseline) followed by trough to below the 
initial intensity after 110 minutes (Palero, Bader et al. 2011) over the 3.3 hour time period they 
monitored the mouse skin.  Although these results are more consistent with those found in this 
study, a large increase in intensity was not seen and no ensuing decrease was seen. Our data 
demonstrated a steady rise in the fluorescence intensity over time. The nature of this change was 
not investigated further in this study, but one can speculate it was caused by either a change in the 
metabolic state of the tissue as a direct result of the excision or a photochemical induced reaction.  
5.5.3 Fluorescence Lifetime Changes 
Table 5.2 shows that τ1 and τ2 in the yellow and red spectral channels are significantly shorter than in 
the remaining channels. This is likely to reflect an increase in the contribution of melanin to the 
fluorescence in these channels. The data shown in this table can also be used to summarise the 
fluorescence lifetime parameters found in normal human skin. A direct comparison of these 
lifetimes with the published literature is complicated by differences in the excitation parameters, 
emission spectral filters and spectral channels used and method of lifetime calculation used between 
studies despite imaging similar tissue with the same device (the DermaInspect®). Benati et al. 
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performed FLIM analysis of normal skin in vivo (Benati, Bellini et al. 2011). They also used 760 nm 
excitation power, 25.5 seconds acquisition times and similar sized FOVs. They used higher powers of 
20-45 mW and only measured lifetimes in one very broad spectral channel. Cellular lifetimes 
calculated using a single exponential decay model for the lower epidermis (s.spinosum/basal layer) 
ranged between 882-1145 ps depending on age and body site. This was shorter than those 
calculated for our data for any spectral channel (range 1343-2460 ps). Breunig et al. also published 
lifetimes of each layer of human skin taken in vivo from the forearm (Breunig and König 2011). In 
keeping with our data, pixels were fitted with a double exponential lifetime model. Images were 
taken over 7-13 seconds but at 740 nm excitation wavelength, using excitation powers of 10 – 40 
mW and the fluorescence was not separated into multiple spectral channels. τ1 and τ2 were found to 
be 450 ps and 3.0-3.2 ns respectively in the stratum spinosum. His co-author, Karsten König cites τ2 
of 2.3 ns for the lifetime of cells in this same skin layer in vivo (τ1 fitting the SHG IRF) in his review 
article using the same equipment (König 2008). These published figures for lifetimes  calculated 
using a double exponential decay model are most similar to the mean lifetimes calculated for the 
green channel of τ1 of 347 ps and τ2 of 2366 ps in our data and attributed to mainly NADP(H) 
fluorescence. 
Figure 5.8 shows that there is change in τmean of the skin over time following excision in all spectral 
channels. The calculations presented in the first row of table 5.3 and in table 5.4 also show that this 
variation is small compared to the natural variation found in intracellular τmean between cells in this 
skin layer.  
The results illustrated in figure 5.9 demonstrate a small but consistent drop in τmean of between 18-
75 ps/hour over the time imaged, dependent on spectral channel. This trend was difficult to 
appreciate in the plots of τmean over time in figure 5.8 and represents between 1.7-8.0 % drop in 
lifetime over time over the study. To determine if this change could be due to changes in NAD(P)H 
fluorescence, lifetime parameters in the green spectral channel were examined, see figure 5.10. It 
shows that the reduction in lifetime over time was not a direct consequence to changes in NAD(P)H 
metabolism, as τ1 and τ2 changed by just < 1% over this time. These results do not support the 
findings by Sanchez et al. They noted a new peak in τ1 at ~800 ps and a broadening of the lifetime 
peak of τ2 following excision on day 0 in the fluorescence lifetime of their NAD(P)H spectral channel. 
Palero et al. did not measure lifetimes but did conclude that changes occurred in the free to protein 
bound NAD(P)H ratio over time, based on their analysis using spectral unmixing. As stated above, 
this was not seen in our data as no changes were seen in NAD(P)H metabolism based on the 
lifetimes from our green spectral channel.  
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The papers by Sanchez et al. and Palero et al. do have some similarities. They both describe 
increases in the total fluorescence intensity, followed by a decrease with time. They also both 
describe some change to the fluorescence from NAD(P)H over time. These changes may relate to the 
differences in the metabolic rates between the human skin and mouse skin used for these 
investigations. The human skin appears to have a slower metabolic rate than the mouse skin and 
therefore more resistant to the ischaemic changes caused by excision/euthanasia. It is possible that 
these changes may have been reproduced if the skin had been investigated over a longer time 
period. 
Finally, images taken from 27 patient samples acquired from normal skin in vivo and ex vivo were 
analysed and compared. The median τmean per sample between ex vivo and in vivo measurements 
was not found to be statistically significant using the Wilcoxon rank sum test in any spectral channel. 
5.6 Conclusions 
In conclusion the changes in tissue autofluorescence of normal human skin following surgical 
excision between 11 minutes and 3 hours in 5 samples have been investigated using multispectral 
FLIM for the first time. The skin was excited at 760 nm wavelength and the autofluorescence was 
collected from the s.spinosum using four emission spectral channels. A steady increase in the mean 
pixel fluorescence intensity of 105-112% with time was demonstrated, dependent on spectral 
channel suggesting that photobleaching did not occur. A small but consistent drop in the τmean over 
time of 1.7-8.0% was also demonstrated. A <1% change was seen τ1 and τ2 in the green spectral 
channel in which NAD(P)H fluorescence dominates. 
The changes described by Sanchez et al. in human skin over 7 days and those described by Palero et 
al. in mouse skin over 3.3 hours were not seen in this study. This difference may be caused by the 
difference in the metabolic rates between human skin and mouse skin. 
It has then been shown that there is no statistical difference in lifetime between samples of normal 
skin acquired in vivo vs. ex vivo. These results support the use of freshly excised human skin as a 
surrogate for in vivo imaging for MPT and MPT FLIM investigations over the initial few hours post 
excision. It also validates the conclusions draw by previous authors using MPT whom have studied 
freshly excised skin to extrapolate changes seen in vivo. 
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Chapter 6. An analysis of cellular morphology and FLIM of 
normal human skin using MPT.  
6.1 Introduction 
In this chapter multiphoton tomography (MPT) FLIM images and spectral images taken from normal 
skin both in vivo and ex vivo are examined. The results & discussion section of this chapter can be 
divided into 3 sections. This is the first time a detailed analysis has been performed on normal skin 
using multispectral FLIM. 
A- Morphological features seen in multispectral MPT images from normal skin are presented 
and discussed. Emission spectra from depth resolved images and spectrally resolved images 
are then presented and correlated with the lifetime resolved images. 
B- Investigation of the differences in cell morphology and lifetimes between cells from different 
epidermal skin layers within normal skin. 
C-  Investigation of the differences in cell morphology and lifetimes between cells from normal 
skin in patients with differing age, sex, skin type and body site. 
6.2 Methods 
6.2.1 Instrumentation 
The instrument used and the minor modification made during the acquisition of data analysed in this 
section have previously been described in chapter 4. The FLIM detection module acquired FLIM 
images using time correlated single photon counting (TCSPC) using 256 time bins. The emitted 
fluorescence was spectrally separated using four emission spectral channels, defined as blue (360-
425 nm), green (425-515 nm), yellow (515-620 nm) and red (620- 640/655nm). The emission spectral 
filter in the red channel was altered so that its long edge was broadened from 640 to 655 nm over 
the period of data collection and 5/30 samples were imaged prior to this alteration.  This could be 
accounted for by daily calibrating by acquiring an IRF and fluorescence decay from a blue 
fluorescence slide. A spectrometer module was used to collect the steady state hyperspectral 
images separately. 
6.2.2 Tissue preparation 
For this investigation imaging was performed both in vivo (n=18) and on freshly excised ex vivo 
samples (n=12). Patients attending the dermatology clinic at the Hammersmith site of Imperial 
College London Healthcare NHS Trust gave written informed consent to participate. 
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In vivo imaging was performed on either the inside (medial) and/or outside (lateral) forearm of 
patients. An area was selected without skin pathology or obvious skin blemishes for imaging of 
‘normal skin’. 
Excised samples of suspected malignancies with sufficient normal peri-lesional skin were selected for 
imaging of ex vivo ‘normal skin’. The peri-lesional normal skin was separated from the lesion using a 
surgical blade immediately following excision of the lesion. Freshly excised tissue was rinsed with 
Hanks Balanced Salt Solution buffer without phenol red, calcium or magnesium (Gibco®, 
Invitrogen™, CA, USA), its surface moistened with the buffer solution and placed on damp gauze in 
an inverted glass bottomed petri dish (80-170 µm cover slip Matek®, MA,USA) following excision. A 
field of view (FOV), sited centrally within the sample, without obvious superficial blemishes, was 
then selected for imaging. 
6.2.3 Imaging protocol 
Imaging was performed as outlined previously in Chapter 4.6 (pp95). Image stacks were typically 
taken from each FOV at 10 µm depth intervals until the dermis was reached. In 10/144 images tissue 
movement had occurred, rendering the depth readout inaccurate.  
All images were taken using 760 nm excitation wavelength, unless specifically stated otherwise. FLIM 
images were acquired over 25.5 seconds. These images were taken using either 128 x 128 pixel or 
256 x 256 pixel resolution with FOV varying between 56 µm x 56µm2 and 203 µm x 203 µm2 (usually 
107 µm x 107 µm2). Therefore pixel size ranged from 0.42-0.84 µm between images. The ex vivo 
cells/ROIs used in the analysis were imaged on average ±SD of 60 ±41 minutes from excision. 
Hyperspectral images acquired using the spectrometer required higher excitation powers to achieve 
an adequate photon count and were always taken following FLIM image acquisition. Images were 
either 32x256 or 41x256 pixels in size and acquired over 49.9 seconds. 
6.2.4 Image Analysis 
A detailed description of the lifetime analysis is outlined in chapter 4.10 (pp103). In summary, FLIM 
images in each channel were generated by fitting a single exponential decay to the fluorescence in 
each pixel in the image. For the lifetime analysis fluorescence decays for each ROI (not pixel) in each 
channel were fitted to a double exponential decay model. ROI fluorescence decay curves from a 
single spectral channel containing fewer than 1000 photons were felt to have insufficient photons to 
allow the double exponential decay fitting to be sufficiently reliable and so were excluded from the 
analysis. The number of ROIs (± SD) per patient was 230 (±179). 
 135 
 
For the analysis of lifetime changes with depth, each image containing cells was defined as 
originating from the stratum granulosum, stratum spinosum or the basal layer based on the 
morphology of the cells in the image. The keratinocyte morphology from MPT images from each 
epidermal layer published by Koehler et al. (Koehler, Zimmermann et al. 2011) was used as a guide 
to label the epidermal layer of each image and is reproduced in Chapter 3.4. The actual depth 
recorded by the piezo objective positioner was not felt to be sufficiently accurate or reliable as great 
variability existed in the thickness of all cellular layers of the epidermis between patients. The 
undulated shape of the basal layer also meant that the cell layer would vary for a given depth within 
a small area, even within the same patient, depending on the depth of the dermal papilla. 
As the stratum corneum is acellular in normal skin, no ROIs were defined from this layer. Due to the 
angle of the sectioned images and the undulating nature of the basal layer, a number of images 
spanned more than one layer. In such cases images were labelled according to the layer of the 
majority of the cells in the image. 
Morphological features in the images were identified from the MPT intensity and FLIM images. 
6.3 Results & Discussion 
The results and discussion have been separated into 3 distinct sections that examine different 
aspects of normal skin fluorescence.:-  Sections A-C. 
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6.4 SECTION   A – Image Analysis 
The results presented in section A show that depth resolved spatially co-registered multispectral 
fluorescence intensity and FLIM images can be acquired using this instrument. Initially a complete 
set of fluorescence images from a single sample of ex vivo skin is presented. The data sets acquired 
were sufficiently detailed to perform an analysis of emission spectra and lifetimes from user defined 
ROIs within each image, which is also demonstrated.  
Following this, specific features seen in the acquired images and an analysis of the spectral images & 
FLIM images of the dermis is presented. 
6.4.1 Fluorescence Images 
Figure 6.1 is split over two pages demonstrating a montage of images taken from a sample of ex vivo 
normal skin. Both multispectral FLIM images and hyperspectral images were taken in succession 
from the same FOV at each depth. The FLIM images were acquired using the FLIM detector module 
and were 107 µm x 107 µm2 in size, 256x256 pixels in resolution and taken over 25.5 seconds. The 
hyperspectral images were acquired using the spectrometer module (described in Chapter 4.6.3) 
over 49.9 seconds. They were from the same area but were 32x256 pixels in resolution. For each 
depth, the following images are presented:- a combined fluorescence intensity image from the four 
FLIM module PMTs; false colour FLIM/intensity images from the blue, green, yellow and red 
channels; a total fluorescence intensity image collected from the spectrometer camera and a false 
colour hyperspectral/intensity image. 
From figure 6.1, little structure can be seen from the s.corneum layer (column a). Cells in the 
epidermis can be seen in the s.granulosum (column b &c) & s.spinosum (column d &e). An increase 
in the nuclear to cytoplasm ratio can then be seen with depth. Cells with increased melanin content 
have shorter τmean and appear redder in colour in the FLIM images (rows 2-5). The images from the 
basal layer (column f) demonstrate the transition from the basal layer (identified by the cellular 
areas on the bottom left of the images in column f, except f2) to the dermis (identified by the lack of 
cells in the top right of the images, except f2). Panel f2 shows the images taken from the blue FLIM 
channel and identifies collagen fibres by their SHG signal. The emission wavelength spectral range in 
the blue channel is too short for cellular fluorescence to be detected and is therefore relatively 
‘selective’ for dermal collagen, except for some melanin fluorescence, which has a broad emission 
spectrum. Melanin fluorescence can be seen in panel d2, whilst dermal collagen is seen in panel g2 
clearly. Panels g3 and g4, also taken from the dermis, show cord like structures. The emission 
spectra from these structures (i.e. in the green and yellow channels), their shape and their presence 
in the dermis would suggest dermal elastin fibres. However, the lifetime of these fibres from the 
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FLIM images would suggest that their lifetime is ~1-1.5 ns with is shorter than a τmean ~2-3 ns found 
in previous studies of elastin (see Chapter 2.6.3). One explanation is the presence of other 
fluorophores in proximity to the fibres affecting the calculated lifetimes due to the binning and 
smoothing that occurs to generate the FLIM images. When elastin fibres are imaged in isolation (see 
section 6.4.4), their lifetime is closer to that found in the literature. 
Rows 6 and 7 in figure 6.1 show the images acquired from the spectrometer. The images in row 7 
merge the wavelength of peak intensity with the intensity image. The cell outlines appear less well 
defined than the merged FLIM images (in rows 2-5) because they have a reduced horizontal 
resolution, as described above. Despite this, the resolution remains sufficient to co-register 
individual cells from images taken using the FLIM PMTs and the spectrometer. The images in row 7 
of the spectral images illustrate the low spectral contrast between the cellular and acellular areas in 
the images, ranging from ~425 -450 nm. 
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Figure 6.1 Fluorescence images from a number of depths from a sample of normal skin acquired ex vivo. Images were 
acquired using the FLIM module detectors and the hyperspectral camera in the spectrometer module of the 
DermaInspect®. Scale Bar 25 µm. FLIM scale shown to right of each row for each spectral channel. Spectral images plot the 
mean spectral emission wavelength. 
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6.4.2 Cellular Emission Spectra and lifetimes 
The software allows the emission spectrum from manually defined ROIs within the spectral images 
to be extracted from the data collected. This allows the emission spectra from individual cells at 
different depths to be compared. 
 
Figure 6.2 Figure plotting the emission spectra from cells at different depths taken from the sample of freshly excised 
normal skin illustrated in figure 6.1 using the hyperspectral depth resolved images. 
Figure 6.2 shows emission spectra from ROIs taken from the spectral images illustrated in figure 6.1. 
The emission spectrum taken from the  s.corneum (7 µm) combined the fluorescence signal from the 
entire image. The spectra shown for the remaining layers were taken by drawing a ROI around either 
single cells or small groups of cells in an image, depending on their size.  
The figure shows that the emission spectrum acquired from the s.corneum (7 µm layer) is noticeably 
shorter than the remaining layers. A peak intensity between 440-480 nm can be seen which is 
expected to arise from keratin fluorescence, since this is the major constituent in this layer. It 
correlates well with the emission spectrum published for keratin in solution, which peaks at 450 nm 
when excited at 750 nm (Pena, Strupler et al. 2005) and ~465 nm when excited at 760 nm (Palero, 
de Bruijn et al. 2007).  
The cellular fluorescence from the s.granulosum (depths 30 µm) and s.spinosum (60µm) have similar 
emission spectral shapes and peak intensities ~470 nm. This is at the upper limit of the range 
expected for NAD(P)H and may be longer because of contributions from flavins that have a spectral 
peak ~525 nm. A shift in the emission spectrum towards longer wavelengths in the basal layer and 
dermis (depths 100 µm and 120 µm) can also be seen in figure 6.2. This might represent a greater 
contribution from melanin autofluorescence or a different metabolic rate of the cells in these lower 
layers affecting the emission spectra of NAD(P)H between bound and unbound fractions (Palero, 
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Bader et al. 2011).The fluorescence emission spectrum taken from the cells in the dermis (120 µm 
depth) has a large peak present at 365 nm. This wavelength corresponds to SHG from extracellular 
collagen when excited at 760 nm which should have been rejected by the manually defined ROIs 
used for the lifetime analysis. It proves that, although a cluster of cells in this layer were defined, 
some collagen was also selected. As collagen is ubiquitous in the dermis and its SHG signal is very 
strong, this signal is not surprising. 
 
Figure 6.3 The variation of τmean acquired from cells/cell clusters plotted according to spectral channel and cell layer/depth 
in the sample from the ex vivo skin illustrated in figure 6.1. 
As paired spectral and FLIM images were acquired from the same FOV, intracellular fluorescence 
lifetimes could also be calculated from these cells/cell clusters. The results of τmean of these ROI are 
shown in figure 6.3. As stated in the previous section, the greatest contribution to the lifetime in the 
s.corneum is from keratin. The lifetimes calculated from this layer in the 4 spectral channels (1033-
1625 nm) are in keeping with the lifetime for pure keratin taken from a single spectral channel of 
1400 ps (Ehlers, Riemann et al. 2007). Also as stated in the previous section, a SHG signal from 
extracellular collagen in the cellular ROIs from the basal layer and dermis (100 µm, 120 µm depth) 
accounts for the spuriously short intracellular lifetimes calculated for these layers in the blue 
channel. 
The lifetimes from the green channel in the s.granuolsum, s.spinosum and basal layer are expected 
to to be dominated by NADP(H) but also include a contribution from flavins. The τmean of NAD(P)H is 
dependent on environment and has been reported to vary between 444-948 ps, with the protein 
bound component (τ2) calculated to vary between 2.03 and 6.04 ns (Vishwasrao, Heikal et al. 2005; 
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Skala, Riching et al. 2007). The lifetime of free flavins varies between 2.3-5.2 ns when free and ~250 
ps when protein bound (Nakashima, Yoshihara et al. 1980; König and Schneckenburger 1994; Yang, 
Luo et al. 2003). These values compare with an average τmean calculated from the data presented 
above over all the images of 2.02 ns. This figure is in reasonable agreement with the published 
values. We suggest that the drop in τmean between the s.granulosum and the deeper layers either 
reflects an increased melanin contribution to the fluorescence in this channel or reflects a difference 
in fluorescence arising from NAD(P)H & flavin in these metabolically more active cells deeper in the 
epidermis. 
The cellular lifetimes in the red spectral channel shows little variation with depth and an average 
τmean of 1.01 ns over the cellular layers (30-100 µm). The lifetime of melanin is expected to  dominate 
in this channel and this value is consistent with a  τmean of 1.23 ns reported for synthetic melanin 
(Teuchner, Freyer et al. 1999). 
6.4.3 Epidermal Cytoplasmic Autofluorescence 
 
Figure 6.4 Illustrates paired images of the same FOV within the s.spinosum using different excitation wavelengths and 
acquired from the green spectral channel. Scale Bar 25µm 
Figure 6.4 shows a selection of paired images taken in the green channel, from identical FOVs and 
depths, but using different excitation wavelengths (760 and 880 nm). The images were taken from 
the s.spinosum from an ex vivo sample of normal skin (ID 4038 fov1). The images taken using an 
excitation wavelength of 760 nm illustrate the typical appearance of non-fluorescent nuclei, 
fluorescent peri-nuclear cytoplasm and the presence of apparent intercellular spaces with little/no 
20 µm 30 µm 40 µm
Depth
760 nm
880 nm
Ex
ci
ta
ti
o
n
 W
av
el
e
n
gt
h
 143 
 
fluorescence. The brighter ring of autofluorescence around the nucleus of the cell may reflect the 
higher concentration of mitochondria, and therefore NAD(P)H in this area of the cell. 
Different contrast can be seen in the images shown when excited at 800 nm. This reflects the 
different fluorophore absorption and emission profiles at 880 nm compared to 760 nm. These 
images appear to now show the cell membrane, which was absent from the images taken at 760 nm. 
They show that the cells are in fact confluent. The appearance of intercellular spaces was therefore 
an artefact of low/absent autofluorescence from the peripheral cellular cytoplasm in images when 
excited using 760 nm. This is consistent with images of the skin acquired in vivo using confocal 
microscopy, which show cellular confluence in the epidermis (Rajadhyaksha, Grossman et al. 1995). 
It is noted that this artefact will therefore affect all morphological assessments of cells, including 
calculations of the cell size and shape when images acquired at 760 nm are used. This artefact was 
not as apparent in the images acquired from the basal layer. It is postulated that the cytoplasmic 
volume for cells in the basal layer was sufficiently small compared to the size of the nuclei and their 
cytoplasm was sufficiently metabolically active, that the artefact of spaces between cells was not 
seen for images from this layer. 
6.4.4 The Dermis 
 
Figure 6.5 (a-d) Fluorescence images of the reticular dermis taken using the FLIM detector module, with close up image (e). 
Box in (d) indicates a representative area of collagen for ROI analysis. Box in (e) indicates representative area of elastin for 
ROI analysis. (f-h) Corresponding images taken using spectrometer detector module from FOV (e). 
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f) Intensity Image g) Image of mean 
emission spectrum
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Figure 6.5 shows both intensity and spectral images taken from the underside of a sample of normal 
skin (the reticular dermis). The top images (a-e) show a combined fluorescence intensity images and 
the intensity images taken from three spectral channels (b-d, no red channel image taken). The last 
panel (e) shows a close up image of the same FOV. These images are of collagen and elastin. 
Collagen SHG is very strong in the blue channel (b), appearing as the only visible feature. As collagen 
fibres are fine, individual fibres cannot be resolved at this image resolution and they appear as 
diffusely fluorescent. The remaining spectrally segmented images (c,d) show a weaker collagen 
autofluorescence compared to a more dominant elastin fluorescence in this spectral range. The 
elastin fibres are coarser, allowing individual fibres to be distinguished. 
Figure 6.5e-h show images taken at a higher magnification of an elastin fibre. The spectral images 
mapping the mean emission spectrum (g,h) suggest that elastin has a mean emission spectrum ~490 
nm. 
 
Figure 6.6 Emission spectra from areas of collagen and elastin from image FOV shown in figure 6.5  
To examine these dermal structures further, emission spectra were extracted from the hyperspectral 
images from areas representative of collagen and elastin, e.g. highlighted boxes in figure 6.5d,e. 
These are plotted in figure 6.6. The emission spectrum of elastin shows a peak spectral intensity at 
507 nm. This is slightly higher than those found in the literature of peak emission spectrum between 
445-500 nm (Pena, Strupler et al. 2005; Palero, de Bruijn et al. 2007). 
Collagen has two signals evident from this graph. The emission spectrum shows a small peak at 
360 nm consistent with its SHG signal when excited at 760 nm. This SHG peak is smaller than 
expected as the signal is known to be very strong compared to autofluorescence. It is not clear from 
the data why this is the case. It may have been caused by a low excitation power used to acquire the 
preceding FLIM image and not sufficiently increased prior to acquiring the spectral image. Figure 6.2 
showed a significantly larger SHG peak when the dermis was imaged on another occasion suggesting 
again that a user defined parameter was suboptimal. 
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The collagen autofluorescence spectrum has a peak ~490 nm. This is longer than that reported in the 
literature by Lutz et al. who excited purified collagen at 750 nm using the DermaInspect® and saw a 
spectral peak ~460 nm (Lutz, Sattler et al. 2012). This longer peak may be related to the slight 
changes in emission spectra associated with collagen subtype, its post-translational modification 
with additional proteins or its environment. Another contributing factor could be autofluorescence 
from the brighter elastin fibres. 
 
Figure 6.7 Bar Graph of τmean from ROIs corresponding to collagen and elastin derived from the FLIM images illustrated in 
figure 6.5 b-e, categorised by spectral channel. 
Figure 6.7 show the τmean for selected ROI within the FLIM images illustrated in figure 6.5 of collagen 
in the unmagnified FLIM images (figure 6.5b,c,d), and elastin from the set of magnified images (of 
which the total intensity images is shown in figure 6.5e). The lifetime from collagen in the blue 
channel is short (137 ps) due to the dominance of its SHG signal in this channel. The average collagen 
lifetime calculated from ROIs in the green & yellow channels were τ1 =568, τ2= 3186 and τmean =2672 
ps. This is consistent with lifetimes reported in the literature. As discussed in the introduction ~80% 
of dermal collagen is type I that has a reported τmean ranging between 2466-2335 ps (Marcu, Cohen 
et al. 2000; Lutz, Sattler et al. 2012). 
The lifetime calculated for elastin in the blue channel is also short and probably reflects contaminant 
signal from the much stronger collagen SHG signal in this channel. The average lifetime for an elastin 
fibre averaged between the green and yellow channel is τ1 =437, τ2= 2869, τmean =2471 ps. The τmean is 
close to that found for collagen in these channels so contaminating fluorescence from collagen 
cannot be excluded. This lifetime is also longer than that reported in the literature of 2.05 ns for 
elastin (Fang, Papaioannou et al. 2004).  
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6.5 SECTION B - Epidermal Cell Layers 
In this section MPT FLIM data is used to investigate differences in lifetimes between the cellular 
layers of the epidermis. The MPT images taken from the skin were initially acquired as controls 
against images taken of skin cancers. Therefore, the data presented in sections B and C was not 
collected with this analysis in mind. The analysis focuses on the data that has been collected, not 
necessarily that needed to perform a conclusive study. 
6.5.1 Introduction  
As described in detail in the introduction chapter 1.2 (pp27), the epidermis can be subdivided into a 
number of layers based on cell morphology in normal skin. The stratum corneum lies on the surface 
and is acellular. Beneath this are the cellular layers, namely the stratum granulosum, the stratum 
spinosum and finally the basal layer. These layers become progressively more metabolically active 
with depth.  
A number of groups have published lifetime data from different layers in the skin previously. For 
example, Cicchi et al.(Cicchi, Massi et al. 2007) performed a pixelwise fit using a single exponential 
decay model to images taken from various depths from ex vivo normal skin, excited at 740 nm. They 
found an increase in the lifetime to 50 µm depth, followed by a sharp decrease with a maximum 
positive shift of ~+90 ps and negative shift of -10 ps from zero depth. In their conference 
proceedings, Breunig et al. performed a pixelwise fit using a double exponential decay model to 
images taken from different layers in the skin after excitation using 720 nm in vivo (Breunig and 
König 2011). The data was not spectrally separated so τ1 was dominated by collagen SHG and may 
have masked a fluorescence decay arising from free NAD(P)H in their results. They found τ2 shorter 
in the basal layer (2700 ps) compared to the s.spinosum (3000 ps) which they felt in keeping with the 
lifetime for protein bound NAD(P)H. 
The only systematic analysis was performed by Benati et al. (Benati, Bellini et al. 2011). They 
compared the lifetimes between the upper and lower epidermis in two age groups and body sites 
(forearm, thigh). They performed a single exponential decay fit to a pixel within a cell (after binning 
5x5 pixels) and made an average over 5 cells for each group. In the 20-35 year old age group, they 
found a statistically significant differences in the lifetimes between layers  in all body sites e.g. 
1171±116 upper vs 935±174 ps lower epidermis on the outside forearm (difference of 236 ps). 
However, this was not found in the >60 years age group. They suggested that the reduction in 
lifetime with depth related to the cellular melanin content of the cells and speculated that 
differences in the metabolic activity between the layers also contributed to these differences. 
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6.5.2 Methods 
The differences in lifetime with depth in the epidermis using the MPT FLIM images collected from 
normal skin has been investigated. Images of normal skin acquired both in vivo and ex vivo have 
been investigated and it has already been shown in Chapter 5 (pp115) that fluorescence lifetime 
does not alter significantly post excision over the initial few hours. 
To combine data from multiple patients, images were categorised by cell layer and not absolute 
depth. The thickness of each cellular layer in the epidermis varies widely between patients and body 
sites. This renders the absolute depth of the images taken (in relation to the s.corneum) unhelpful. 
Therefore the skin layer of each image of normal skin analysed was manually assigned. This was 
based on the MPT exemplar images and definitions of each layer described by Koehler et al. 
(Koehler, Zimmermann et al. 2011) and illustrated in figure 3.1 in Chapter 3.4 (pp69). 
Number of 
Patients   30 
Demographics Male/Female 17/13 
  Age (Range) 45.1 (17-88) 
  Skin Type (Range) 2.5 (1-4) 
In vivo/Ex vivo    18/12 
FOV by Inner Forearm 17 
body site Outer Forearm 8 
  Back 8 
  Face 3 
  Lower Leg 1 
Images Taken   144 
Total Cells/ROIs   6904 
Cells/ROIs per S.Granulosum 973 (14.1%) 
Skin Layer (%) S.Spinosum 3647 (52.8%) 
  Basal Layer 2284 (33.1%) 
 Table 6.1 Summary of the images taken from normal skin that were analysed. 
Table 6.1 outlines the images that were analysed in this section. It lists details of the patients from 
which the images were taken, whether the images were acquired in vivo or ex vivo and the number 
of images and ROIs analysed. As previously stated, all images were acquired with an excitation 
wavelength at 760 nm. The table shows that more than ½ of the cells arise from the s.spinosum, the 
thickest layer in the epidermis. 
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6.5.3 Change in cell size with depth 
It is known that cells in the epidermis reduce in size with depth (i.e. reducing from the s.granulosum 
to the basal layer. It should also be noted that the elongated polygonal cells in the s.granulosum and 
s.spinosum are orientated horizontally (with their long axis parallel to the skin), whilst the columnar 
cells of the basal layer lie vertically (with their long axis perpendicular to the skin). It might therefore 
be expected that a sharp reduction in the measured size of cells from the s.spinosum would be seen, 
when imaged en face, (as is the case in MPT images compared) to the basal layer due to the change 
cell orientation. 
To investigate this, the shapes and sizes of the manually defined ROIs were analysed. It has already 
been shown in Section 6.4.3 (pp142) that the autofluorescence does not extend to the cell periphery 
for the larger cells seen in the s.granulosum and upper s.spinosum. The size of cells in these layers 
will therefore be underestimated, making it difficult to make an accurate comparison. In addition, 
the cell density between cell layers has been compared, which is not subject to the inaccuracy 
outlined above. 
 
Figure 6.8 Plots the distribution of (a) cell area and (b) cell density (calculated using the Gabriel method) of cells 
categorised by cell layer. Key: Blue-S.Granulosum, Black- S.Spinosum, Red- Basal Layer. 
Figure 6.8 shows histograms of the cell area and density of the analysed ROIs by cell layer. Figure 
6.8a shows that a small proportion of cells in the s.granuosum are very large in size compared with 
cells in other layers. As the sizes of cells in the s.spinosum are underestimated, it is not possible to 
assess for a sharp reduction in the cell area from the s.spinosum compared to the basal layer. 
Figure 6.8b shows the density of the cells between layers. The methods used to calculate the density 
have been outlined in Chapter 4.10.7 (pp109). The histogram shows a smoother progression of 
increased density with depth between the layers with a median density of 0.00221, 0.00522 and 
0.00561 cells/µm2 for the cells in the s.granulosum, s.spinosum and basal layer respectively. 
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However, this too does not demonstrate a sharp decrease between the s.spinosum and the basal 
layer. 
6.5.4 Change in lifetime with depth 
Previous groups have found a decrease in fluorescence lifetime with depth of between 236-300 ps 
(Benati, Bellini et al. 2011; Breunig and König 2011). It is suggested that this drop in lifetime with 
depth reflects an increase in melanin content from melanocytes and keratinocytes. Melanin has a 
short lifetime  with components as short as 200 ps (Teuchner, Freyer et al. 1999) and is expected to 
contribute most to fluorescence detected in the yellow and red spectral channels, based on its 
emission spectrum (refer to figure 2.7,pp51; & figure 2.11;pp57 of the emission spectrum of 
melanin).  However changes are likely to be seen in all spectral channels as melanin has a broad 
emission spectrum that covers the whole detection emission spectral range. 
An increase in the melanin content would therefore be expected to present as a decreasing τ1 (& 
possibly τ2) and an increasing f1, reflecting a greater contribution and increasing quantity of melanin 
to the shorter lifetime component. This would result in a progressive shortening in τmean with depth 
that would predominantly affect the yellow and red spectral channels. 
Figure 6.9 Distribution of τmean with epidermal cell layer. Key: Blue-S.Granulosum, Black- S.Spinosum, Red- Basal Layer.  
Figure 6.9 shows the distribution of τmean in all spectral channels categorised by cell layer. A trend 
towards shorter lifetimes can be seen in all channels as the cell layer progresses from the 
s.granulousm to s.spinosum to the basal layer. 
        Percentile   
 
Channel Level 25 50 75 
τmean (ps) Blue S.Granulosum 2087 2313 2575 
    S.Spinosum 1563 1892 2157 
    Basal Layer 696 1027 1513 
  Green S.Granulosum 2411 2705 2990 
    S.Spinosum 1999 2393 2826 
    Basal Layer 937 1499 1981 
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  Yellow S.Granulosum 1616 1925 2346 
    S.Spinosum 1220 1594 2132 
    Basal Layer 428 755 1163 
  Red S.Granulosum 1079 1410 1620 
    S.Spinosum 851 1204 1548 
    Basal Layer 456 719 1035 
Table 6.2 Distribution of τmean with epidermal cell layer, categorised by spectral channel 
This can be confirmed by the median τmean for each layer in each channel, listed in table 6.2. It shows 
a decrease in the median τmean between the s.granulosum and the basal layer of 1286, 1206, 1169 
and 691 ps for the blue, green, yellow and red spectral channels respectively. This difference is 
significantly larger than has been previously reported of up to 300ps and is consistent with the 
presence of increased melanin content with cell layer.  
Figure 6.10 Histograms showing the changes seen in τ1, f1 & τ2 with cell layer. Key: Blue-S.Granulosum, Black- S.Spinosum, 
Red- Basal Layer. 
To explore this trend further, individual lifetime parameters can be examined.  Changes to τ1 and τ2 
will reflect differences in the contributions to each lifetime component of each intracellular 
fluorophore between layers. 
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Figure 6.10a-d shows the distribution of τ1 categorised by cell layer. The median τmean is very short 
(between 31-73 ps) in the blue channel for all cell layers (not just the basal layer). This suggests that 
melanin fluorescence contributes significantly to this channel, as other tissue fluorophores have 
significantly longer lifetimes. This short lifetime is not thought attributable to collagen SHG because 
no collagen should be seen in the upper cell layers and a large peak ~0 ps can be seen for the basal 
layer that is distinct from the other peaks and would account for collagen SHG. 
The τ1 lifetime component of the cells in the basal layer, tend to be the shortest for all spectral 
channels. The peaks seen for the basal layer with a median τ1 ~ 50 ps in the green and yellow 
channels cannot be attributed to collagen SHG, as this should only be detected in the blue channel. 
This finding strongly suggests that the shorter lifetimes of cells in the basal layer are caused by an 
increased presence of melanin. Interestingly, a median τ1 of 80 ps in the red channel for cells in the 
basal layer is longer than the median τ1 for other channels, despite the dominance of melanin in this 
channel. One would expect the lifetime to be even shorter. It has been shown previously that the 
emission spectrum and lifetime of melanin can depend of the size of its aggregates (Nofsinger and 
Simon 2001), see Chapter 2.6.4 (pp56). This discrepancy might therefore be attributable to melanin 
aggregates that have longer emission spectra (i.e. 1000 – 10,000 MW) also having longer lifetimes. 
Unfortunately, Nofsinger et al. did not correlate the lifetime differences with emission spectra to 
support this theory. It might also be accounted for by the presence of another fluorophore that 
emits strongly in the red spectral channel with a longer lifetime than melanin contributing to the 
fluorescence e.g. porphyrins. 
Figure 6.10 e-h show the contribution of the short lifetime component (f1) to τmean. These histograms 
confirm a greater f1 seen for the basal layer for all spectral channels. As τ1 has already been shown to 
be more strongly influenced by melanin in the basal layer, a high f1 strongly supports the conclusion 
that these cells have higher cellular melanin content. 
Figure 6.10 i-l shows τ2 for all channels categorised by cell layer. These histograms show many of the 
trends described above for τ1. For example, cells in all layers exhibit similar lifetimes in the blue 
channel and cells from the basal layer have a shorter τ2 than the other layers for all spectral 
channels. These features are consistent with an increased melanin content in cells from the basal 
layer. 
6.5.5 Change in metabolism with depth 
The basal layer of the epidermis is metabolically more active than the layers above. It was 
investigated if this might be detected as a change in the autofluorescence from NAD(P)H and FAD 
which fluoresce in the green and yellow spectral channels respectively. The assumption that the 
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changes in NAD(P)H and FAD autofluorescence associated with the increased metabolism in normal 
skin mimic those seen with epidermal malignancy has been made.  
Skala et al. studied malignancy in a hamster cheek pouch model and found these changes to include  
a decrease in the contribution and lifetime of the protein bound component of NAD(P)H (f2 & τ2 in 
the green channel), a less significant decrease in the lifetime of the free component of NAD(P)H (τ1 
in the green channel), increase in the lifetime of protein bound FAD (τ1 in the yellow channel) and a 
decrease in its contribution (f1 in the yellow channel) (Skala, Riching et al. 2007). The changes in 
NAD(P)H fluorescence could therefore be screened for by a decrease in τmean in the green channel. 
It has been suggested above (section 6.5.4) that melanin strongly influences the lifetimes in many 
channels. As the highest melanin content has been suggested to be in the basal layer, our ability to 
use lifetime to detect changes in metabolic rate in this layer is adversely affected. One method to 
account for this is to attempt to separate the cells that have high melanin content. This might allow 
other trends in fluorescence lifetime to be detected more easily in the remaining cells. 
Figure 6.11 The distribution of spectral contributions from each channel categorised by cell layer. Key: Blue-S.Granulosum, 
Black- S.Spinosum, Red- Basal Layer. 
Figure 6.11 a-d are histograms that show the distribution of spectral contributions for each spectral 
channel, separated by cell layer. The histograms in yellow and red channels show 2 peaks for the 
s.granulosum and s.spinosum. Further analysis (not shown) show that these peaks represent two 
distinct populations of cells. By assuming that these populations differ primarily in their melanin 
content all cells can be described as having a low melanin content (with < 0.1 contribution in the 
yellow channel) or a high melanin content (with > 0.1 contribution in the yellow channel).  
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Figure 6.12 The distribution of τmean for ‘low melanin content’ cells with a spectral contribution in the yellow channel <0.1, 
categorised by cell layer and spectral channel. Key: Blue-S.Granulosum, Black- S.Spinosum, Red- Basal Layer. 
 
Figure 6.12 replots τmean for all spectral channels for this population of cells that have a spectral 
contribution in the yellow channel <0.1 and have been described as having a low melanin content. 
These histograms for τmean are very similar to those shown in figure 6.9. Slight changes in the 
distribution and size of the peaks can be seen but the overall trends have not changed. A reduction 
in τmean in the green channel with depth is not seen, which could be caused by a higher metabolic 
rate affecting NAD(P)H fluorescence. However, as no significant changes are seen in the histograms 
between figure 6.9 and 6.12, melanin cannot be excluded as the cause for all the trends seen and 
are unable to confidently attribute any findings to changes in NAD(P)H fluorescence . The individual 
lifetime parameters have therefore not been analysed further because confident conclusions cannot 
be made. 
 
6.5.6 Section B - Conclusions 
In this section it has been shown that the cell density increases with cell layer for normal skin. In 
addition we have demonstrated a shortening in τmean with increasing depth which is summarised in 
table 6.2. The data demonstrated a decrease in the median τmean between cells in the s.granulosum 
and the basal layer of 1286, 1206, 1169 and 691 ps for the blue, green, yellow and red spectral 
channels respectively. This is a larger difference detected than previous groups, whom have found 
lifetime changes of between 236-300 ps (Benati, Bellini et al. 2011; Breunig and König 2011). 
Evidence has then been presented that this change can be attributed to increasing melanin with 
depth. Like Benati et al., we also proposed that the shorter lifetime with depth is contributed to by 
increased metabolic activity. However, the data collected in this study does not support this. 
Also, melanin was expected to be the most dominant fluorophore in the red channel, especially for 
τ1. An interesting finding from the data is that the lifetimes seen for τ1 in the red channel (figure 
6.10d) had longer than expected lifetimes for all cell layers, especially the basal layer, which is 
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expected to have the highest melanin content. The cause for this difference remains unclear and 
was not investigated further. It may represent aggregates of melanin with longer lifetimes 
fluorescing in this channel or may be attributable to another fluorophore such as porphyrin. 
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6.6 SECTION C- Changes with demographics 
In this section the variation in fluorescence lifetimes between patients is examined. Despite inter-
patient variation, the presence of distinct populations of cells are presented and discussed. Finally a 
more detailed analysis of the changes in lifetime with patients age, sex and skin type and body site is 
made. 
As previously stated, the MPT images taken from normal skin, both in vivo and ex vivo, were initially 
acquired as controls against images taken of skin cancer. Therefore, the images were not collected 
with the purposes of this analysis in mind. As a result, the analysis focuses on the trends seen in the 
data collected, not the ideal data set. 
6.6.1 Lifetime variability by patient 
Initially intrapatient vs interpatient variability in fluorescence lifetimes is evaluated. Intrapatient 
variation was made by comparing MPT FLIM images taken from a patient (ID 5010) in vivo, from 
their outer forearm in 2 separate FOVs (1 & 3). As lifetimes have been shown to alter with cell layer 
in section B, the comparison has been restricted to cells from the s.spinosum. 
 156 
 
 
Figure 6.13 Scatter plots comparing various lifetime parameters in images acquired in the green spectral channel from cells 
from (a,b) 2 FOVs within the same patient. (c,d) Cells from the s.spinosum between patients. (e,f) Cells from the basal layer 
between patients.  
Figure 6.13 a,b are scatter plots contrasting the fluorescence parameters from these two FOVs. Two 
sets of parameters calculated for the green spectral channel were chosen for this comparison, τ1 vs 
τ2 and τmean vs the spectral contribution. In the plots, cells from each FOV are distinguished by colour 
(blue vs red). Both scatter plots show that the cells have similar fluorescence profiles, however 
distinct clusters of points derived from each FOV exist, despite matching all possible parameters.  
To assess interpatient variability, two further patients (ID 4061 and 5009)with normal skin imaged in 
vivo were matched for sex, skin type, body site to patient 5010. Ages were similar but not matched 
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(29, 36, 43 years). Figure 6.13c,d shows scatter plots of cells from the s.spinosum between these 
patients using the same lifetime parameters as figure 613a,b. ROIs from each patient (not FOV) are 
distinguished by colour in these plots. Figure 6.13e,f plots cells from the basal layer between these 
patients. 
In the plot of τ1 vs. τ2 of cells from the s.spinsoum (panel c), the distribution from patient 4061 (blue) 
are very similar to those from patient 5010 (red). However, the plot of τmean vs. spectral contribution 
(panel d) clearly distinguishes the cells from these patients. The plots of the cells from the basal layer 
(panel e,f) show greater separation between them than the cells from the s.spinosum.  
In conclusion, the plots (panels c-f) show a greater interpatient variability between lifetimes than the 
intrapatient variability shown between FOVs. The cells from the s.spinosum between patients 
(panels c,d) do demonstrate some interpatient overlap between clusters and the plots also 
demonstrate that the spectral contribution parameter seems to contrast cell fluorescence more than 
either τ1 or τ2. 
These findings are consistent with those described previously  by our group using a 2 spectral 
channel detector module with the DermaInspect® (Patalay, Talbot et al. 2011). In this paper, greater 
separation of cells was seen on scatter plots of τmean vs spectral contribution between FOVs taken 
from dysplastic naevi within the same patient than between different patients. This trend was not 
detected in images taken from basal cell carcinomas. 
6.6.2 Cell Populations 
In section 6.6.1, we have shown the clustering of cells between FOVs from the same patient on 
scatter plots of lifetime parameters. Figures 6.13c,d also demonstrate some overlap between 
clusters of cells between patients. It is known from the anatomy and physiology of the cells in the 
epidermis that cells have specific structural and functional properties. The finding that cells from 
different patients exhibit similar fluorescent properties raises the possibility that cells types with 
similar properties may be distinguished by their spectral properties.  To investigate this, fluorescence 
from all cells and all patients were plotted. 
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Figure 6.14 Scatter plot of spectral contribution from the green and yellow spectral channels for all cells from normal skin. 
4 distinct clusters of cells have been identified. 
Our research group has previously found the spectral contribution parameter to maximally contrast 
the autofluorescence between cells in section 6.6.1 above. Figure 6.14 shows that a number of 
spectrally separated clusters of cells can clearly be defined when plotting the spectral contribution in 
the green against the yellow channel for all cells from normal skin in all patients. These channels 
have been selected to find clusters of cells with similar metabolism as NAD(P)H is the brightest 
fluorophore in the green channel and melanin & FAD are the brightest fluorophores in the yellow 
channel.  
It could be speculated that cells clusters with a similar spectral contributions in these channels (i.e. 
clusters 2 & 3) would have similar NAD(P)H and melanin (&FAD) quantities and function. The 
remaining clusters (1 & 4) appear to be distributed in a linear arrangement. This might represent a 
structural link between the cells. For example cluster 4 has low contribution from the yellow 
channel, which would suggest that these cells contain little melanin. The range of contribution to the 
green channel of these cells might represent variation in NAD(P)H fluorescence (secondary to 
metabolism) or the effect of other fluorophores that emits in the blue or red spectral channels. 
In summary, distinct clusters of cells could be identified from the plot in figure 6.14. One method to 
assess these clusters further is to see how these vary with the origin of the normal skin imaged. 
Figure 6.14 has therefore been re-plotted, but colour coded the data based on sex, skin type, age 
group and body site. These can be seen in figure 6.15. 
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Figure 6.15 Scatter plots of the spectral contribution from all cells from normal skin, categorised by (a) sex (b) skin type (c) 
age group (d) body site.  
These plots show that the cells from all sexes, age groups, skin types and body sites (panel a-d) 
contribute to clusters 2 and 4 (defined in figure 6.14). Cells from every cell layer of the epidermis are 
also found to contribute to all clusters (data not shown). Cluster 1 contains cells from all sexes and 
age groups but appears not to contain cells from the outer forearm (panel d) or from skin type 1 
(panel b). As no cells from skin type 1 are seen in cluster 1, cells in this cluster might represent 
melanocytic cells. Contrary to this would be our expectation that the cells from the outside forearm 
have more melanin that those on the inside forearm which is the opposite of our findings. 
Finally the presence of cells into cluster 3 varies with category. Patients from the 30-42 year old age 
group and cells from the outside forearm are absent from group 3. Also, cells plotted on the right 
side of group 3 seem to be restricted to cells from males, patients <30 years old and those with skin 
type 4. Similarly the left of this group only contains cells from females, >42 years old and those with 
skin type 3. These findings are difficult to explain easily from the data collected and require further 
work in the future. 
In conclusion, different populations of cells based on their spectral characteristics have been 
identified. Although it has been speculated that these differences are based on cell pigmentation 
and metabolism, no definitive conclusions can be drawn from our data alone.  These findings would 
benefit from further investigation such as using a larger population of cells or using cells grown in 
culture so the biological basis for the spectral changes described could be observed more directly 
and investigated. 
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6.6.3 Age 
In this sub-section trends in the fluorescence lifetime from the cells from normal skin with the age of 
the patient are examined. Although Keohler et al. have shown a statistically significant increase in 
the fluorescence lifetime of the dermis with age (Koehler, Preller et al. 2011), just one publication 
has attempted to quantify the changes in lifetime of the epidermis with age. Benati et al. (Benati, 
Bellini et al. 2011) compared the lifetimes of skin in vivo between patients aged 20-35 and >65 years. 
They showed that a statistical increase in fluorescence lifetime with age for comparisons between 
the upper and lower epidermal layers. When fitted using a single exponential decay model, a 
lifetime of 1171±116 ps vs 1280±85 ps was found in the upper epidermis for the younger (n=21) and 
lower age groups (n=21) respectively (difference of +109 ps with age). For the lower epidermis 
lifetimes of 935±174 ps vs 1145±167 ps were found between the age groups (difference of +210 ps 
with age). 
Our aim was to compare the cells from patients with different age groups and determine if a similar 
trend in lifetime existed with our cohort of patients. Initially patients were allocated into 3 roughly 
equal age group categories :-  <30, 30-42 and >42 years. 
      
Age Group 
(years)     
    < 30 30 - 42 > 42 Total 
Patient 
Numbers   9 9 12 30 
Demographics Sex (M/F)  6/3  4/5  7/5 17/13 
  Skin Type (Range) 2.4 (1-4) 2.4 (1-4) 2.6 (1-4)   
In vivo/Ex vivo    8/1  7/2  3/9  18/12 
FOV by Inner Forearm 7 7 3 17 
body site Outer Forearm 2 5 1 8 
  Back 1 2 5 8 
  Face 0 0 3 3 
  Lower Leg 0 0 1 1 
Images Taken   41 50 53 144 
Total 
Cells/ROIs   1897 2300 2707 6904 
Cells/ROIs per S.Granulosum (%) 262 (13.8) 335 (14.6) 376 (13.9) 973 
Skin Layer (%) S.Spinosum (%) 912 (48.1) 1007 (43.8) 1728 (63.8) 3647 
 161 
 
  Basal Layer (%) 723 (38.1) 958 (41.7) 603 (22.3) 2284 
Table 6.3 Characteristics of samples used and images taken for comparison of ages with fluorescence lifetime. 
Table 6.3 summarises the characteristics from the 3 age groups and shows that all are broadly 
matched. The eldest group includes samples from a wider variety of body site and a slight bias 
towards ex vivo samples. They also have slightly more cells from the s.spinosum than other groups 
(63.6% vs. 48.1% & 42.8%) with a corresponding fall in the proportion of cells from the basal layer.  
 
Figure 6.16 Histogram of the distribution of densities of cells from images of normal skin, categorised by age group 
calculated using the Gabriel method. 
In section 6.5.3 (pp148) it has already been shown that cell density is a more reliable surrogate 
indicator for cell size. The cell density of the cells by age group has therefore been plotted in figure 
6.16. The median density is 0.00301, 0.00435 and 0.00141 cells/µm2 for the <30, 20-42 and >42 year 
old age groups respectively. It shows that the density of cells is similar for the age groups <42 year. 
The median density would appear lower for the eldest age group. From this sample, it is not clear if 
this difference is a true finding or caused from a lower proportion of cells arising from the basal layer 
in the eldest age group. Fewer cells in this layer, which have already been shown to have a higher 
density, would have the effect of decreasing the density measured (see figure 6.8 in section 6.5.3). 
Figure 6.17 Distribution of τmean with spectral channel categorised by age group. 
Figure 6.17 shows the distribution of τmean for all spectral channels categorised by age group. Like the 
cell densities, the distribution is very similar between the 2 age groups below 42 years. However, the 
>42 years group shows longer lifetimes in the green, yellow and red channels. Apart from the blue 
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channel, there is an increasing median τmean with age group seen in all channels. The increase in the 
median τmean between the 30-42 and >42 year old groups are +199, +550, +514 and +417 ps in the 
blue, green, yellow and red channels respectively. This is a larger lifetime difference between closer 
age groups than the difference of +109 and +210 ps found between patients 25-35 years and >65 
years old seen by Benati et al. using a single spectral detection channel (Benati, Bellini et al. 2011). 
The differences in τmean between all age groups was found to be significant when analysed on a per 
cell basis but was not found to be statistically significant when compared on a per patient basis using 
the Wilcoxon rank sum test. 
It has already been discussed in section 6.5.5 (pp151) that Skala et al. had associated specific lifetime 
changes from the fluorescence of NAD(P)H (green channel) and FAD (yellow channel) with an 
increased metabolism associated with dysplasia (Skala, Riching et al. 2007). By inference the reverse 
of these changes might suggest a decrease in cellular metabolism. The individual lifetime 
components from our data were therefore examined to look for clues to the underlying cause for 
this increase in lifetime with age. However no changes were seen in the lifetime components with 
age consistent with either a faster or slower cellular metabolism.  
In conclusion, a decrease in the cell density was found in the >42 year old age group. However, it 
was not clear if this change was caused by a reduced proportion of the smaller cells from the basal 
layer in this category. Also a trend of longer median τmean was found with age. Between the 30-42 
and >42 year old groups a lifetime difference of +199, +550, +514 and +417 ps in the blue, green, 
yellow and red channels respectively was found. The data supports the trends found by Benati et al., 
but our data does not demonstrate a significant difference in median τmean between age groups. 
6.6.4 Sex 
In this sub-section the changes in lifetime between the sexes is investigated. No work has previously 
been published on this and no difference is expected. 
      Sex   
    Male Female Total 
Patient 
Numbers   17 13 30 
Demographics Age (Range) 45.4 (18-81) 44.7 (17-88)   
  Skin Type (Range) 2.5 2.5   
In vivo/Ex vivo    7/10  11/2  18/12 
FOV by Inner Forearm 7 10 17 
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body site Outer Forearm 1 7 8 
  Back 8 0 8 
  Face 1 2 3 
  Lower Leg 1 0 1 
Images Taken   74 70 144 
Total 
Cells/ROIs   3559 3345 6904 
Cells/ROIs per S.Granulosum (%) 300 (8.4) 673 (20.1) 973 
Skin Layer (%) S.Spinosum (%) 1978 (55.6) 1669 (49.9) 3647 
  Basal Layer (%) 1281 (36.0) 1003 (30.0) 2284 
Table 6.4 Characteristics of samples used and images taken for comparison of sexes with fluorescence lifetime. 
Table 6.4 summarises the characteristics from the two sexes. From the table, it can be seen that 
there are a significant proportion of samples from the back in males and a similar proportion from 
the outer forearm in females. Also, a greater proportion of ROIs arise from the s.granulosum in 
females compared to males (20.1 vs 8.4%). 
Figure 6.18 Distribution of τmean with spectral channel categorised by sex. 
Figure 6.18 shows the distribution of τmean in all spectral channels, categorised by sex. Although 
histograms are similar, there is a noticeable population of cells with a longer lifetime in the green, 
yellow and red channels in the female group. In particular there is a population of cells with a τmean of 
1500 ps in the red channel. 
Further analysis found that 50% of the cells above a threshold of 1250 ps for τmean in the red channel 
arose from a single tissue sample (id 5010). The sample came from a patient who was skin type 1 
and images were taken from both the inside and the outside forearm. The remaining cells arose 
from a further 8 samples, pointing against an outlier data set i.e. from id 5010, as the sole cause for 
this finding.  
It was also found that the cells above this threshold in the red channel accounting for the peak seen 
for females were also the cells that formed the highest peak in the green channel (above threshold 
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of 2750 ps) and the peak with the longest τmean for females in the yellow channel (above threshold of 
2250 ps). Further analysis was performed as it was not clear what the underlying cause for this 
finding was. 
    % of ROIs   
 Red Channel τmean threshold Layer Male Female Difference 
<1250 ps s.granulosum 6.46 13.57 7.11 
  s.spinosum 49.68 40.16 -9.51 
  basal layer 43.87 46.26 2.40 
>1250 ps s.granulosum 15.37 27.93 12.56 
  s.spinosum 76.37 61.51 -14.86 
  basal layer 8.26 10.56 2.30 
Table 6.5 Percentage of cells in each cell layer categorised by sex, above and below a threshold of 1250 ps for τmean in the 
red channel. 
To investigate if this could be explained by an increased proportion of cells arising from the 
s.granulosum (where cells have longer lifetimes) in the female group, the % of cells above and below 
a threshold of 1250 ps for τmean in the red channel for each sex and categorised by cell layer was 
calculated, see table 6.5. If this was a cause, it would be expected that the population of cells above 
this threshold in the female group would have a greater proportion of cells from the s.granulosum. 
The table shows that 27.93% of cells vs 13.57% cells arose from the s.granulosum above and below 
the threshold respectively for females. The table also shows that there is an increase in the % of cells 
in the s.granulosum for females compared to males above this threshold (7.11 to 12.56%). The net 
effect would be a rise in the median τmean in the population of cells above the threshold for females 
because it has been shown in section 6.5.4 (pp149) that lifetimes increase with distance from the 
basal layer.  
In summary, a difference in the lifetime was found between the sexes. However, further analysis 
revealed that this difference was heavily contributed to by a single ‘outlier’ patient’s data and may 
have arisen from the differences in the proportion of cells from each cell layer. 
6.6.5 Skin type 
The difference in lifetime with the Fitzpatrick skin type of patients was then investigated. The 
Fitzpatrick skin type measures the skin pigmented by clinical phenotype and its ability to tan and 
burn in the sun. The scale extends from 1 (pale skin, blue eyes, blond/red hair, always burns and 
never tans) to 6 (dark brown or black skin, easily tans and never burns). FLIM images have been 
taken from patients of skin type 1-4. Although the number of melanocytes in the basal layer remains 
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similar for all skin types, their activity increases with skin type. One would therefore expect to see an 
increase in melanin content in both the melanocytes and keratinocytes in the epidermis with skin 
type and thus expect to see a decrease in τ1, τmean and increase in f1, with a possible increase in 
spectral contributions from the yellow and red channels. Although studies have investigated the 
differences in fluorescence between skin types in vivo (Krasieva, Stringari et al. 2013), to our 
knowledge, a detailed investigation of fluorescence lifetime has not been performed before. Dancik 
et al. measured arms from patients with each skin type using colourimetry and MPM. They noted a 
positive correlation of b* (a measure of colour along the blue-yellow axis), which also correlates with 
skin type, to τ1 with R
2 of 0.71 for the inside forearm and R2 of 0.81 for the outside forearm (Dancik, 
Favre et al. 2013). 
      Skin Type       
    1 2 3 4 Total 
Patient 
Number   5 10 10 5 30 
Demographics Age (Range) 
30.8 
(18-43) 
50.9 
(21-88) 
51.5 
(17-81) 
35 
(25-60)   
  Sex (M/F)  2/3  7/3  5/5  3/2 
 
17/13 
In vivo/Ex 
vivo    5/0  4/6  4/6  5/0 
 
18/12 
FOV by Inner Forearm 4 4 4 5 17 
body site Outer Forearm 3 3 1 1 8 
  Back 0 4 4 0 8 
  Face 0 1 2 0 3 
  Lower Leg 0 1 0 0 1 
Images Taken   31 50 37 26 144 
Total 
Cells/ROIs   1578 2246 1849 1231 6904 
Cells/ROIs per S.Granulosum (%) 327 (20.7) 322 (14.3) 182 (9.8) 142 (11.5) 973 
Skin Layer (%) S.Spinosum (%) 922 (58.4) 1313 (58.5) 917 (49.6) 495 (40.2) 3647 
  Basal Layer (%) 329 (20.8) 611 (27.2) 750 (40.6) 594 (48.3) 2284 
Table 6.6 Characteristics of samples used and images taken for comparison of skin type with fluorescence lifetime. 
Table 6.6 summarises the characteristics from the different skin types. The sample size is small 
(n=30) for this number of categories and the 4 groups are not of equal size which may confound the 
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results. For example, the table shows skin types 1 and 4 have ½ the number of patients compared to 
skin types 2 and 3. In addition they are younger, all images were taken in vivo and taken from the 
forearm only. Also, a greater proportion of ROIs were taken from the s.granulosum and s.spinosum 
for skin types 1 and 2 with smaller contribution from the basal layer, compared to skin types 3 and 4.  
To summarise, groups with skin type 1 and 4 are younger (decreasing the expected median τmean, see 
section 6.6.3, pp160) and skin type groups 1 and 2 have ROIs from higher skin layers (increasing the 
expected median τmean , see section 6.5.4, pp149).The net effect is difficult to predict. 
        Percentile 
Index Channel 
Skin 
Type 25 50 75 
τmean (ps) Blue 1 1571 1928 2256 
    2 1149 1659 2126 
    3 1232 1915 2202 
    4 1021 1642 2081 
  Green 1 2456 2926 3079 
    2 1867 2277 2587 
    3 1490 2084 2493 
    4 921 1590 2045 
  Yellow 1 1649 2254 2564 
    2 1072 1464 1838 
    3 778 1287 1685 
    4 388 818 1232 
  Red 1 1246 1484 1611 
    2 885 1150 1491 
    3 604 867 1141 
    4 403 569 742 
Table 6.7 Summary of the distribution of τmeanfor each spectral channel, categorised by skin type. 
Figure 6.19 Distribution of τmean with spectral channel categorised by skin type. 
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The quartiles of τmean for each skin type and spectral channel is listed in table 6.7. Figure 6.19 
illustrates the distribution of τmean with channel and skin type. All groups have similar distributions of 
τmeanin the blue channel. There is also a consistent trend (that can be confirmed in table 6.7) that the 
median τmean decreases with increasing skin type (i.e. darker skin colour) across the remaining 
channels. The median τmean decreases between skin type 1 and 4 by 286, 1336, 1436 and 915 ps in 
the blue, green, yellow and red channels respectively. This difference was found to be statistically 
significant when τmean was averaged and comparing on a per patient basis using the Wilcoxon rank 
sum test for the green (p=0.016), yellow (p=0.016) and red (p=0.016) spectral channels. 
Figure 6.20. The distribution of τ 1 , τ2 and f1 by spectral channel for each skin type. 
To investigate this trend further, histograms of the distribution of τ1and τ2 and f1 in all spectral 
channels for each skin type were plotted, see figures 6.20. Again, there is very little difference 
between the skin types in the blue channel. In the remaining channels there is a progressive shift 
towards shorter lifetimes with skin type for both τ1 and τ2. f1 shows an increased contribution from 
the shorter lifetime component with increasing skin type.  
Can these changes be attributable to differing melanin content between patients with different skin 
types? A large population of cells with a τ1 of <100 ps in all channels from all skin types suggests that 
melanin is a dominant fluorophore for the short lifetime component. Therefore the progressively 
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higher f1 with skin type supports the conclusion that an increased melanin content accounts for the 
changes seen in τmean with skin type.  
As noted previously in section 6.5.4 (pp149), either a particular melanin aggregate or contribution 
from a fluorophores other melanin may account for a population of cells, with a τ1 >200 ps in the red 
channel. This lifetime is most noticeably from patients with skin type 1 (whom have lower baseline 
melanin quantities in their skin and a greater pheomelanin: eumelanin ratio in their pigment) and 
raises a further possibilities as to the origin of this difference. 
In summary a progressive shortening of the median τmean was seen with skin phototype. This was 
greatest between type 1 and 4 skin and caused a 286, 1336, 1436 and 915 ps decrease in the median 
τmean in the blue, green, yellow and red channels respectively. This trend was reflected in τ1, τ2 and f1 
and felt to arise from increasing melanin content of the cells with increasing skin type. As a clear 
trend was detected, the biases described above between the groups known to affect lifetime i.e. age 
and cell layer do not appear to have affect the results significantly.  
6.6.6 Body site 
In this section, the differences in the fluorescence lifetime between body sites is investigated. Dancik 
et al. measured the fluorescence intensity and  lifetimes from the forearms from 5 patients with 
different skin types from the inside and outside forearms (Dancik, Favre et al. 2013). They were 
unable to measure a difference in the fluorescence intensity between these sites in African skin, but 
measured between 1.4-2 times increase from Asian skin in the outside compared to the inside 
forearm. They also compared the fluorescence lifetimes from the skin against the fluorescence 
intensity within the images for body site and skin type, but did not make a direct comparison of the 
fluorescence lifetimes between body sites. 
Benati et al. did study the fluorescence lifetime variation with body site (Benati, Bellini et al. 2011). 
They recorded the lifetimes of skin in vivo in 21 patients aged 20-35 years from the inside forearm, 
outside forearm and the thigh. They fitted single pixels (after binning 5x5) using a single exponential 
decay model. They found that the average lifetimes were found to be 1215±100, 1171±116 and 
1080±103 ps from cells in the upper skin layers and 882±201, 935±174 and 931±101 ps from the 
lower skin layers in the inside forearm, outside forearm, and thigh respectively. The only statistically 
significant difference in lifetime they found was between the inside forearm and the thigh in the 
upper skin layers.  
No explanation was offered for these differences in the paper. One may have expected less sun 
exposure to the skin on the thigh and possibly the inside forearm leading to a longer τmean than the 
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outside forearm. As this was not seen, one could conclude that either the melanin induction from 
photo-exposure does not have a significant contribution towards the changes seen between body 
sites, or differences between the patients, such as skin type, obscure this effect. 
      Body Site     
    
Inside 
Forearm 
Outside 
Forearm Back Total 
FOV imaged   17 8 8 33 
Demographics Age (Range) 
34.1 
(17-60) 
35.6 
(25-43) 
58 
(28-81)   
  Sex (M/F)  7/10  1/7  8/0   
  Skin Type (Range) 2.6 (1-4) 2 (1-4) 2.5 (2-3)   
In vivo/Ex vivo    17/0  8/0  0/8  25/8 
Images Taken   72 26 34 132 
Total Cells/ROIs   3295 1288 1560 6143 
Cells/ROIs per S.Granulosum (%) 511 (15.5) 290 (22.5) 67 (4.3) 868 
Skin Layer (%) S.Spinosum (%) 1699 (51.6) 493 (38.3) 859 (55.1) 3051 
  Basal Layer (%) 1085 (32.9) 505 (39.2) 634 (40.6) 2224 
Table 6.8 Characteristics of samples used and images taken for comparison of body site with fluorescence lifetime 
From our data sets, the greatest numbers of images were taken from the inside forearm, outside 
forearm and the back, see Table 6.8. As more than one body site was imaged from some patients 
(inside and outside forearm), the number of sites imaged (n=33) is greater than the number of 
patients (n=30). There are a number of key differences between the groups. The images taken from 
the back were all taken from ex vivo tissue, all tissue originated from males who were older than the 
remaining groups. The skin type of the inner forearm group was higher (i.e. darker skin) than those 
of the outside forearm group, potentially obscuring changes of melanin related to photo-exposure. 
Finally, apart from the different number of images taken & ROIs between groups, the proportion of 
cells in the s.granulosum and s.spinosum varied.  
        Percentile 
Index Channel Body Site 25 50 75 
τmean (ps) Blue Back 1194 1820 2155 
    Inside Forearm 1208 1741 2145 
    Outside Forearm 1167 1823 2257 
  Green Back 1670 2148 2463 
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    Inside Forearm 1486 2070 2636 
    Outside Forearm 1709 2337 2825 
  Yellow Back 923 1320 1676 
    Inside Forearm 747 1298 1933 
    Outside Forearm 873 1434 2026 
  Red Back 823 1053 1496 
    Inside Forearm 579 866 1447 
    Outside Forearm 831 1156 1393 
Table 6.9 Distribution of τmean with body site, categorised by spectral channel 
Table 6.9 shows the distribution of τmean by body site for each spectral channel. The median cell 
densities were 0.00174 cells/µm2 for the back, 0.00323 cells/µm2 for the inside forearm and 0.00286 
cells/µm2 for the outside forearm. The median cell density taken from the back was lower than 
those taken from the forearm. Table 6.9 shows a progressive reduction in the median τmean from the 
outside forearm to the back to the inside forearm for in all spectral channels. This decrease was 
found to be 82, 267, 136 and 291 ps between the outside and inside forearm in the blue, green, 
yellow and red spectral channels respectively. This difference was not found to be statistically 
significant when lifetimes were averaged and compared on a per patient basis using the Wilcoxon 
Rank Sum Test. This compares to an increase of +44 ps in the upper skin layer and a decrease of -53 
ps in the lower skin layer between these same body sites found by Benati et al. (Benati, Bellini et al. 
2011). There is no clear explanation for this finding. 
Figure 6.21 Distribution of τmean with spectral channel categorised by body site. 
On closer analysis of the data, the trends in τmean detailed above and seen in the table are not as 
clearly visible from the histograms of τmean, shown in figure 6.21. These histograms suggest a more 
complex picture than originally implied by table 6.9. It has already been noted that the groups are 
not ideally matched and although real differences in lifetime may have been detected with our data, 
a more carefully controlled study would be necessary to investigate further. 
One method to minimise such discrepancies is to analyse paired data taken from different body sites 
but from the same patient. In this way each patient acts as their own control for all parameters 
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except the number of cells arising from each cell layer. It is a more sensitive approach and might 
therefore be more successful with our small sample size. This approach was tried for 5 patients who 
were imaged in vivo from the inside and outside forearm. The results showed that no trends could 
be seen in τmean between pairs.  
Figure 6.22 The spectral contribution in the red channel from 5 patients imaged from inside and outside forearm in vivo. 
Patient ID and number of cells indicated. 
The only consistent change found was a larger spectral contribution from the outside forearm in the 
red channel in all patients. This is illustrated in figure 6.22 which shows the spectral contribution of 
the red channel from the 5 patients. This difference was not detected in the unpaired data. It was 
not possible to attribute this to increased melanin in the skin from the outside forearm as no 
consistent reduction in τmean or increase in f1 in the yellow or red channels was seen, which might be 
expected with increased melanin. Therefore this trend also requires further study in order to verify it 
and investigate its origin. 
In conclusion, a decrease in fluorescence lifetime was found between the outside and inside forearm 
of 82, 267, 136 and 291 ps in the blue, green, yellow and red spectral channels respectively. 
However, as the groups of cells analysed were not well matched, it was not clear if this difference 
represents a true finding. A difference in the fluorescence lifetime was also not found when paired 
images taken from the same patient of the inside and outside forearm. The only consistent 
difference detected in the paired images was a larger spectral contribution in the red channel from 
the outside forearm. This is of uncertain significance and should be confirmed in future studies. 
These findings are in agreement with those reported by Benati et al. (Benati, Bellini et al. 2011), that 
no difference could be concluded between the 2 sides of the forearm. The fact that differences were 
seen in the lifetimes between the inside forearm, outside forearm and the back suggests that a 
larger, more controlled study may find statistically significant differences that our study did not have 
the power to detect. 
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6.6.7 Section C- Conclusions 
In the first half of section C the intra and interpatient variability in lifetimes in normal skin has been 
evaluated. It has been shown that cells from the same patient have a tendency to cluster together in 
respect to their spectral and lifetime properties. A greater interpatient variability between lifetimes 
has also been shown than the intrapatient variability shown between the FOV.  
When all cells were plotted by their spectral contribution in the green and yellow channels, the 
appearance of distinct cell populations that transcend individual patients emerged.  Although it was 
speculated that the differences in these populations were based on cell pigmentation and 
metabolism, no definitive conclusions could be drawn. 
The second half of section C investigated the changes in the fluorescence lifetime with a number of 
parameters including age, sex, skin type and body site. A longer median τmean was found between the 
30-42 and >42 year old groups of +199, +550, +514 and +417 ps in the blue, green, yellow and red 
channels respectively. The data supports the trends found by Benati et al., but our data demonstrate 
a significantly longer median τmean between age groups than their cohort, although not statistically 
significant. 
Although a difference in the fluorescence lifetime between the sexes was initially seen, it became 
unclear if this was a true finding and further work was suggested to investigate this. 
A progressive shortening of the median τmean was seen with skin phototype of 286, 1336, 1436 and 
915 ps in the blue, green, yellow and red channels respectively between skin type 1 and 4. This trend 
was reflected in τ1, τ2 and f1 and felt to arise from increasing melanin content of the cells with 
increasing skin type and was found to be statistically significant using the Wilcoxon Rank Sum Test 
for the green (p=0.016), yellow (p=0.016) and red (p=0.016) spectral channels. 
Finally, a decrease in fluorescence lifetime was found between the outside and inside forearm of 82, 
267, 136 and 291 ps in the blue, green, yellow and red spectral channels respectively. However, as 
the groups of cells analysed were not well matched, it was not clear if this difference represented a 
true finding and further work was suggested. 
6.7 Summary 
The results in this chapter are the first study of normal skin using multispectral FLIM. This 
conclusions section aims to highlight the findings from all sections in this chapter. 
In section A the morphological features seen in MPT images from normal skin are presented and 
discussed. An example of paired multispectral MPT FLIM images is presented with hyperspectral 
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images taken from the same FOV using a modified DermaInspect®. It is then demonstrated that a 
detailed spectral and lifetime analysis can be performed from these images using a set of epidermal 
and dermal images as an example. Following this, a number of morphological features noted in the 
FLIM images are discussed. 
Section B specifically investigates the fluorescence lifetime changes seen between the different cell 
layers of the epidermis. In conclusion the cell density was found to increase with depth in the 
epidermis. A decrease in the median τmean between the s.granulosum and the basal layer of 1286, 
1206, 1169 and 691 ps for the blue, green, yellow and red spectral channels respectively was then 
found, which is significantly longer than the difference reported previously (300ps). Further analysis 
of the lifetime parameters support the conclusion that this related to increased melanin content in 
the cells from the basal layer. There was however insufficient evidence from this data that a change 
in NAD(P)H lifetime (reflecting an increased metabolic activity) accounted for some shortening of the 
lifetime with depth. 
On a number of occasions the lifetime seen in the red channel, especially for τ1 , had a longer than 
expected lifetime than could be expected for melanin. The cause for this difference remains unclear 
and might be attributable to an aggregate of melanin of a size that has a longer emission spectrum 
and a longer than average lifetime than other aggregate sizes. Another possibility is the presence of 
another fluorophore in the red spectral channel, other than melanin. 
Section C evaluated intra- and interpatient variability in fluorescence lifetimes of normal skin. A 
greater variability between lifetimes has been shown between patients than the intrapatient 
variability shown between the FOV.  The presence of distinct cell populations has also been 
demonstrated, for the first time using cellular fluorescence from the green and yellow channels. 
Although it has been speculated that the differences in these populations were based on cell 
pigmentation and metabolism, no definitive conclusions could be drawn without further 
investigation. 
The changes in the fluorescence lifetime with age, sex, skin type and body site was then 
investigated. A longer median τmean was found between the 30-42 and >42 year old groups of +199, 
+550, +514 and +417 ps in the blue, green, yellow and red channels respectively which was larger 
than found by previous groups. Although this was a significant difference when analysed on a per 
cell basis, it was not found to be statistically difference on a per patient basis. 
A progressive shortening of the median τmean was also seen with skin phototype of 286, 1336, 1436 
and 915 ps in the blue, green, yellow and red channels respectively between skin type 1 and 4. This 
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trend was reflected in τ1, τ2 and f1 and felt to arise from increasing melanin content of the cells with 
increasing skin type. This difference was found to be statistically significant when comparing on a per 
patient basis using the Wilcoxon Rank Sum Test for the green (p=0.016), yellow (p=0.016) and red 
(p=0.016) spectral channels which has not been recorded in the literature previously. 
Finally, a decrease in fluorescence lifetime was found between the outside and inside forearm of 82, 
267, 136 and 291 ps in the blue, green, yellow and red spectral channels respectively. However, as 
the groups of cells analysed were not well matched, it was not clear if this difference represented a 
true finding and further work was suggested.  
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Chapter 7. The use of autofluorescence to evaluate Basal Cell 
Carcinoma 
7.1 Aim 
The aim of the work described in this chapter was to evaluate MPT FLIM as a means to discriminate 
basal cell carcinomas (BCCs) from normal skin. Fluorescence intensity and FLIM images were 
collected from normal skin (in & ex vivo) and freshly excised BCCs using four emission spectral 
channels. This is the first time images from BCCs have been analysed using multispectral MPT FLIM 
and the first detailed analysis of their lifetime parameters.  
A selection of FLIM images is initially presented and the visual architectural features associated with 
BCCs (basal cell carcinoma) are discussed. The diagnostic accuracy of using these features is then 
calculated. Next the diagnostic accuracy and degree of discrimination provided by the spectroscopic, 
lifetime and automatically calculated cellular morphological parameters are then explored.  
7.2 Introduction 
Basal cell carcinoma  is most common in Caucasian populations and has a high prevalence in the 
western world (Diepgen and Mahler 2002; Demers, Nugent et al. 2005) with a rising incidence in all 
age groups (Christenson, Borrowman et al. 2005; Staples, Elwood et al. 2006). They are tumours that 
are thought to arise from the basal layer of the epidermis and can manifest as a number of clinically 
and histologically defined sub-types. A further introduction can be found in Chapter 1.3.1, pp30. 
Initial assessment of a possible BCC is currently made on clinical examination. If a lesion arises on the 
face (the most common site of presentation), a diagnostic biopsy is typically performed to confirm 
the diagnosis. The biopsy rate is driven by the desire for a high threshold of diagnostic certainty and 
different subtypes can be treated differently e.g. superficial BCCs can be treated with topical cream 
instead of surgical excision which has cosmetic implications for the patient. This threshold for biopsy 
is higher for BCCs on the body and definitive excisions are more often performed based on a clinical 
diagnosis alone. Sometimes a biopsy may not be fully diagnostic e.g. superficial biopsies may miss 
the presence of deeper infiltrative components of tumour. Furthermore, identifying recurrence on 
biopsy may be challenging and skin with lots of adnexal elements and actinic change can add to the 
difficulty in the interpretation of the biopsy slides. 
As a result, a large proportion of suspected BCCs have diagnostic biopsies. This involves a portion of 
the tumour first being excised, fixed, processed, sectioned and stained before it can be reviewed. 
Biopsies can be both uncomfortable, cosmetically disfiguring to the patient, time-consuming and 
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expensive to the clinician. As the biopsy does not always confirm a BCC or other lesion that requires 
further treatment, it can be seen an unnecessary in some cases.  
In these circumstances a non-invasive imaging modality capable of producing optically sectioned 
images in situ with high spatial resolution and correlation with histology would be highly desirable in 
terms of time, cost and patient experience. Such a device could also, for the first time allow real time 
monitoring of the response to topical chemotherapy. The assessment of clearance or recurrence 
following non-invasive topical therapy is also only performed on clinical judgement, with only 
clinically apparent recurrences being biopsied/treated. Real time non-invasive monitoring would 
allow recurrences to be diagnosed earlier and facilitate more lesions to be treated with topical 
chemotherapy i.e. without surgery. Therefore modalities such as multiphoton tomography (MPT) 
FLIM have the potential to be relevant in the clinical management for patients with BCCs.  
7.3 Methods 
Further details regarding all aspects of the methods are outlined in Chapter 4, pp87. 
7.3.1 Instrumentation 
MPT was performed using the modified DermaInspect®, as described in Chapter 4.4 & 4.5, pp89,92. 
Fluorescence was recorded using time correlated single photon counting (TCSPC) into 256 time bins 
and 4 spectral channels. The spectral channels were defined as 360-425nm (blue), 425-515nm 
(green), 515-620nm (yellow) and 620-640/655nm (red). Minor modifications were made to the 
system during the study to broaden the longest wavelength channel’s detection bandwidth from 
620-640 to 620-655 nm and to improve the spectral separation between the 360-425 nm and 425-
515 nm channels.   
A motorised microscope stage (Scan IM 120 x 80, Märzhäuser Wetzlar Gmbh, Germany) was used for 
the sequential acquisition of data from several fields of view in a number of ex vivo samples (without 
the use of the metallic coupling ring) to allow image mosaics to be created.  
Ex vivo specimens in an inverted glass bottomed petri dish were coupled to the DermaInspect® 
magnetically using a metallic coupling ring, attached to the dish with an adhesive tape prior to 
imaging. For in vivo imaging, a glass coverslip was attached to the metallic ring and then attached to 
the patient using an adhesive tape. 
7.3.2 Patients and Samples 
Patients attending clinics at the Department of Dermatology at Imperial College Healthcare NHS 
Trust were recruited. Patients gave written informed consent to participate.  Images were collected 
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from normal skin (in & ex vivo) and freshly excised BCCs. Further details of the patient selection and 
sample preparation are described in Chapter 4.2 & 4.6 (pp87,95).  
Freshly excised BCCs were rinsed with Hanks Balanced Salt Solution buffer without phenol red, 
calcium or magnesium (Gibco®, Invitrogen™, CA, USA), its surface moistened with the buffer solution 
and placed on damp gauze in an inverted glass bottomed petri dish (80-170 µm cover slip Matek®, 
MA,USA) immediately following excision.  
Ex vivo normal skin was acquired from the margins of larger surgical excisions for suspected skin 
cancers. This normal skin was sufficiently distant from the tumour site to not be affected and 
appeared normal by clinical inspection of the surface. Ex vivo samples were kept at room 
temperature and imaged 66±38 minutes (mean±SD) after excision and prepared for imaging as 
outlined above for BCC samples. Images of normal skin in vivo were taken from patients from areas 
without cutaneous disease or malignancy.  
The diagnoses of all excised suspected BCCs were confirmed histologically. 
7.3.3 Imaging 
The excitation wavelength was fixed at 760 nm. The power was adjusted according to the depth of 
imaging (<50 mW) and was restricted by the manufacturers to <12 mW for imaging the s.corneum. 
Each FLIM image was either 128×128 or 256x256 pixels and was acquired over 25.5 s. The mean 
depth imaged per sample and range (25th - 75th centile) was 65 µm (range 40-85 µm) for the BCCs 
and 62 µm (range 40-72µm) for normal skin, i.e. within the lower epidermis for most samples of 
normal skin. All images from BCCs were acquired from intact skin and not areas of ulceration. 
7.3.4 Data Analysis 
FLIM images were generated by fitting a single exponential decay to the fluorescence from each 
spectral channel of each pixel in the image using software written in Matlab® (R2010b, The 
Mathworks Inc.,USA). Regions of interest (ROI) were defined manually in each image corresponding 
to each cell. An example is illustrated in Chapter 4.10.4, pp105. Each ROI in each channel was then 
fitted to a double exponential decay model. ROI fluorescence decay curves from a single spectral 
channel containing fewer than 1000 photons were excluded from the analysis as they contained too 
few photons to reliably fit to a double exponential mode for that channel. Morphological parameters 
were calculated from the manually segmented ROIs within each image. These included descriptors 
of each ROI individually and how these relate to each other spatially. A full description of the 
parameters can be found in Chapter 4.10.7, pp109. 
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The linear discriminant analysis (LDA) was initially performed on the data using the manually 
segmented ROIs.  ROIs containing <1000 photons in any spectral channel were also excluded from 
the analysis in addition to the photon threshold criteria outlined above. All the ROIs from two 
patients (one normal, one BCC) had <1000 photons in all spectral channels and so were excluded 
from the LDA entirely. Finally, the LDA was repeated using ROIs defined by automatic image 
segmentation as described in Chapter 4.10.8 (pp111) and using unsegmented images. 
7.3.5 Image montaging 
The motorised microscope stage was used to image a total of 12x8 FOVs. Each image in the montage 
was acquired over 25.5 s with an image resolution of 256x256 pixels. The total acquisition time for 
the montage was ~100 minutes. Fitting a single exponential decay model to every pixel in an image 
required approximately 2.5 s using an 8-core, 3.16 GHz PC with 32 GB RAM running MATLAB R2011a 
under Windows 7, 64 bit. Therefore the FLIM decay fitting process required a total of ~4 minutes for 
the entire montage in one spectral channel. Due to backlash when reversing the direction of stage 
motion, fully automatic image stitching using the programmed stage translation distance did not 
provide satisfactory results. Therefore, semi-manual image registration was employed using a 
software package developed in-house in LabVIEW, which required approximately 1 hour aligning the 
whole montage. 
7.3.6 Statistics 
It should be noted that all the spectroscopic, lifetime and morphological parameters and the 
statistical calculations were performed by Dr Yuiry Alexandrov. The Wilcoxon Rank Sum test (Lupton 
1993;P119-28) was applied to study the difference in distribution of lifetimes parameters between 
BCC and normal groups and assess their significance. The discriminative ability of the spectroscopic 
and morphological ROI measurements were assessed using 2 parameters: Receiver Operator 
Characteristic  Area Under the Curve (AUC,(Mathews 2010;P158)) and the Cohen’s d  statistic 
(Gravetter and Wallnau 2009;P262).  
As described in Chapter 4.10.9 (pp112), principal component analysis (PCA) was used to reduce the 
dimensionality of the large number of spectroscopic and cellular morphological parameters. The first 
4 principal components were then used in the linear discriminant analysis (LDA).  
 The LDA was performed for each ROI to classify it as arising within a BCC or normal skin. The fraction 
of cells classified as BCC could then be determined for each patient and an AUC and sensitivity and 
specificity for the correct diagnosis of each patient was then calculated. 
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All spectroscopic and cellular morphology parameters were included for the analysis of the manually 
segmented ROIs. For the automatically segmented data, only the spectroscopic parameters were 
included as the ROIs correlated less accurately to individual cells compared to the manually defined 
method, as illustrated in Chapter 4.10.8 (pp111). Unsegmented images were binned per FOV 
analysed by first spatially integrating the fluorescence decay profiles over each field of view, fitting 
the resulting decays and then calculating the mean spectroscopic parameters for each patient. These 
mean parameters were then included in a PCA and the first 4 components were selected for the 
LDA, as previously described in Chapter 4.10.9 (pp112).  
7.4 Results & Discussion 
          
 Median τmean (ps) 
(Inter-quartile range) 
Diagnosis 
Patients 
(M/F) 
Mean 
Age 
(Range) Images 
ROIs/
Cells Blue Green Yellow Red 
BCC 
19  
(11/8) 
64  
(44-86) 110 4259 2419 2624 1908 1448 
     
(1759-2773) (2412-2819) (1582-2200) (1240-2013) 
Normal 
Skin 
27  
(15/12) 
42  
(17-80) 122 6203 1797 2189 1380 1036 
     
(1282-2175) (1656-2709) (888-1974) (709-1428) 
% difference from 
Normal       34.6 19.9 38.3 39.8 
Table 7.1 Patient characteristics and median lifetimes for each spectral channel. 
Table 7.1 summarises the patients and data used in the analysis. 19 patients with normal skin were 
imaged in vivo, the remaining samples in the study were imaged ex vivo. Patients had skin 
phototypes I-IV with a mean of 2.5 and 2.2 for normal skin and BCCs respectively. All BCCs except 2 
had nodular components and 8 were mixed subtypes including infiltrative and superficial. Skin was 
imaged from the scalp, face, neck, chest, forearm and back for BCCs and face, forearm, back and 
lower leg for normal skin. The difference in median τmean between BCC and normal samples 
(compared on a per patient basis) was found to be statistically significant to p<0.01 using the 
Wilcoxon rank sum test (p = 0.0013, 0.0049, 0.0061, 0.0006 in the blue, green, yellow and red 
channels respectively). The fluorescence lifetimes are further discussed in section 7.4.3 (pp187). 
Figure 7.1 shows an exemplar image stack taken from a BCC. 
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Figure 7.1 Multispectral FLIM images taken at multiple depths from a nodular/superficial BCC. 
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30 µm
50 µm
60 µm
70 µm
90 µm
100 µm
110 µm
Spectral Channel
25µm
2190 ps
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7.4.1 Visual Morphological Analysis 
 
Figure 7.2 FLIM images acquired from BCCs. (a-g) FLIM images taken from the green channel illustrating visual architectural 
features seen in BCC using MPT. (h) FLIM image taken from the blue channel of a BCC. (i,j) paired FLIM images taken from 
the green and blue channels respectively of a BCC nest. Depth of image acquisition stated in bottom left corner of each 
panel. Scale bar 25 µm. 
Figures 7.2a-j illustrates architectural changes seen in BCCs using MPT. These were identified by 
comparing the differences between the MPT FLIM images taken from BCCs to those from normal 
skin. A number of features described previously (Paoli, Smedh et al. 2008; Seidenari, Arginelli et al. 
2012) (images from Seidenari et al. reproduced in Chapter 3.5, pp78) were observed. These include 
‘detached cells with enlargement of intercellular spaces’ (panel a), ‘cells with irregular contours’ and 
‘random arrangement of cells’ (both seen in panel b), ‘aligned elongated cells’ (panel c, white 
arrow), ‘double alignment of monomorphous cells’ (panel d, white arrows), ‘palisading’ (panel i) and 
‘sheets of cells intermingled with fibres’ (panel h).  The paired images in panel i, j are taken from the 
green and blue channels respectively and show the proximity of BCC nests to the surrounding 
collagen fibres (‘cell islands surrounded by fibres’). 
In addition to these features, a pattern of monomorphous cells, often heterogeneous in size, with 
large nuclear/cytoplasmic ratios, poorly defined cell margins and appearing to overlap was 
repeatedly observed. This new feature of ‘merging cells’ can be seen in Figure 7.2 c,e,f,g. 
2190 ps
25 ps
BCC – morphology, green channel (a-g,i) & blue channel (h,j)
g)
h)
e) f)
j)
c) d)a) b)
i)
50 m 30 m 80 m 70 m
100 m
60 m 110 m 70 m
100 m 100 m
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Criteria for BCCs 
BCC  
(N=19) 
Normal Skin 
(N=27) 
Sensitivity Specificity 
Random arrangement of cells 1 0 5.3 100 
Cells with irregular contours 0 0 N/A N/A 
Detached cells with enlargement of 
intercellular spaces 2 0 10.5 100 
Aligned elongated cells 6 1 31.6 96.3 
Double alignment of monomorphous 
cells 1 0 5.3 100 
Palisading 2 0 10.5 100 
Sheets of cells intermingled with fibres 4 0 21.1 100 
Cell islands surrounded by fibres 1 0 5.3 100 
Merging Cells 8 1 42.1 96.3 
Table 7.2 The sensitivity and specificity for the diagnosis of BCC listed by individual morphological feature. 
Blinded to the diagnosis, all FLIM images were assessed for the presence of the MPT diagnostic 
morphological features for BCC described above. The results are outlined in table 7.2 which outlines 
the specificity and sensitivity of each feature individually. The sensitivity and specificity have been 
calculated as follows:- 
Sensitivity = 
              
                               
    =   
                          
               
               (Equation 7.1) 
Specificity = 
            
                                
 =    
                                      
               
  (Equation 7.2) 
As can be seen from Table 7.2 the frequency that each individual morphological feature is present in 
both samples of normal skin and BCCs is low. The highest frequency was the presence of ‘merging 
cells’ that was detected in 8/19 samples of BCC (42.1%).  
In situations where multiple diagnostic criteria have been identified, using a threshold number of 
positive criteria to positively identify a disease is commonly used. . For example, this approach has 
been applied to diagnose systemic lupus erythematosus (threshold of 4 out of 11 criteria) (Tan, 
Cohen et al. 1982). More recently it has been applied to optimize the accuracy of the diagnosis of 
BCCs using confocal microcopy (threshold of 4 out of 5 criteria) (Nori, Rius-Diaz et al. 2004). Table 
7.3 outlines the sensitivity and specificity of these criteria using several example thresholds and 
shows a sensitivity/specificity of 79%/93% for the presence of at least one feature. 
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Number of features 
present 
BCC 
(N=19) 
Normal Skin 
(N=27) Sensitivity (%) Specificity (%) 
>=1 15 2 78.94 92.59 
>=2 6 0 31.58 100 
>=3 2 0 10.53 100 
Table 7.3. The number, sensitivity and specificity for the diagnosis of BCC by the presence of multiple morphological 
features. 
Although the incidence of each morphological criterion was low in our images, the presence of more 
than one per sample was only detected in BCCs. As a result, no images from normal skin reached the 
increased threshold of 2 or more criteria present, leading to a high specificity for the test. We can 
speculate that this arises from sampling bias in the location the images were taken within the BCC, 
as tumours are heterogeneous in structure. 
Similarly, the number of BCC images that also have more than 2 criteria present is also lower (but 
not zero). Consequently the sensitivity also reduces from 15/19 for 1+ criterion to 6/19 for 2+ 
criteria (as calculated from equation 7.1). The sensitivity reduces further for 3 or more criteria as 
only two specimens meet this condition. 
An alternate but similar method of expressing the presence of the morphological criteria is to list the 
actual score and not the threshold. This data has been listed in Table 7.4. Clearly the greater the 
score, the higher the probability that the images are from a BCC. Using this method and for this data, 
we can select a threshold of 1 for diagnosis of a BCC. This ultimately calculates the same 
sensitivity/specificity as above of 78.94% / 92.59%. 
Score 
BCC 
(N=19) 
Normal Skin 
(N=27) 
0 4 25 
1 9 2 
2 4 0 
3 1 0 
4 0 0 
5 1 0 
Table 7.4. Outline of numerically scoring the presence of morphological features in images of BCCs and normal skin. 
In summary, it has been shown that the morphological features described by Seidenari et al. 
(Seidenari, Arginelli et al. 2012) together with the newly proposed feature of ‘merging cells’ provide 
a good specificity and sensitivity for identifying BCCs from FLIM images using a visual architectural 
analysis. The presence of at least one morphological feature was able to diagnose BCCs from the 
images taken by a sensitivity/specificity of 79%/93%.The added contrast provided by the colour FLIM 
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images and the spectral selectivity of features using multispectral FLIM, aided the identification of 
many features, especially when assessing cells within fibres, e.g. see Figure 7.2 h, j.  
7.4.2 Spectroscopic & morphological analysis 
        Percentile 
Index Channel Diagnosis 25 50 75 
τmean (ps) Blue BCC 1759 2419 2773 
    Normal 1282 1797 2175 
  Green BCC 2412 2624 2819 
    Normal 1656 2189 2709 
  Yellow BCC 1582 1908 2200 
    Normal 888 1380 1974 
  Red BCC 1240 1448 2013 
    Normal 709 1036 1428 
f1 Blue BCC 0.268 0.312 0.428 
    Normal 0.299 0.397 0.589 
  Green BCC 0.326 0.349 0.380 
    Normal 0.307 0.342 0.415 
  Yellow BCC 0.378 0.406 0.448 
    Normal 0.374 0.455 0.617 
  Red BCC 0.490 0.532 0.585 
    Normal 0.488 0.564 0.652 
τ1 (ps) Blue BCC 56 115 302 
    Normal 34 47 71 
  Green BCC 325 418 470 
    Normal 67 178 397 
  Yellow BCC 187 293 368 
    Normal 53 94 232 
  Red BCC 200 263 388 
    Normal 80 130 208 
τ2 (ps) Blue BCC 3053 3379 3766 
    Normal 2800 2986 3205 
  Green BCC 3512 3857 4122 
    Normal 2812 3141 3786 
  Yellow BCC 2630 3058 3476 
    Normal 2217 2475 2985 
  Red BCC 2301 2917 3790 
    Normal 1803 2211 2634 
Spectral Blue BCC 0.2533 0.2740 0.3149 
Contribution   Normal 0.2263 0.2527 0.2964 
  Green BCC 0.5269 0.5633 0.5923 
    Normal 0.5301 0.5653 0.6633 
  Yellow BCC 0.1199 0.1601 0.1994 
    Normal 0.0314 0.1828 0.2185 
  Red BCC 0.0002 0.0006 0.0036 
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    Normal 0.0001 0.0005 0.0011 
Total Photons Blue BCC 5722 11739 22650 
per ROI   Normal 2363 5540 11220 
  Green BCC 32062 66009 120605 
    Normal 17529 31816 58006 
  Yellow BCC 15051 28605 54824 
    Normal 10994 20143 37669 
  Red BCC 743 3822 24041 
    Normal 4386 8837 15841 
Table 7.5 – Summary of all spectroscopic parameters calculated for each ROI/cell. 
A number of spectroscopic and cellular morphology parameters were calculated using code written 
in MATLAB to process the manually defined regions of interest (ROI), as described and illustrated in 
Chapter 4.10.7 (pp109). The median ROI τmean is summarised for each spectral channel in Table 7.1. 
The complete table of the calculated lifetime parameters, categorised by diagnosis and spectral 
channel is shown in Table 7.5 
Parameter Index Channel 
Cohen's 
d AUC 
Fluorescence Spectral Contribution Blue 0.45 0.63 
Intensity Spectral Contribution Red 0.73 0.61 
  Fluorescence Coefficient of Variation Yellow 0.17 0.59 
  Spectral Contribution Green 0.48 0.58 
  Fluorescence Coefficient of Variation Blue 0.17 0.53 
  Spectral Contribution Yellow 0.03 0.52 
  Fluorescence Coefficient of Variation Red 0.20 0.52 
  Fluorescence Coefficient of Variation Green 0.06 0.51 
Fluorescence τ1 Red 1.44 0.82 
Lifetime τ1 Blue 1.22 0.80 
  τ1 Yellow 1.00 0.77 
  τ2 Red 0.20 0.74 
  τ2 Green 0.87 0.73 
  τ2 Blue 0.38 0.73 
  τ1 Green 0.83 0.72 
  τ2 Yellow 0.53 0.71 
  f1 Blue 0.40 0.63 
  f1 Yellow 0.57 0.62 
  f1 Red 0.34 0.59 
  f1 Green 0.29 0.52 
Table 7.6 The AUC for Spectroscopic parameters. 
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Parameter Index 
Adjacency 
Calculation 
Cohen's 
d AUC 
    Method     
 Cellular Number of Neighbours Delaunay 0.14 0.66 
 morphology Number of Neighbours Gabriel 0.12 0.64 
  Number of Neighbours SOI 0.17 0.62 
  Cell Confluency Gabriel 0.02 0.60 
  Cell Confluency SOI 0.02 0.60 
  Cell Confluency Delaunay 0.29 0.60 
 
Solidity   0.27 0.58 
  Area   0.00 0.58 
  Cell Density Delaunay 0.29 0.57 
  Cell Density SOI 0.02 0.57 
  Distance to Neighbours SOI 0.14 0.57 
  Distance to Neighbours Delaunay 0.11 0.56 
  Cell Density Gabriel 0.02 0.56 
  Distance to Neighbours Gabriel 0.11 0.56 
  Distance to Neighbours SOI 0.13 0.56 
  Distance to Neighbours Delaunay 0.04 0.55 
  Distance to Neighbours Gabriel 0.02 0.54 
  Orientation SD Gabriel 0.12 0.53 
  Orientation SD Delaunay 0.14 0.53 
  Orientation SD SOI 0.13 0.53 
  Flattening Factor SOI 0.18 0.53 
  Flattening Factor Gabriel 0.17 0.52 
  Gyration Radius   0.16 0.52 
  Flattening Factor Delaunay 0.16 0.52 
  Shape Factor   0.05 0.52 
Table 7.7 The AUC for cellular morphology parameters. 
The discriminating parameters of area under the curve (AUC) the Cohen’s d statistic were then 
calculated for individual spectroscopic and morphological parameters. The results are listed in table 
7.7 and 7.7. Although the Cohen’s d suggests that many of the morphological parameters are poor 
discriminators between BCCs and normal skin, differences can be seen in some cases. 
 
Figure 7.3 Histograms of cellular morphology features demonstrating the difference between normal skin (Blue) and BCCs 
(Red). 
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Figure 7.3a-c present histograms of the three cellular morphology parameters, namely the flattening 
factor (ratio of minor to major axis length), orientation SD (the standard deviation of the ROI major 
axis angle of a cell and its neighbours), and the cell confluency (combined area of ROI and adjacent 
ROIs relative to intercellular space). The difference in the median value for the orientation SD and 
cell confluency between BCC and normal samples was found to be statistically significant at the 5% 
level using the Wilcoxon rank sum test (p = 0.03, 0.05 respectively), but was not significant for the 
flattening factor (p = 0.33). The difference in orientation SD reflects the increase in BCCs of aligned 
and elongated cells and of “palisade”-like structures. The differences seen in cell confluency suggest 
that cells from BCCs are, on average, more sparsely arranged in an x-y plane than those from normal 
skin. These differences are in accordance with visual assessments of tissue morphology discussed by 
Seidenari et al. (Seidenari, Arginelli et al. 2012). 
7.4.3 Fluorescence Lifetime 
 
Figure 7.4 Histograms of τ1, τ2, spectral contribution for all spectral channels for BCC and normal skin. Curves are color-
coded according to channel. 
Histograms of fluorescence lifetime parameters (Figure 7.4a-f) show a shift toward longer lifetimes 
for BCCs in τ1 and τ2 for all channels compared with normal skin. Strong peaks are seen in the BCC 
histograms at τ1 = 450 ps and τ2 = 4000 ps in the green channel, the peak in τ2 shifts from 2400 ps to 
3000 ps in the yellow channel and new peaks in τ1 around 250 and 500 ps are present in the red 
channel in BCCs. The difference in median τmean between BCC and normal samples were compared 
on a per patient basis and was found to be statistically significant to p<0.01 using the Wilcoxon rank 
sum test (p = 0.0013, 0.0049, 0.0061, 0.0006 in the blue, green, yellow and red channels 
respectively). 
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Analysis with respect to the fraction of the total fluorescence signal in each spectral channel 
(spectral contribution, Figure 7.4c) indicates a population of cells with a high contribution in the 
green channel in normal skin and a broader distribution in the yellow channel in normal skin 
compared to BCC (figure 7.4f). There is also an increase in spectral contribution in the red channel 
for BCCs which can also be seen from table 7.5. 
In the cell-based spectroscopic analysis, longer τmean in all spectral channels for BCC compared to 
normal were observed, in agreement with earlier non-spectrally resolved FLIM MPT studies of BCC 
(Cicchi, Massi et al. 2007; De Giorgi, Massi et al. 2009; Seidenari, Arginelli et al. 2012). It is important 
to note that since normal keratinocytes are present within BCC, many cells/ROIs in the BCC FLIM 
images will have actually been normal cells, yet statistically significant differences were observed 
between groups in spite of this. From a spectroscopic perspective, it could be argued that the 
observed fluorescence lifetime contrast is due to a higher concentration of melanin (with a short 
fluorescence lifetime) in normal samples. It was not believed to be the case in this instance because 
the BCC dataset includes some pigmented BCCs and well matched spectral contributions were 
observed between groups in the melanin dominated yellow and red spectral channels (see Table 
7.4). It is interesting to note that the spectroscopic parameters providing the highest discrimination 
(AUC) between groups are the fluorescence lifetimes of the red and yellow channels. It is possible 
that increased porphyrins, a dominant fluorophore in this spectral range, may account for finding. 
Policard originally described increased endogenous autofluorescence due to porphyrins associated 
with cancer in 1924 (Policard 1924). This phenomenon has since been described and commented on 
by others (Wagnieres, Star et al. 1998) in other tumour types. Further research is required to verify if 
this is the case for BCCs and if not, to elucidate the origin of this contrast. 
Previous in vivo measurements in a hamster cheek pouch model of oral cancer by Skala et al.(Skala, 
Riching et al. 2007) show a decrease in the fluorescence lifetime of NAD(P)H and flavins associated 
with malignancy. The measurements found in our study have the opposite trend. This which may be 
due to differences between animal model and human, in disease pathophysiology or the absence of 
melanin in mucosal epithelium. 
Potential confounding factors in fluorescence lifetime measurements include (Benati, Bellini et al. 
2011) imaging depth in the skin (τmean decreases with depth) and patient age (τmean increases with 
age). In this study, image depths were well matched between groups (62 v. 65 µm mean cell/ROI 
depth) and are not expected to influence the results significantly. In a previous study of two very 
distinct age populations (20-35 and >60 years) using a single spectrally broad FLIM channel (Benati, 
Bellini et al. 2011), lifetimes were observed to differ between age groups by 109 ps for upper skin 
 189 
 
layers and by 210 ps for lower layers. In this study the age disparity was much lower (mean age 42 v. 
64, Table 7.1) and the observed changes in fluorescence lifetime between normal and BCC are much 
larger (412-622 ps, Table 7.1).  
7.4.4 Lifetime variation of BCC vs normal skin 
It has already been shown in Chapter 5 that there is no significant difference in the fluorescence 
lifetimes between in vivo and ex vivo samples over the time scale of these experiments. One factor 
that was explored was the variation in the median τmean for BCCs compared to normal skin.  
 
Figure 7.5 Bar chart showing sample median ROI/cell mean fluorescence lifetime per sample for BCCs, in vivo normal and 
ex vivo normal skin for the four spectral detection channels. Error bars indicate value of 25th and 75th percentile. 
Figure 7.5 illustrates the median and variation in τmean between samples (not ROIs) of normal skin (in 
vivo and ex vivo) compared to BCCs. It highlights that the lifetimes calculated for BCCs are 
significantly longer than those seen in either in vivo or freshly excised normal skin in all channels, 
despite the range in lifetimes calculated. 
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7.4.5 Discrimination 
 
Figure 7.6. Histograms of the fraction of cells classified as BCC for the samples of actual BCCs and of those from normal 
skin. This analysis was performed using (a) manually segmented ROIs & spectroscopic and morphological parameters or (b) 
automatically segmented ROIs & spectroscopic parameters only. 
 
In this section the use of LDA to discriminate between normal skin and BCCs is explored. PCA-based 
dimensionality reduction was employed to develop a diagnostic algorithm using all of the 
spectroscopic and cellular morphology parameters, as discussed in section 7.3.4 (pp177). LDA was 
then applied to the first 4 principal components of the data. This allowed each ROI to be classified as 
either ‘Normal’ or ‘BCC’. The fraction of cells/ROIs classified as ‘BCC’ was then determined for all 
patients and is illustrated in figure 7.6a. The separation of these variables’ distributions as measured 
using the AUC, was 0.83. For example, if the threshold for classifying a patient as having BCC is set at 
having 30% of cells classified as BCC, then this yields a sensitivity/specificity of 89%/73%. 
To further automate the discrimination, the step of manual segmentation was replaced by 
automatic ROI segmentation. This procedure identified 2343 BCC and 4034 normal ROIs. Here, the 
cellular morphology parameters were not included in the PCA because the automatic ROI detection 
did not provide a clean outline of the cells and did not always correctly identify individual cells. 
Examples are illustrated in Chapter 4.10.8 (pp111) and Chapter 5.3.4 (pp119). However, the cellular 
morphology parameters only provide very weak discrimination between normal and BCC, as 
illustrated by the low AUC and Cohen’s d values seen in table 7.6, so their exclusion was not 
expected to significantly affect the outcome.  
(a) (b)
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Although the resulting fraction of cells/ROI’s classified as ‘BCC’ using automatic segmentation (see 
Figure 7.6b) is different to that obtained with manual segmentation, the separation of these two 
distributions also yielded an AUC of 0.83. One might expect the discrimination based on 
automatically segmented ROIs to score lower than the one based on manual segmentation, due to 
the loss of information on the cellular morphology, the occasional grouping of more than one cell 
into the same ROI and erroneous inclusion of some extracellular fluorescence by the segmentation 
algorithm. In practice, however, the exact shape of the ROI around a single cell was not expected to 
greatly affect the spatially integrated fluorescence decay from that ROI or the derived fluorescence 
lifetime parameters. This is because the fluorescence decay profile is reasonably uniform across 
individual cells and the erroneous inclusion of extracellular fluorescence makes only a small 
contribution to the total signal analysed.  Although the automatic segmentation is not perfect, it did 
allow bi-exponential fluorescence decay parameters to be measured at multiple regions across an 
image and was much less time-consuming than manual segmentation. Further work and larger 
numbers of patients/samples will be required to compare the relative performance of these two 
methods more precisely. An analysis that did not include any image segmentation was also 
performed for comparison and resulted in a reasonable sensitivity/specificity of 72%/84% 
respectively. 
7.4.6 Mosaic 
Figure 7.7 False colour mosaic FLIM image from the green channel of a BCC consisting of 12x8 FOVs covering an area of 
1.86x1.24 mm2. Bar 0.2 mm. 
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To observe the variation of spectroscopic and morphological parameters of a lesion across a larger 
field of view than is possible with the MPT instrument (350 µm x 350 µm2), a motorised stage was 
employed to move ex vivo samples within the x-y plane and mosaics of high resolution images were 
then assembled. Figure 7.7 shows an example comprising 12x8 individual FLIM images from the 
green spectral channel acquired from a BCC.  It illustrates the potential of this technique to be used 
for high resolution label-free histology over a large field of view. 
Combining the subcellular resolution of multispectral MPT FLIM with a motorised stage to facilitate 
imaging over large fields of view provides a means to identify small nests of BCCs in normal skin, 
such as those seen with infiltrative BCCs, whose margins are notoriously difficult to define. Currently 
the manual acquisition and processing of montage data is slow with data acquisition, FLIM data 
analysis and montaging requiring approximately 100, 4 and 60 minutes respectively for 12x8 images. 
In the future, full automation of the image acquisition process would reduce the image acquisition 
time to ~45 minutes. Further reductions in image acquisition time may be possible by reducing the 
time required to acquire each sub-image, at the expense of signal-to-noise ratio in the final image. A 
wide range of sophisticated image stitching algorithms exist that could be used to greatly speed up 
the montaging compared to the current manual image stitching. While the current depth of 
penetration of MPT is too limited to assess the margins of many infiltrative BCCs in vivo, its high 
sensitivity, specificity and high spatial resolution can be exploited by stitching multiple images 
together to provide an extended multidimensional mosaic of such lesions. This could be useful for 
clinical ex vivo margin assessment for the future, e.g. during Mohs procedures where currently, 
assessment of fresh frozen sectioned tissue can take several hours. 
7.5 Conclusions 
This chapter presents a detailed study using multispectral MPT FLIM imaging to differentiate BCCs 
from normal skin for the first time. Images were acquired from 19 freshly excised BCCs and 27 
samples of normal skin (in & ex vivo).  
In this chapter existing MPT morphological features have been assessed and, together with a newly 
proposed feature (‘merging cells’), demonstrated that visual assessment of the images provides a 
sensitivity/specificity of 79%/93%. Statistically significant increases were found in the fluorescence 
lifetimes of cells from BCCs in all spectral channels, ranging from 19.9% (425-515 nm spectral 
emission) to 39.8% (620-655 nm emission). These differences are greater than those found between 
in vivo and ex vivo normal skin. 
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In addition, a detailed analysis of the discrimination between BCCs and normal skin has been 
performed using a number of spectroscopic and cell-based morphologic parameters for the first 
time. They have then been ranked them by their discriminatory power.  
The first semi- and fully-automated diagnostic algorithms based on manual and automatic 
segmentation of MPT FLIM images is also reported. Segmentation of images into ROIs followed by 
principal component analysis based dimensionality reduction yielded an AUC of 0.83 for the 
discrimination of BCC from normal skin using LDA with both methods of segmentation. 
Finally, a mosaic of BCC fluorescence lifetime images covering >1mm2 is also presented for the first 
time, demonstrating the potential for tumour margin delineation. 
In the future, the combination of automatically calculated spectroscopic information together with 
manually identified visual architectural features could lead to higher diagnostic accuracies. This work 
demonstrates the diagnostic potential of multispectral MPT FLIM for the evaluation of BCC and its 
margins. 
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Chapter 8. The use of autofluorescence to investigate pigmented 
lesions: Dysplastic Naevi & Melanoma 
8.1 Aim 
This chapter describes the evaluation of melanocytic lesions using MPT multispectral FLIM. To 
achieve this, clinically dysplastic naevi and melanomas were imaged ex vivo and the images 
analysed. Morphological features are identified that characterise melanomas from naevi and an 
analysis of the cellular lifetimes comparing naevi with melanomas is made with a quantitative 
discrimination of lifetime parameters being made, for the first time. Also mosaic MPT FLIM images 
acquired from both naevi and melanomas are presented for the first time. 
8.2 Introduction 
A naevus can be defined as benign collection of melanocytes in the skin. Melanocytes are the cells in 
the skin that synthesise melanin. Naevi can be subdivided into congenital naevi (those present at 
birth) and acquired. The acquired naevi arise from a proliferation of melanocytes at the dermo-
epidermal junction after birth. Over time the natural evolution of some acquired naevi is to migrate 
into the dermis (Burns, Breathnach et al. 2010). This can be seen clinically as a change in appearance 
such as decrease in pigment and increase in nodularity. During this process they are described as 
compound naevi (when part of the naevus has migrated) or intradermal naevi (when the naevus has 
completed its migration into the dermis). 
When the proliferation of a naevus deviates from that described above, its clinical appearance can 
be described as atypical or dysplastic in regards to size, shape and colour compared to benign naevi. 
These naevi are typically >5 mm in size and have some asymmetry in shape or colour. Ultimately, 
most of these naevi cease to proliferate and revert to the path of maturation outlined above. Their 
significance is that they are likely to be a precursor to and often indistinguishable from early 
melanoma i.e. a malignant naevus. 
A clinical history from the patient and clinical examination of the lesion can help evaluate the 
likelihood that a dysplastic naevus is malignant. However many cases cannot be distinguished 
clinically and a definitive diagnosis can only be made from a histological examination of the lesion, 
which requires the lesion to be surgically removed. The prognosis of melanoma is critically 
dependent on its depth of invasion at diagnosis. Clinicians therefore have a low index of suspicion 
for surgical excision because the consequences of clinically monitoring a growing melanoma by a few 
millimetres can impact on the prognosis significantly (Roberts, Anstey et al. 2002). 
 196 
 
In recent decades, the use of a dermatoscope, to more clearly visualise the epidermis and upper 
dermis, has made a significant impact on a clinician’s ability to diagnose melanomas at the bedside 
compared to clinical examination alone (Kittler, Pehamberger et al. 2002). A number of diagnostic 
algorithms have been validated such as the ABCD system (asymmetry, boarder irregularity, colour, 
diameter) (Nachbar, Stolz et al. 1994), pattern analysis (Argenziano, Soyer et al. 2003), 7 point score 
(Dal Pozzo, Benelli et al. 1999) and the Menzies method (Menzies, Ingvar et al. 1996). These have 
been shown to have a high sensitivity (range 83-86%) and specificity (range 70-83%) for identifying 
melanomas from other pigmented lesions (7 point score, Menzies method) or from pigmented 
melanocytic lesions (ABCD system, pattern analysis). They have allowed more melanomas to be 
diagnosed at the bedside, and by confidently excluding melanoma, reduce the rate of unnecessary 
biopsies. 
Despite this tool, the number of naevi excised for every melanoma still range from 8.7 to 29.4 
between specialist and non-specialist dermatology centres respectively (Argenziano, Cerroni et al. 
2012). This range highlights the continued importance of clinical experience, even between 
dermatologists for the recognition of melanomas, despite the use of a dermatoscope. This number 
of ‘unnecessary’ excisions creates a physical and financial burden on hospital services and causes 
unnecessary, potentially disfiguring scars for patients. 
A number of non-invasive imaging modalities have been used to assess pigmented lesions, including 
high frequency ultrasound, optical coherence tomography and reflectance confocal light microscopy. 
The studies examining pigmented lesions using these modalities have been previously summarised 
in Chapter 1.4 (pp33-42). 
This work used MPT FLIM to assess dysplastic naevi and melanomas and attempts to distinguish 
them using spectroscopic and morphological parameters. Although other groups have presented 
studies investigating lesion margins and the thickness using other non-invasive imaging modalities, 
this has not been measured here due to the limited penetration depth of MPT. 
8.2.1 Prior studies investigating autofluorescence of pigmented lesions 
Previous studies investigating tissue autofluorescence from pigmented lesions are limited with most 
studies investigating the emission spectra and/or fluorescence intensity images only. In 1988 
Lohmann et al. (Lohmann and Paul 1988) used excitation at 366 nm (bandwidth of 11 nm) and 
recorded the emission spectrum  from melanomas and naevi in 82 patients  in vivo. They found that 
melanomas had a maximum emission peak at 475 nm wavelength which was not present in benign 
moles or the other inflammatory skin diseases that were measured.  
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Ten years later Chwirot et al. used similar equipment and an identical excitation wavelength to 
record fluorescence images from 408 pigmented lesions that included 90 melanomas and 205 naevi  
in vivo (Chwirot, Chwirot et al. 1998). Images were acquired through a transmission filter centred at 
475 nm and were used to distinguish melanomas from naevi with as sensitivity of 82.5% and 
specificity of 78.6%. 
In contrast Sterenborg et al. were unable to detect a difference when comparing fluorescence 
intensity images and emission spectra from 8 melanomas and 8 benign pigmented lesions, using and 
excitation wavelength of 375 nm (Sterenborg, Motamedi et al. 1994). 
In 2007 De Beule et al. published the autofluorescence lifetime taken from melanocytic lesions (De 
Beule, Dunsby et al. 2007). They used picosecond pulsed lasers to excite various freshly excised skin 
lesions, including 2 melanomas and 6 benign naevi at 355 nm and 435 nm wavelength.  The 
autofluorescence was collected using a fibre optic point probe and was spectrally and time resolved. 
They found that melanomas exhibited a redshift in the emission spectrum and a lower average 
fluorescence lifetime than benign neavi when excited at 435 nm. However this was not quantified in 
the paper and the sample size was too small to perform any statistical evaluation. 
The investigation of melanocytic lesions using MPT has been reported by three groups. Pavone’s 
group published spectral and lifetime resolved fluorescence histograms from samples of normal skin, 
BCCs and a single melanoma (Cicchi, Sestini et al. 2008; De Giorgi, Massi et al. 2009).  
Arginelli et al. used MPT images from 16 ex vivo benign naevi to define descriptors for naevi. These 
were then tested blindly on 102 lesions that were imaged ex vivo, of which 51 were melanocytic 
naevi and 51 were a miscellaneous group of conditions, both malignant and benign (Arginelli, 
Manfredini et al. 2012). They determined that ‘small short-lifetime cells’ in the upper and lower 
epidermal layers, ‘edged papillae’, ‘junctional nests of short-lifetime cells’ and ‘dermal cell clusters’ 
were 5 sensitive and specific descriptors for diagnosing benign naevi. These have been reproduced 
in figure 3.4 in Chapter 3 (pp.83) They also fitted the lifetimes from 3 cells per image using a single 
exponential decay model for images taken from 48 naevi and 48 areas of normal skin imaged ex vivo. 
They recorded a lifetime ± SD for normal skin of 1000±200 ps and 360±120 ps for naevi. 
König et al. have published both a morphological analysis (Dimitrow, Ziemer et al. 2009) and a 
lifetime analysis (Dimitrow, Riemann et al. 2009) comparing melanocytic lesions using MPT. In the 
former study, 83 melanocytic lesions were imaged both in vivo and ex vivo using the DermaInspect® 
with an excitation wavelength of 760 nm. They found the following morphological features to be 
statistically significant for the diagnosis of melanoma: architectural disarray of the epidermis, poorly 
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defined keratinocyte cell boarders, the presence of pleomorphic cells and the presence of dendritic 
cells. These features are reproduced in figure 3.3 in Chapter 3 (pp81) and were found to have 
sensitivities ranging from 71-95% and specificities between 69-97% for each feature individually. The 
features of large intercellular distance and ascending melanocytes were also noted but not found to 
be statistically significant. The feature of pleomorphic cells associated with melanomas was also 
illustrated in Seidenari et al.’s review paper (Seidenari, Arginelli et al. 2012). 
In Dimitrow et al.’s second paper, fluorescence lifetimes (13 naevi, 10 melanomas) and emission 
spectra (4 lesions) were collected from pigmented lesions. Images from lesions were taken both in 
vivo and just after excision using both 760 nm and 800 nm excitation wavelengths. They found that 
although FLIM could distinguish between the keratinocytes and melanocytic cells within the images, 
it was unable to distinguish between benign naevi and melanoma (Dimitrow, Riemann et al. 2009). 
8.3 Methods 
The methods for patient recruitment, image acquisition, image analysis are outlined in Chapter 4 (pp 
87). In summary, patients were recruited from those attending the dermatology department at the 
Hammersmith Hospital site of Imperial College Healthcare NHS Trust, London. Those patients with 
clinically suspicious dysplastic naevi that required surgical excision were invited to participate in the 
study. Only lesion that were histologically confirmed as naevi or melanomas were then included in 
the analysis. Only image sets with all 4 spectral channels present and for which a gold nanorod IRF 
could be applied to the analysis were included. 
All images were acquired ex vivo, from freshly excised samples. The time from excision for all 
melanomas and 26/32 naevi were recorded, allowing the imaging time post excision to be calculated 
for 92.9% of the cells (ROIs). The mean±SD of the acquisition time post excision were 80.6±35 
minutes for the cells from naevi and 81.9±34 minutes for the cells from melanomas.  
All images were acquired at 760 nm excitation wavelength with the power (<50mW) adjusted 
according to the depth of the image and restricted to <12mW for the s.corneum. A number of 
samples were imaged from more than field of view (FOV) with images acquired at ~10 µm intervals 
for most samples. The mean depth imaged was 45.5 µm for naevi and 59.0 µm for melanomas. 
The FLIM images were generated by fitting a single exponential decay to the fluorescence from each 
spectral channel of every pixel in the image, as outlined in Chapter 4.10.3 (pp104). The FLIM analysis 
used ROI defined manually in each image corresponding to each identifiable cell. A double 
exponential decay was then fitted to the spatially integrated fluorescence from each ROI for each 
channel independently, as outlined in Chapter 4.10.5 (pp106). For each ROI in each spectral channel, 
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the total fluorescence was recorded and a τ1, τ2, f1, f2 , and τmean were calculated. ROIs with fewer 
than 1000 photons in a channel had insufficient photons to reliably fit a double exponential decay 
and were excluded. 90.5%, 100%, 100% and 98.6% of the ROIs were fitted for melanoma and 85.3%, 
99.1%, 98.4%, 95.9% of the ROI for naevi were fitted for the blue, green, yellow and red channel 
respectively. 
In addition the ROIs were used to make assessments of the cell shape, area and the spatial 
orientation between them. The parameters calculated are outlined in Chapter 4.10.6 (pp108). 
The image montages presented in this chapter were acquired using the methods outlined in the 
Chapter 4.5.4 (pp95).  
A more detailed description of the statistical methods used can be found in Chapter 4.10.9 (pp112). 
The statistical tests were performed using MATLAB®.  
The discrimination between melanomas and naevi was made using the first 4 components of a 
principle component analysis (PCA) of the spectral, lifetime and morphological parameters. This was 
then categorised using linear discriminant analysis (LDA). Only ROIs that had >1000 photons for all 
spectral channels were included for this analysis. 89.3% and 81.2% of ROIs for melanoma and naevi 
respectively had sufficient ROIs in all spectral channels to be included in the analysis. 
8.4 Results Summary 
Diagnosis 
Patients 
(M/F) 
Mean Age 
(Range) Images ROIs/Cells 
Melanoma 8   (5/3) 38.3 (27-73) 81 2177 
Naevus 32 (11/21) 34.6 (20-65) 221 12632 
Table 8.1 Summary of the patients and images taken from pigmented lesions used. 
Table 8.1 summarises the data used in the analysis. 40 patients with histologically confirmed 
dysplastic naevi or a melanoma were selected for the analysis. The mean skin phototype was 2.5 for 
the patients with naevi and 1.9 for those with melanomas. The site of origin of the 32 naevi were as 
follows : 14 from the back, 6 from the arms, 4 from the legs, 4 from the abdomen, 2 from the chest 
and 2 from the shoulder. These were histologically classified as 14 junctional, 6 intradermal and 8 
compound naevi. The sites of origin of the 8 melanomas were 4 from the back, 2 from the lower leg, 
1 from the chest and 1 from the forearm. They were histologically classified as 2 in situ melanomas, 
6 superficial spreading malignant melanomas of which 1 containing a nodular component. The mean 
Breslow thickness of the 6 invasive melanomas was 1.03 (range 0.7-1.4) mm. 
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8.5 Manual Morphological Analysis 
8.5.1 Naevi 
Figure 8.1 (4207 fov1) shows a typical image stack from a junctional neavus. Melanocytes lining the 
basal layer around the dermal papilla can most clearly be seen in the images taken between 80-100 
µm by their short lifetimes (false colour coded in red). 
Minimal differences in architectural features were seen between the FLIM images taken from 
dysplastic naevi and those from normal skin. One difference between FLIM images from normal skin 
and those from the pigmented lesions was the presence of increased melanin within the cells of the 
lower epidermis and basal layer in the pigmented lesions. 
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Figure 8.1 illustrates MPT FLIM images of a junctional naevus (4207 fov1) acquired using the DermaInspect® showing 
images taken from each spectral channel at various depths of the epidermis. 
8.5.2 Melanomas 
Figure 8.2 (4205 fov1) shows an image stack including all spectral channels from a superficial 
spreading melanoma. These images demonstrate the lack of architectural order with depth and the 
transition between the different layers within the epidermis has been lost. 
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Figure 8.2 illustrates MPT FLIM images of a superficial spreading melanoma (4205 fov1) acquired using the DermaInspect® 
showing images taken from each spectral channel at various depths of the epidermis. 
A selection of characteristic features of melanoma seen from our MPT FLIM images can be seen in 
figure 8.3. The identification of a number of features defined by Dimitrow et al. for the diagnosis of 
melanoma was difficult, particularly the presence of pleomorphic cells and poorly defined cell 
borders, due to the subjective nature of their identification (Dimitrow, Ziemer et al. 2009).  
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Figure 8.3 illustrates characteristic features found in melanomas. All MPT FLIM images were acquired from the green 
channel at various depths.(a) Melanocyte dendritic cell (arrow). (b) Multiple melanocytic dendritic cells. (c) Ascending 
melanocytes. (d,e) Cells with poorly defined cell borders and large intercellular distance. (e,f) Pleomorphic cells 
(asterisk).(g,h) Areas of fragmented cells and architectural disarray. 
In Figure 8.3a a melanocyte and melanocytic dendrites (arrows) can be seen. The short lifetime 
(colour coded red) of the cell body and the dendrite highlighted by the arrows identify these 
structures as containing melanin and distinguish them from other dendritic cells that may be present 
in the epidermis, such as Langerhans cells. This distinction and the identification of the dendrite 
would be difficult without the lifetime information merged with the fluorescent intensity image. 
Figure 8.3b shows many dendritic cells with varying melanin content and exhibiting architectural 
disarray. The image in figure 8.3c was taken from the s.corneum and illustrates the presence of 
ascending melanocytes. Figure 8.3d,e illustrate images of cells with poorly defined boarders and 
large intercellular distance. It has been our experience that these two features co-existed together in 
6/8 cases of melanoma. 
It has previously been discussed in chapter 6.4.3 (pp142) that the feature of large intercellular 
distance is an artefact of fluorescence imaging and represents a lack of cellular autofluorescence at 
the cell periphery. Cells in figure 8.3e and 8.3f are pleomorphic cells (asterisk), as defined by the 
description and fluorescence images provided in the paper by Dimitrow et al. (Dimitrow, Ziemer et 
al. 2009). Figure 8.3g and 8.3h illustrate areas of fragmented cells, architectural disarray and cells 
with unusually morphology and increased heterogeneity of intracellular lifetimes. 
8.5.3 Quantification of morphological features  
The accuracy of the morphological diagnostic criteria for melanomas discussed and illustrated above 
(Dimitrow, Ziemer et al. 2009) were then assessed using our data. The presence of the six defined 
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features was assessed from the MPT FLIM images taken from each lesion. This assessment was 
blinded to the histological diagnosis and performed by myself. 
  
Melanoma 
(N=8) 
Naevi 
(N=32) AUC Sensitivity % Specificity % 
Large intercellular distance 5 1 0.797 62.5% 96.9% 
Dendritic cells 5 2 0.781 62.5% 93.7% 
Ascending melanocytes 3 2 0.656 37.5% 93.7% 
Poorly defined cell boarders 3 2 0.656 37.5% 93.7% 
Architectural disarray 2 2 0.594 25.0% 93.7% 
Pleomorphic cells 1 2 0.531 12.5% 93.7% 
Table 8.2 summarises the frequency of each morphological feature identified in images from melanomas and naevi and the 
calculated area under the curve (AUC), sensitivity and specificity for each feature for the diagnosis of melanoma. n=40. 
Table 8.2 lists the number of times that each of the morphological features was identified in the 
images from melanomas and naevi. The diagnostic accuracy for each feature is then calculated for 
each feature. The table shows that all features appear specific to the diagnosis of melanoma but 
have poorer sensitivities. In part, this disparity arose through the difference in the numbers of 
patients with each diagnosis (melanoma n=8, naevi n=32). The number of patients with melanoma is 
small. Therefore small differences in the number of times a morphological feature is detected 
translate into a large difference in the sensitivity. For example, the sensitivity for ‘ large intercellular 
distance’ is calculated as 5/8 = 62.5%. If another 2 patients were included with melanoma and this 
feature was seen in both sets of images (likely), the sensitivity would increase to 7/10 = 70%. In 
contrast, the number of naevi is comparitatively large. If another 2 patients were included with naevi 
and this feature was seen (unlikely) then the specificity would change from (32-1)/32 = 96.9% to (34-
3)/34=91.2%. This is a smaller percentage difference. 
These results compares to a sensitivity range of 90-95% and specificity range of 69-86% found by 
Dimitrow et al. for pigmented lesions imaged ex vivo (n=72)(Dimitrow, Ziemer et al. 2009). In 
comparison our data had a similarly high specificity but lower sensitivity. Dimitrow et al. used logistic 
regression to determine the optimal discriminatory features. They agreed with our findings that the 
presence of dendritic cells was important but did not find large intercellular distance a good 
discriminator. However, they found that architectural disarray, poorly defined keratinocytes and the 
presence of pleomorphic cells as important discriminators, whilst this was not found from our data, 
assessed by AUC. 
The study population appeared to be similar between the studies and therefore not likely to have 
caused the differences in the results seen between the studies. Both studies imaged naevi that were 
sufficiently dysplastic/suspicious to require surgical excision. Dimitrow et al. imaged melanocytic 
 205 
 
lesions either in vivo or ex vivo or both. Although 26/83 (31.3%) patients had melanomas in the 
Dimitrow et al. paper, compared to 8/40 (20%) in our data (all imaged ex vivo), the proportion of 
these were imaged ex vivo was not explicitly stated.  
  
Melanoma 
(N=8) 
Naevi  
(N=32) sensitivity %   specificity % 
N>=1 6 6 75.0%   81.3% 
N>=2 5 3 62.5%   90.6% 
N>=3 4 2 50.0%   93.8% 
N>=4 2 0 25.0%   100.0% 
N>=5 2 0 25.0%   100.0% 
N=0   Negative Predictive Value of 92.8% 
Table 8.3 shows the effect of changing the threshold of the number of features necessary for the diagnosis of melanoma to 
be made.  . 
Another approach was to assess the presence of 1 or more of the diagnostic criteria for melanoma in 
the images from each lesion. The results are outlined in Table 8.3. It shows that the presence of 1 or 
more features would have a sensitivity and specificity of 75.0% and 81.3% respectively.  This 
compares with a sensitivity and specificity of 93% and 74% respectively by Dimitrow et al.  
The sensitivity significantly reduces as the number of features required increases. When tests have a 
high specificity but lower sensitivity, as is the case for the presence of multiple features, they are 
useful in clinical practice to exclude a condition confidently. In this case, the absence of all 6 features 
has a negative predictive valve against melanoma of 92.8%. 
In summary the morphological features defined by Dimitrow et al. for the identification of 
melanomas from MPT intensity images has been applied to MPT FLIM images successfully. In many 
instances the false colour coded FLIM images facilitated the identification of the features. The 
features were found to have high specificities but varied in their sensitivities for the diagnosis of 
melanoma. Importantly the absence of all features had a negative predictive value of 92.8%. 
8.5.4 Mosaics 
Figure 8.4 and 8.5 are image mosaics made from images taken in the green spectral channel from 
junctional naevi. The image in figure 8.4 has been manually assembled and arranged within 
Microsoft® Powerpoint whilst the image in figure 8.5 has be semi-automatically stitched together, as 
described in Chapter 7.3.5 (pp178) for the BCC image montage. Figure 8.4 illustrates the distribution 
of the melanocytes around the dermal papilla. The lifetime information in the image allows the 
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keratinocytes between the dermal papilla (coloured green), the melanocytes (coloured red) and the 
elastic fibres in the dermis (coloured blue) to be easily distinguished. The two green vertical lines 
toward the right of the image the mosaic are hair follicles. Figure 8.5 (4201 fov2) shows a larger 
mosaic taken higher within the epidermis, above the level of the dermal papilla and shows individual 
cells clearly. These two image mosaics demonstrate the ability of this device to assess large areas of 
skin. 
 
Figure 8.4 shows a montage of 7x5 MPT FLIM images taken from the green channel at a depth of 95 µm from a junctional 
naevus (4207 fov2). It represents an area of 1055 x 715 µm2.  Scale Bar 250 µm. 
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Figure 8.5 shows a montage of 10x7 MPT FLIM images taken from the green channel at a depth of 50 µm from a junctional 
naevus (4201 fov2). It represents an area of 1055 x 715 µm2. Scale Bar 250 µm. 
 
Figure 8.6 (4205 fov3) shows a mosaic generated manually within Microsoft ® PowerPoint taken 
from the green channel at a depth of 100 µm from a superficial spreading malignant melanoma.  
Many of the features described and illustrated in figure 8.3, can be seen within this mosaic. 
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Figure 8.6 shows a montage of 10x7 MPT FLIM images taken from the green channel at a depth of 100 µm from a 
superficial spreading melanoma (4205 fov3). It represents an area of 1055 x 715 µm2. Scale Bar 250 µm. 
8.6 Analysis of calculated morphological and lifetime parameters 
A comparison of the autofluorescence from manually segmented ROIs from images of naevi and 
melanomas was then performed. 
8.6.1 Morphological Comparison 
The morphological parameters and parameters describing the relationship between cells, previously 
outlined in Chapter 4.10.7 (pp109) were calculated using the manually defined ROIs. Table 8.4 lists 
these parameters in descending order of their discriminatory ability using AUC (area under the 
curve), which is a combined measure of the sensitivity and specificity and Cohen’s d, a measure of 
discrimination between two populations. 
Parameter Index 
Adjacency 
Calculation Cohen's d AUC 
    Method     
Morphology Gyration Radius   1.38 0.85 
  Area   1.27 0.75 
  Cell Density SOI 0.02 0.74 
  Distance to Neighbours SOI 1.36 0.74 
  Cell Density Gabriel 0.06 0.74 
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  Distance to Neighbours Gabriel 1.23 0.74 
 
Cell Density Delaunay 0.61 0.73 
 Distance to Neighbours Delaunay 0.96 0.73 
  Distance to Neighbours SD SOI 1.15 0.72 
  Shape Factor   0.58 0.68 
  Distance to Neighbours SD Delaunay 0.36 0.66 
  Distance to Neighbours SD Gabriel 0.50 0.66 
  Flattening Factor Delaunay 0.55 0.62 
  Flattening Factor Gabriel 0.55 0.62 
  Flattening Factor SOI 0.54 0.62 
  Solidity   0.01 0.54 
  Orientation SD Delaunay 0.12 0.54 
  Number of Neighbours Gabriel 0.25 0.54 
  Orientation SD Gabriel 0.09 0.53 
  Orientation SD SOI 0.07 0.53 
  Cell Confluency SOI 0.02 0.52 
  Number of Neighbours Delaunay 0.35 0.52 
  Number of Neighbours SOI 0.31 0.52 
  Cell Confluency Gabriel 0.01 0.51 
  Cell Confluency Delaunay 0.04 0.51 
Table 8.4 lists the morphological parameters with corresponding spectral channel showing the greatest discrimination 
between melanoma and naevi as measured by the area under the curve (AUC) and Cohen’s d. 
The gyration radius (an indirect linear measure of size), area, cell density, distance to neighbour and 
distance to neighbour standard deviation all having a AUC of > 0.65. The gyration radius and cell area 
have a high Cohen’s d, suggesting that they are good parameters for distinguishing melanomas from 
naevi. However, it has previously been shown that the manually defined ROI using the fluorescence 
intensity images can underestimate the cell area, especially in the s.granulosum (see Chapter 6.4.3) 
and is not a reliable parameter to use for discrimination. As the cell density parameter has been 
shown to be a more reliable surrogate marker for cell area, the discrimination for this was expected 
to be even higher. However, Table 8.4 shows that in contrast to the gyration radium and area, 
discrimination using cell density has less discrimination between the two groups (Cohen’s d of 0.06 
using the Gabriel calculation method). 
The manual assessment of morphological features above in section 8.5.3 found larger intercellular 
spaces to show the best discrimination between melanomas and naevi with an AUC of 0.797. The 
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cell confluency (the closest equivalent measure), might be expected to give a similar result. 
However, this parameter was the worst discriminating index with an AUC of 0.51- 0.52, depending 
on the adjacency method used. 
In conclusion, the calculated morphological and architectural parameters vary in their ability to 
distinguish melanomas from naevi using the AUC and Cohen’s d measures of discrimination. They 
appear to be less sensitive at highlighting the differences observed in the FLIM images than by eye. 
This could be improved on in the future by using more sophisticated image analysis methods that 
are better able to detect the six morphological criteria defining melanomas automatically. 
8.6.2 Lifetime Comparison 
Table 8.5 below lists the 25th, 50th and 75th centiles for the distribution of the calculated lifetime 
parameters for the manually defined ROIs for melanomas and naevi. 
        Percentile 
Index Channel Diagnosis 25 50 75 
τmean (ps) Blue Melanoma 1440 1860 2300 
    Naevus 1105 1480 1919 
  Green Melanoma 1525 1948 2417 
    Naevus 1286 1735 2207 
  Yellow Melanoma 1027 1293 1635 
    Naevus 698 1027 1410 
  Red Melanoma 580 748 1002 
    Naevus 516 711 922 
f1 Blue Melanoma 0.303 0.390 0.520 
    Naevus 0.378 0.515 0.645 
  Green Melanoma 0.346 0.397 0.463 
    Naevus 0.351 0.409 0.521 
  Yellow Melanoma 0.395 0.447 0.532 
    Naevus 0.452 0.560 0.677 
  Red Melanoma 0.568 0.628 0.689 
    Naevus 0.583 0.659 0.733 
τ1 (ps) Blue Melanoma 53 70 106 
    Naevus 37 46 63 
  Green Melanoma 90 147 239 
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    Naevus 58 92 202 
  Yellow Melanoma 69 97 143 
    Naevus 56 73 112 
  Red Melanoma 71 83 102 
    Naevus 75 94 125 
τ2 (ps) Blue Melanoma 2781 3070 3424 
    Naevus 2687 2942 3284 
  Green Melanoma 2780 3111 3561 
    Naevus 2609 2843 3206 
  Yellow Melanoma 2087 2353 2694 
    Naevus 2025 2253 2505 
  Red Melanoma 1608 1908 2322 
    Naevus 1584 1850 2157 
Spectral Contribution Blue Melanoma 0.12127 0.15324 0.19174 
    Naevus 0.18247 0.20841 0.23530 
  Green Melanoma 0.44752 0.51903 0.58275 
    Naevus 0.52299 0.55204 0.59021 
  Yellow Melanoma 0.18264 0.31657 0.42360 
    Naevus 0.16768 0.22879 0.26678 
  Red Melanoma 0.00048 0.00104 0.00152 
    Naevus 0.00056 0.00084 0.00131 
Total Photons Blue Melanoma 1725 3578 6667 
per ROI   Naevus 1347 2417 5029 
  Green Melanoma 23340 49433 84359 
    Naevus 14572 24976 42678 
  Yellow Melanoma 23276 49273 97096 
    Naevus 10821 19508 36582 
  Red Melanoma 4334 10982 27808 
    Naevus 3124 5585 12173 
Table 8.5 outlines the 25th, 50th and 75th centiles of the fluorescence intensity, fluorescence lifetime of melanomas and 
naevi imaged. Fluorescence parameters are subcategorised by spectral channel. 
Using the data summarised in Table 8.5, histograms of the τmean and f1 for each spectral channel 
were plotted between the naevi and melanomas (figure 8.7a-h). The histograms of τmean show a 
tendency for τmean to be longer in all spectral channels for melanomas than naevi. This consistent 
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difference between spectral channels reflects a longer τ1 and τ2 in the melanoma group for all 
channels except τ1 in the red channel. The shorter median f1 for all spectral channels for melanoma 
also contributes to the differences in τmean seen (see table 8.5), with a noticeable difference in its 
distribution seen in the blue and yellow channels (see figure 8.7e,g).  
This change in distribution of f1 between naevi and melanomas would suggest the presence of cells 
with a different fluorophore mix favouring the fluorophores contributing to the long lifetime 
component.  
Figure 8.7 shows the τmean and f1 for each spectral channel comparing fluorescence between naevi and melanomas.  
The difference between the median τmean of naevi and melanoma are +380, +213, +266 and +37 ps 
for the blue, green, yellow and red spectral channels respectively and were found to be statistically 
significant using the Wilcox Rank Sum Test with P<0.001 for all spectral channels when compared on 
a per cell basis. However, when the median τmean was averaged per patient and compared, no 
statistically statistical difference was found between patients with melanoma and naevi. 
Figure 8.8 The distribution of the spectral contribution for the ROIs between the spectral channels comparing naevi with 
melanomas. 
To investigate further the spectral contribution from each channel was analysed and can be seen in 
figure 8.8. The histograms in figure 8.8 show that the distribution of spectral contribution differs 
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significantly between the groups for all channels. The multi-peaked distribution of the histograms for 
melanoma, again suggest the presence of different population of cells contributing to the 
‘melanoma’ group. As the spectral contribution in the red channel remains almost identical between 
groups (difference in median τmean of 0.0002), the increase in spectral contribution in the yellow 
channel for melanomas of 0.0878 is matched by a decrease in the blue and green channels. It shows 
that melanomas fluoresced relatively more brightly in this channel (515-620 nm). This increased 
peak in fluorescence intensity is slightly longer in wavelength than the increased fluorescence 
intensity commented on in Section 8.2.1 (pp198), and seen at ~475 nm by Lohmann et al. (Lohmann 
and Paul 1988). 
The increased spectral contribution seen in the yellow channel for melanomas supports the 
supposition that melanoma cells have increased melanin content, which increases the relative 
fluorescence intensity above 500 nm. However, against this is the finding that the median τmean is 
increased for melanomas in the yellow channel from 1027 to 1293 ps, which does not support this 
theory. 
The underlying cause for the differences in τmean and spectral contribution is not clear from the data 
collected and warrants further study for more biological correlation and to investigate further the 
possibility of multiple cell populations. 
Parameter Index Channel Cohen's d AUC 
Fluorescence Fluorescence Coefficient of Variation Red 1.05 0.79 
Intensity Fluorescence Coefficient of Variation Blue 0.98 0.78 
  Fluorescence Coefficient of Variation Green 0.89 0.76 
  Spectral Contribution Blue 0.83 0.75 
  Fluorescence Coefficient of Variation Yellow 0.86 0.75 
  Spectral Contribution Yellow 1.03 0.71 
  Spectral Contribution Green 0.37 0.64 
  Spectral Contribution Red 0.05 0.55 
Fluorescence τ1 Blue 0.58 0.74 
Lifetime f1 Yellow 0.74 0.71 
  f1 Blue 0.60 0.67 
  τ2 Green 0.41 0.63 
  τ1 Green 0.19 0.63 
  τ1 Yellow 0.16 0.62 
  τ1 Red 0.36 0.60 
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  f1 Red 0.34 0.59 
  τ2 Yellow 0.26 0.58 
  τ2 Blue 0.02 0.56 
  f1 Green 0.27 0.56 
  τ2 Red 0.10 0.55 
Table 8.6 lists the fluorescence intensity and lifetime parameters with corresponding spectral channel showing the greatest 
discrimination between melanoma and naevi as measured by the area under the curve (AUC) and Cohen’s d. 
The ability of the fluorescence and fluorescence lifetime to discriminate between naevi and 
melanomas can also be evaluated. Table 8.6 lists the florescence intensity and lifetime parameters. 
The results in the table support the findings above that the spectral contribution and the coefficient 
of variation (a measure of the variability of the fluorescence intensity) differ between the groups and 
can be used to discriminate between them. It also shows that although f1 is ranked amongst the 
highest fluorescence lifetime parameters for discrimination using Cohen’s d, overall they rank poorly 
compared to the fluorescence intensity and morphological parameters. 
If all calculated fluorescent and morphological parameters are ranked in order of Cohen’s d, 
morphological parameters account for the top 6/10 and fluorescence intensity for the remaining 4. 
The highest ranking fluorescence lifetime parameters rank 13th, 15th and 16th out of 45. 
These results mirror the findings of  Dimitrow et al. who concluded that lifetimes were unable to 
distinguish between melanoma and naevi (Dimitrow, Riemann et al. 2009). 
8.6.3 Discrimination of combined parameters 
The methods used to assess discrimination have treated each ROI as independent data and assigned 
it to either the naevi or melanoma categories. Whilst this approach is the most simple and 
appropriate for this sample size, it does not account for ROIs being clustered into distinct 
samples/patients, i.e. the sample identification for each ROI is discarded. 
Therefore, to combine the discriminatory ability of combining multiple parameters (based on the 
manually defined ROIs) and making an assessment of diagnosis at the patient level, a linear 
discriminant analysis (LDA) was employed. The methods are described further in Chapter 4.10.9 
(pp112). In brief, principle component analysis (PCA) was initially performed to reduce the 
dimensionality of the data using the calculated parameters. The first 4 components where then 
selected for inclusion in the LDA. The proportion of ROIs identified as malignant for each patient 
could then be used to calculate an AUC. 
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Using the manually segmented ROI data, when all spectral intensity, fluorescence lifetime and 
morphological parameters were included for the PCA, an AUC of 0.66 was calculated for the 
discrimination on a per patient basis. This reduced to 0.54 when the morphological parameters were 
excluded. This reduction in AUC is consistent with the results above that each individual 
fluorescence parameter has a poor discriminatory ability. 
As a comparison, just the spectral intensity and fluorescence lifetime parameters were used for the 
LDA using automatically segmented images, as described in Chapter 4.10.8 (pp111). The AUC 
calculated on a per patient basis was 0.65. Finally, these parameters were used to compare non-
segmented images using LDA. An AUC of 0.65 was also found for this comparison. Although this 
suggests segmentation is unnecessary, the large difference in the number of images included 
between melanomas and naevi (43 vs 145) makes this a less valid comparison to make and further 
work would need to be undertaken to quantify this difference further. 
These calculations show that although the discrimination using manually characterised images for 
features of melanomas is good, the spectral, lifetime and automatically defined morphological 
features are poor at discriminating them. 
8.7 Conclusions 
In conclusion, a detailed qualitative and quantitative assessment of the autofluorescence and 
autofluorescence lifetime from pigmented lesions has been made for the first time. Fluorescence 
lifetime images acquired ex vivo using multispectral MPT FLIM between 8 melanomas and 32 
dysplastic naevi were compared. A number of exemplar image stacks from naevi and melanomas 
including mosaic images taken from both naevi and melanomas of larger fields of view are shown. 
A sensitivity and specificity for identifying melanomas using 6 features previously identified by 
Dimitrow et al. (Dimitrow, Ziemer et al. 2009) was made. Specificities ranging between 93.7 – 97% 
were calculated for all parameters, with only the sensitivity of ‘large intercellular distance’ and the 
presence of dendritic cells reaching >50%. However, when the presence of 1 or more feature was 
assessed, a sensitivity and specificity of 75% and 81% respectively was found, with the absence of all 
6 features having a negative predictive valve against melanoma of 92.8%.  
A qualitative and quantitative analysis of the morphological/architectural features calculated from 
the manually segmented ROIs was then performed. These parameters varied widely in their ability 
to distinguish between the two groups, as measured by AUC and Cohen’s d.  
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For the first time, a detailed analysis of the cellular fluorescence intensity and lifetimes was made 
between naevi and melanomas using multispectral FLIM. Although no statistical difference was seen 
comparing the τmean between the two groups when compared on a per patient basis, differences in 
the distribution of fluorescence lifetime parameters on a per cell basis were clearly detectable. 
However, the degree of separation between these distributions was insufficient for most 
fluorescence intensity and lifetime parameters to be used for discrimination. These differences, 
detected for the first time, do raise interesting questions as to their biological origin, for which 
further work is suggested. 
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Chapter 9. Conclusions 
9.1 Aims 
The aim of the work presented in this thesis was to investigate the skin and skin disease by 
measuring tissue autofluorescence and fluorescence lifetime using multiphoton microscopy (MPM). 
In particular we have focused on the differences in autofluorescence and fluorescence lifetime found 
in normal skin compared to those found in skin malignancies such as basal cell carcinoma (BCC) and 
melanoma. 
9.2 Instrumentation 
In order to achieve this aim, a clinically licensed device for in vivo imaging of the skin using 
multiphoton excitation (the DermaInspect®, JenLab, Germany) was adapted. The Mai-Tai laser 
remained the excitation light source allowing a range between 710-920 nm to be selected. The 
focusing optics also remained unchanged, allowing an image resolution of 0.7 µm in the X-Y plane 
and <2 µm in the Z plane to be achieved to a working distance of 200µm depth. In addition to the 
ability to record fluorescence intensity images, fluorescence could be diverted to a detector module 
allowing FLIM to be achieved in four spectral channels simultaneously i.e. a blue channel (360-425 
nm), green channel (425-515 nm), yellow channel (515-620 nm) and red channel (620-655 nm) with 
an image resolution of up to 256x256 pixels. Dr Clifford Talbot designed this to achieve an optical 
transmission efficiency of 85% and the H7722P-40 PMTs used allowed a high peak quantum 
efficiency of 40%. 
In addition a prism-based spectrometer using an EMCCD detector was designed to allow steady state 
hyperspectral images to be acquired in the spectral range of 380-655 nm with a high quantum 
efficiency of 40-65% and an image resolution of up to 41x256 pixels. 
The results, demonstrated in Chapter 6 (figure 6.1, pp138-9), show that sets of depth resolved FLIM 
images can be acquired from unfixed, unsectioned tissue with corresponding hyperspectral images 
and emission spectra. The analysis described in section 6.4 (pp136) then demonstrate that the 
information within these images can be used to made a detailed analysis of the fluorescence of the 
skin. This instrument therefore provides a powerful and versatile tool for investigating the skin. 
MPM and fluorescence lifetime imaging microscopy (FLIM) of the skin using modified versions of the 
DermaInspect® has been reported elsewhere. For example, the research group of Dr Roberts et al. in 
Brisbane, Australia have described measuring multispectral FLIM using a DermaInspect® in up to 
four spectral channels. Their work initially used the instrument to monitor the penetration of Zinc 
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Oxide into the skin (Roberts, Roberts et al. 2008). Subsequently they have investigated the changes 
in autofluorescence over time following excision (Sanchez, Prow et al. 2010) and skin pigmentation 
(Dancik, Favre et al. 2013).  
Similarly, Professor König’s group have presented depth resolved paired FLIM images and emission 
spectra from normal skin by measured the fluorescence emission with a DermaInspect® and using an 
attached spectrometer (Breunig and König 2011). However, the instrument described in this thesis is 
the first time both multispectral FLIM and hyperspectral images have been acquired from a 
significant number of patients. 
A motorised stage was attached to the modified DermaInspect® for the acquisition of image mosaics 
from BCCs, naevi and melanomas. Although a large mosaic image of a BCC acquired using MPM has 
been presented previously by Lin et al. (Lin, Jee et al. 2006), they measured autofluorescence 
intensity from fixed, sectioned tissue. In contrast, for the first time, the images presented in this 
thesis of a BCC (figure 7.7, pp191), naevi (figures 8.4, 8.5, pp206/7) and a melanoma (figure 8.6, 
pp209) were acquired using MPM using freshly excised, unfixed, unsectioned tissue and of FLIM 
images taken with multiple spectral channels. 
9.3 Analysis 
The analysis of the fluorescence lifetime from the skin presented in this thesis has attempted to 
define the cellular fluorescence on a cell by cell basis using the FLIM images acquired. The aim of this 
approach was to exclude extracellular fluorescence from adversely affecting the lifetime analysis, 
which may have occurred if each field of view (FOV) was analysed as a whole. In addition it could 
allow the identification of subpopulations of cells within the skin, based on their autofluorescence 
signature. In contrast to previous studies using FLIM to investigate the skin, most images were 
acquired at comparatively high magnification (107µm x107µm) so as to be able to delineate 
individual cells within the image and, where possible, every cell from every image has been manually 
defined as a region of interest (ROI). This prevents possible selection bias compared to manually 
choosing specific cells from the FLIM images or manually selecting individual pixels from within a cell 
to analyse. This approach has allowed differences in the intra- and interpatient variation in cellular 
lifetimes to be evaluated (Chapter 6.6.1, pp155) and subpopulations of cells based on 
autofluorescence to be described (Chapter 6.6.2, pp157) for the first time. 
9.4 Normal skin following excision 
Chapter 5 (pp115) describes the changes in autofluorescence and autofluorescence lifetimes seen 
over time following surgical excision of normal human skin (n=5, s.spinosum layer) over a 3 hour 
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time period for the first time. Previous studies have reported changes over this time period in mouse 
skin, using fluorescence spectral imaging (Palero, Bader et al. 2011) and in human skin daily, over 
seven days using multispectral FLIM (Sanchez, Prow et al. 2010). 
In this study, a steady increase in the mean pixel fluorescence intensity of 105-112% with time was 
demonstrated, dependent on spectral channel which suggests that the imaging parameters outlined 
in Chapter 5.3 (pp118) did not cause photobleaching. 
A small but consistent drop in the τmean over time of 1.7-8.0% was also demonstrated, dependent on 
the spectral channel. Further analysis showed that a <1 % change was seen τ1 and τ2 in the green 
spectral channel in which NAD(P)H fluorescence dominates, suggesting that the cellular metabolism 
remains minimally affected over this time period. As a comparison, the variation found in lifetime 
over time was compared to the range in variation in lifetime between field of views from cells in the 
s. spinosum (n=31-33 depending on spectral channel). This showed that the changes seen in lifetime 
over time for all spectral channels was small compared to the variation found between cells. In 
addition, it has been shown that there is no statistical difference in lifetime acquired in vivo from 
samples of normal skin (n=19) and from freshly excised ex vivo samples (n=8) over the initial 3 hours.  
In summary the study showed that the fluorescence lifetimes remained fairly constant over the 
initial 3 hours post excision. We were not able to detect the changes described by Sanchez et al. 
described over a 7 day period, as expected, or the changes seen in mouse skin over a 3 hour period 
by Palero et al. It can be speculated that this difference may be caused by the difference in the 
metabolic rates between human and mouse skin but further work would be necessary to validate 
this supposition. 
These results support the use of freshly excised human skin as a surrogate for in vivo imaging for 
MPT and MPT FLIM investigations over the initial few hours post excision. It also validates the 
conclusions draw by previous authors using MPT whom have studied freshly excised skin to 
extrapolate changes seen in vivo (Cicchi, Sestini et al. 2008; Ericson, Simonsson et al. 2008; Paoli, 
Smedh et al. 2008; De Giorgi, Massi et al. 2009). 
9.5 Normal Skin 
A detailed analysis has also been presented in Chapter 6 (pp133) of the variation seen in lifetimes in 
normal skin with cell layer, age, sex, skin phototype and body site. For this analysis, although the 
patient numbers were sub-optimal for a definitive comparison, an attempt has been made to match 
each comparative group. To date, Benati et al. have published the only report to evaluate the 
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changes systematically in fluorescence lifetime of normal skin with age and skin layer (Benati, Bellini 
et al. 2011). 
In the analysis of cell layer, a decrease in the median τmean between the s.granulosum and the basal 
layer of 1286, 1206, 1169 and 691 ps for the blue, green, yellow and red spectral channels 
respectively was found, which is significantly longer than the decrease reported previously of  236 ps 
between the upper and lower epidermis of the forearm (Benati, Bellini et al. 2011) and of 300 ps 
between the s.spinosum and the basal layer (Breunig and König 2011). The data supported the 
conclusion that this change relates to increased melanin content in the cells in the basal layer. 
The cellular lifetime was found to increase with age. A longer median τmean was found between the 
30-42 and >42 year old groups of +199, +550, +514 and +417 ps in the blue, green, yellow and red 
channels respectively. These results support the trend reported by Benati at al., who detected a 
smaller increase in lifetime with age of 109-210 ps (Benati, Bellini et al. 2011) but the data presented 
here was not found to be statistically different. 
A progressive shortening of the median τmean was also seen with skin phototype of 286, 1336, 1436 
and 915 ps in the blue, green, yellow and red channels respectively between skin type 1 and 4. This 
trend was reflected in τ1, τ2 and f1 and felt to arise from increasing melanin content of the cells with 
increasing skin type. This difference was found to be statistically significant using the Wilcoxon rank 
sum test in the green (p=0.016), yellow (p=0.016) and red (p=0.016) spectral channels and has not 
been recorded in the literature previously. 
No difference in lifetime was detected between the sexes. Finally, when the lifetimes from the skin 
from different body sites were compared, a decrease in the median τmean was found between the 
outside and inside forearm of 82, 267, 136 and 291 ps in the blue, green, yellow and red spectral 
channels respectively. However, this finding may have been affected by sub-optimal matching of the 
patient groups and further work is suggested to determine if this represents a true finding. In 
comparison, Benati et al. did not detect a difference in lifetimes between the inside and outside 
forearm, but did detect a significant difference between the inside forearm and the thigh (Benati, 
Bellini et al. 2011). 
9.6 Basal Cell Carcinoma 
Chapter 7 (pp175) presents a detailed ex vivo study using multispectral FLIM imaging to differentiate 
BCCs from normal skin. Previously defined morphologically features for the identification of BCCs in 
MPT images were tested (Seidenari, Arginelli et al. 2012) and a newly proposed feature  of ‘merging 
cells’ was defined (illustrated in figure 7.2, pp181). These features allowed image stacks from BCCs 
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to be identified correctly with a sensitivity/specificity of 79%/93%. The fluorescence lifetimes of cells 
from BCCs were also found to be statistically significantly longer in all spectral channels compared to 
normal skin ranging from 19.9% (425-515 nm green spectral emission channel) to 39.8% (620-655 
nm red emission spectral channel). 
The fluorescence lifetime changes measured using MPT associated with BCCs have been investigated 
by a number of groups previously. For example, Cicchi et al. to record a modest increase in lifetime 
of 90 ps from BCCs compared to normal skin (Cicchi, Massi et al. 2007; Cicchi, Sestini et al. 2008). 
Seidenari et al. repeated the comparison of lifetimes taken from BCC cells and cells from normal skin 
(Seidenari, Arginelli et al. 2012) and confirmed an increase in lifetime between normal skin and BCCs 
of 463 ps. The study of BCCs presented in this thesis, and now published (Patalay, Talbot et al. 2012), 
represent the most comprehensive analysis of fluorescence lifetimes of BCCs and the only study to 
use multispectral FLIM and the results are in agreement with these previous studies. 
In addition, cell-based morphological parameters and the relationship between cells and their 
neighbours could be calculated as all cells were manually identified and delineated in the FLIM 
images. This allowed comparisons to be made in the distributions of these parameters between 
normal skin and BCCs. For the first time also, a quantitative discrimination index of individual 
spectroscopic and cell-based morphologic parameters have been calculated. The discriminatory 
ability of using multiple parameters were then assessed using principal component analysis (PCA) 
based dimensionality reduction and linear discriminant analysis (LDA). This yielded an AUC of 0.83 
for the discrimination of BCC from normal skin. 
Finally, the discrimination using PCA and LDA was repeated using a fully automated image 
segmentation algorithm ‘define’ each cell automatically from the FLIM images. This also yielded an 
AUC of 0.83 for the discrimination of BCC from normal skin and is the first time that this image 
segmentation technique has been applied to this application. 
9.7 Pigmented melanocytic lesions 
Chapter 8 (pp195) investigates the application of multispectral FLIM to pigmented melanocytic 
lesions, namely comparing the fluorescence lifetimes from dysplastic naevi to melanomas. A detailed 
qualitative and quantitative assessment of the autofluorescence and autofluorescence lifetime from 
pigmented lesions has been made for the first time using multispectral FLIM detection. A sensitivity 
and specificity for identifying melanomas using previously defined morphological features in MPT 
intensity images was made (Dimitrow, Ziemer et al. 2009). Specificities ranging between 93.7 – 97% 
were calculated for all parameters. However the sensitivity for these morphological features using 
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this data was generally poor, with only the sensitivity of ‘large intercellular distance’ and the 
presence of dendritic cells reaching greater than 50%. However, when the presence of 1 or more 
feature was assessed, a sensitivity and specificity of 75% and 81% respectively was found and the 
absence of all 6 features had a negative predictive valve against melanoma of 92.8%.  
Cell-based morphological parameters and the relationship between cells and their neighbours were 
calculated for all cells using the manually defined ROIs and this was this first time this was 
performed for these diagnostic groups. Although differences in these parameters could be seen 
between dysplastic naevi and melanomas, they generally had a poor ability to discriminate between 
dysplastic naevi and melanomas. 
Some differences in the distribution of fluorescence lifetimes between the two groups was found, 
however no statistical difference was seen comparing the median τmean. The degree of separation 
between these distributions was insufficient however for most fluorescence intensity and lifetime 
parameters to be used for discrimination. These differences raise interesting questions as to their 
biological origin, for which further work is suggested. 
These findings regarding the fluorescence lifetime are consistent with and build upon the work by 
Dimitrow et al. whom also performed a lifetime comparison of naevi with melanomas (Dimitrow, 
Riemann et al. 2009). They were also unable to detect a difference between naevi and melanomas 
based on lifetime but could distinguish keratinocytes from melanocytes. 
9.8 Future Work 
The work presented in this thesis has used multispectral MPT FLIM to investigate tissue 
autofluorescence and fluorescence lifetime variability in normal skin, between normal skin and BCCs 
and between dysplastic naevi and melanomas. 
The modifications made to the DermaInspect® have produced a useful tool to investigate skin 
disease. Its application could extend to the wide variety of skin diseases, including inflammatory 
dermatoses, which were not possible within the time constrains of this project. 
Future work has been suggested in Chapter 6.6.1 (pp155) to extend the sample size and scope to 
investigate the variability seen in lifetimes in normal skin. Only limited data could be collected to 
delineate the extent of changes in lifetime seen within patients e.g. between body sites and 
between patients e.g. changes with age. 
The fluorescence data collected from normal skin identified population of cells with distinct 
fluorescence characteristics. Further work is suggested to correlate these populations with their 
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morphological appearance in the MPT FLIM images and to correlate the biological basis for the 
changes seen. The greater understanding gained about the autofluorescence of normal skin would 
aid the interpretation of changes detected with malignancy. 
An important result was gained using the automatically segmented images instead of the manually 
segmented images when calculating the discrimination index between BCCs and normal skin. This 
finding is promising because it potentially allows the labour intensive manual segmentation step to 
be automated. This advance would be necessary for high throughput of FLIM images in the future, as 
MPT FLIM becomes increasingly clinically used. 
Finally, as MPT matures as a clinical imaging modality, like reflectance confocal microscopy, the 
barriers to its use will be the availability and clinical awareness of large, blinded, randomised 
controlled trials assessing its usefulness in clinical practice 
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4. The Materials and all of the intellectual property rights therein shall at all times remain the 
exclusive property of John Wiley & Sons Inc or one of its related companies (WILEY) or their 
respective licensors, and your interest therein is only that of having possession of and the right to 
reproduce the Materials pursuant to Section 2 herein during the continuance of this Agreement. You 
agree that you own no right, title or interest in or to the Materials or any of the intellectual property 
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rights therein. You shall have no rights hereunder other than the license as provided for above in 
Section 2. No right, license or interest to any trademark, trade name, service mark or other branding 
("Marks") of WILEY or its licensors is granted hereunder, and you agree that you shall not assert any 
such right, license or interest with respect thereto. 
5. NEITHER WILEY NOR ITS LICENSORS MAKES ANY WARRANTY OR REPRESENTATION OF ANY KIND 
TO YOU OR ANY THIRD PARTY, EXPRESS, IMPLIED OR STATUTORY, WITH RESPECT TO THE MATERIALS 
OR THE ACCURACY OF ANY INFORMATION CONTAINED IN THE MATERIALS, INCLUDING, WITHOUT 
LIMITATION, ANY IMPLIED WARRANTY OF MERCHANTABILITY, ACCURACY, SATISFACTORY QUALITY, 
FITNESS FOR A PARTICULAR PURPOSE, USABILITY, INTEGRATION OR NON-INFRINGEMENT AND ALL 
SUCH WARRANTIES ARE HEREBY EXCLUDED BY WILEY AND ITS LICENSORS AND WAIVED BY YOU. 
6. WILEY shall have the right to terminate this Agreement immediately upon breach of this 
Agreement by you. 
7. You shall indemnify, defend and hold harmless WILEY, its Licensors and their respective directors, 
officers, agents and employees, from and against any actual or threatened claims, demands, causes 
of action or proceedings arising from any breach of this Agreement by you. 
8. IN NO EVENT SHALL WILEY OR ITS LICENSORS BE LIABLE TO YOU OR ANY OTHER PARTY OR ANY 
OTHER PERSON OR ENTITY FOR ANY SPECIAL, CONSEQUENTIAL, INCIDENTAL, INDIRECT, EXEMPLARY 
OR PUNITIVE DAMAGES, HOWEVER CAUSED, ARISING OUT OF OR IN CONNECTION WITH THE 
DOWNLOADING, PROVISIONING, VIEWING OR USE OF THE MATERIALS REGARDLESS OF THE FORM 
OF ACTION, WHETHER FOR BREACH OF CONTRACT, BREACH OF WARRANTY, TORT, NEGLIGENCE, 
INFRINGEMENT OR OTHERWISE (INCLUDING, WITHOUT LIMITATION, DAMAGES BASED ON LOSS OF 
PROFITS, DATA, FILES, USE, BUSINESS OPPORTUNITY OR CLAIMS OF THIRD PARTIES), AND WHETHER 
OR NOT THE PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS LIMITATION 
SHALL APPLY NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY 
PROVIDED HEREIN. 
9. Should any provision of this Agreement be held by a court of competent jurisdiction to be illegal, 
invalid, or unenforceable, that provision shall be deemed amended to achieve as nearly as possible 
the same economic effect as the original provision, and the legality, validity and enforceability of the 
remaining provisions of this Agreement shall not be affected or impaired thereby. 
10. The failure of either party to enforce any term or condition of this Agreement shall not constitute 
a waiver of either party's right to enforce each and every term and condition of this Agreement. No 
breach under this agreement shall be deemed waived or excused by either party unless such waiver 
or consent is in writing signed by the party granting such waiver or consent. The waiver by or 
consent of a party to a breach of any provision of this Agreement shall not operate or be construed 
as a waiver of or consent to any other or subsequent breach by such other party. 
11. This Agreement may not be assigned (including by operation of law or otherwise) by you without 
WILEY's prior written consent. 
12. Any fee required for this permission shall be non-refundable after thirty (30) days from receipt 
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13. These terms and conditions together with CCCs Billing and Payment terms and conditions (which 
are incorporated herein) form the entire agreement between you and WILEY concerning this 
licensing transaction and (in the absence of fraud) supersedes all prior agreements and 
representations of the parties, oral or written. This Agreement may not be amended except in 
writing signed by both parties. This Agreement shall be binding upon and inure to the benefit of the 
parties' successors, legal representatives, and authorized assigns. 
14. In the event of any conflict between your obligations established by these terms and conditions 
and those established by CCCs Billing and Payment terms and conditions, these terms and conditions 
shall prevail. 
15. WILEY expressly reserves all rights not specifically granted in the combination of (i) the license 
details provided by you and accepted in the course of this licensing transaction, (ii) these terms and 
conditions and (iii) CCCs Billing and Payment terms and conditions. 
16. This Agreement will be void if the Type of Use, Format, Circulation, or Requestor Type was 
misrepresented during the licensing process. 
17. This Agreement shall be governed by and construed in accordance with the laws of the State of 
New York, USA, without regards to such states conflict of law rules. Any legal action, suit or 
proceeding arising out of or relating to these Terms and Conditions or the breach thereof shall be 
instituted in a court of competent jurisdiction in New York County in the State of New York in the 
United States of America and each party hereby consents and submits to the personal jurisdiction of 
such court, waives any objection to venue in such court and consents to service of process by 
registered or certified mail, return receipt requested, at the last known address of such party. 
A. Wiley Open Access Terms and Conditions 
Wiley publishes Open Access articles in both its Wiley Open Access Journals program 
[http://www.wileyopenaccess.com/view/index.html] and as Online Open articles in its subscription 
journals. The majority of Wiley Open Access Journals have adopted the Creative Commons 
Attribution License (CC BY) which permits the unrestricted use, distribution, reproduction, 
adaptation and commercial exploitation of the article in any medium. No permission is required to 
use the article in this way provided that the article is properly cited and other license terms are 
observed. A small number of Wiley Open Access journals have retained the Creative Commons 
Attribution Non Commercial License (CC BY-NC), which permits use, distribution and reproduction in 
any medium, provided the original work is properly cited and is not used for commercial purposes. 
Online Open articles  Authors selecting Online Open are, unless particular exceptions apply, offered 
a choice of Creative Commons licenses. They may therefore select from the CC BY, the CC BY-NC and 
the Attribution-NoDerivatives (CC BY-NC-ND). The CC BY-NC-ND is more restrictive than the CC BY-
NC as it does not permit adaptations or modifications without rights holder consent. 
Wiley Open Access articles are protected by copyright and are posted to repositories and websites in 
accordance with the terms of the applicable Creative Commons license referenced on the article. At 
the time of deposit, Wiley Open Access articles include all changes made during peer review, 
copyediting, and publishing. Repositories and websites that host the article are responsible for 
incorporating any publisher-supplied amendments or retractions issued subsequently. Wiley Open 
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Access articles are also available without charge on Wiley's publishing platform, Wiley Online Library 
or any successor sites. 
Conditions applicable to all Wiley Open Access articles:  
 The authors' moral rights must not be compromised. These rights include the right of 
"paternity" (also known as "attribution" - the right for the author to be identified as such) 
and "integrity" (the right for the author not to have the work altered in such a way that the 
author's reputation or integrity may be damaged). 
 Where content in the article is identified as belonging to a third party, it is the obligation of 
the user to ensure that any reuse complies with the copyright policies of the owner of that 
content. 
 If article content is copied, downloaded or otherwise reused for research and other 
purposes as permitted, a link to the appropriate bibliographic citation (authors, journal, 
article title, volume, issue, page numbers, DOI and the link to the definitive published 
version on Wiley Online Library) should be maintained. Copyright notices and disclaimers 
must not be deleted. 
Creative Commons licenses are copyright licenses and do not confer any other rights, 
including but not limited to trademark or patent rights. 
 Any translations, for which a prior translation agreement with Wiley has not been agreed, 
must prominently display the statement: "This is an unofficial translation of an article that 
appeared in a Wiley publication. The publisher has not endorsed this translation." 
B. Conditions applicable to non-commercial licenses (CC BY-NC and CC BY-NC-ND) 
For non-commercial and non-promotional purposes individual non-commercial users may access, 
download, copy, display and redistribute to colleagues Wiley Open Access articles. In addition, 
articles adopting the CC BY-NC may be adapted, translated, and text- and data-mined subject to the 
conditions above. 
C. Use by commercial "for-profit" organizations 
Use of non-commercial Wiley Open Access articles for commercial, promotional, or marketing 
purposes requires further explicit permission from Wiley and will be subject to a fee. Commercial 
purposes include: 
 Copying or downloading of articles, or linking to such articles for further redistribution, sale 
or licensing; 
 Copying, downloading or posting by a site or service that incorporates advertising with such 
content; 
 The inclusion or incorporation of article content in other works or services (other than 
normal quotations with an appropriate citation) that is then available for sale or licensing, 
for a fee (for example, a compilation produced for marketing purposes, inclusion in a sales 
pack) 
 Use of article content (other than normal quotations with appropriate citation) by forprofit 
organizations for promotional purposes 
 Linking to article content in e-mails redistributed for promotional, marketing or educational 
purposes; 
 247 
 
 Use for the purposes of monetary reward by means of sale, resale, license, loan, transfer or 
other form of commercial exploitation such as marketing products 
 Print reprints of Wiley Open Access articles can be purchased from: 
corporatesales@wiley.com 
The modification or adaptation for any purpose of an article referencing the CC BYNC- ND License 
requires consent which can be requested from RightsLink@wiley.com 
D. Other Terms and Conditions: 
BY CLICKING ON THE "I AGREE..." BOX, YOU ACKNOWLEDGE THAT YOU HAVE READ AND FULLY 
UNDERSTAND EACH OF THE SECTIONS OF AND PROVISIONS SET FORTH IN THIS AGREEMENT AND 
THAT YOU ARE IN AGREEMENT WITH AND ARE WILLING TO ACCEPT ALL OF YOUR OBLIGATIONS AS 
SET FORTH IN THIS AGREEMENT. 
v1.8 
If you would like to pay for this license now, please remit this license along with your payment made 
payable to "COPYRIGHT CLEARANCE CENTER" otherwise you will be invoiced within 48 hours of the 
license date. Payment should be in the form of a check or money order referencing your account 
number and this invoice number RLNK500985419. Once you receive your invoice for this order, you 
may pay your invoice by credit card. Please follow instructions provided at that time. 
Make Payment To: 
Copyright Clearance Center 
Dept 001 
P.O. Box 843006 
Boston, MA 02284-3006 
 
For suggestions or comments regarding this order, contact RightsLink Customer Support: 
customercare@copyright.com or +1-877-622-5543 (toll free in the US) or +1-978-646-2777. 
Gratis licenses (referencing $0 in the Total field) are free. Please retain this printable license for your 
reference. No payment is required. 
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V.  Permissions 
A. Arginelli 2012 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116170404706 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content publication Skin Research and Technology 
Licensed content title High resolution diagnosis of common nevi by multiphoton laser tomography and fluorescence 
lifetime imaging 
Licensed copyright line © 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd 
Licensed content author Federica Arginelli,Marco Manfredini,Sara Bassoli,Christopher Dunsby,Paul French,Karsten 
König,Cristina Magnoni,Giovanni Ponti,Clifford Talbot,Stefania Seidenari 
Licensed content date Dec 29, 2012 
Start page n/a 
End page n/a 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) figure 1 - 5 panels only 
Will you be translating? No 
Total 0.00 USD 
B. Dimitrow 2009 
This is a License Agreement between Rakesh Patalay ("You") and Nature Publishing 
Group ("Nature Publishing Group") provided by Copyright Clearance Center ("CCC"). 
The license consists of your order details, the terms and conditions provided by 
Nature Publishing Group, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116170719911 
License date Mar 25, 2013 
Licensed content publisher Nature Publishing Group 
Licensed content Publication Journal of Investigative Dermatology 
Licensed content title Sensitivity and Specificity of Multiphoton Laser Tomography for In Vivo and Ex Vivo Diagnosis 
of Malignant Melanoma 
Licensed content author Enrico Dimitrow, Mirjana Ziemer, Martin Johannes Koehler, Johannes Norgauer, Karsten 
Konig et al. 
Licensed content date Jan 29, 2009 
Volume number 129 
Issue number 7 
Type of Use reuse in a thesis/dissertation 
Requestor type academic/educational 
Format print and electronic 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 1 
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High-res required no 
Figures Figure 5 
Author of this NPG article no 
Your reference number 
Title of your thesis / dissertation The clinical application of multispectral fluorescence lifetime imaging of human skin 
using multiphoton microscopy 
Expected completion date Apr 2013 
Estimated size (number of pages) 200 
Total 0.00 USD 
C. Gambichler 2007 
This is a License Agreement between Rakesh Patalay ("You") and Elsevier ("Elsevier") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order 
details, the terms and conditions provided by Elsevier, and the payment terms and 
conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
Supplier Elsevier Limited The Boulevard,Langford Lane Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Rakesh Patalay 
Customer address Optics, Dept of Physics, Blackett Lab London, SW7 2AZ 
License number 3116170978998 
License date Mar 25, 2013 
Licensed content publisher Elsevier 
Licensed content Publication Journal of Dermatological Science 
Licensed content title In vivo optical coherence tomography of basal cell carcinoma 
Licensed content author Thilo Gambichler,Alexej Orlikov,Remus Vasa,Georg Moussa,Klaus Hoffmann,Markus 
Stücker,Peter Altmeyer,Falk G. Bechara 
Licensed content date March 2007 
Licensed content volume Number 45 
Licensed content issue Number 3 
Number of pages 7 Start Page 167 End Page 173 
Type of Use reuse in a thesis/dissertation 
Intended publisher of new Work other 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 1 
Format both print and electronic 
Are you the author of this Elsevier article? No 
Will you be translating? No  
Order reference number 
Title of your thesis/dissertation The clinical application of multispectral fluorescence lifetime imaging of human skin 
using multiphoton microscopy 
Expected completion date Apr 2013 
Estimated size (number of pages) 200  
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 USD 
VAT/Local Sales Tax 0.0 USD / 0.0 GBP 
Total 0.00 USD 
D. GmbH 2009 
NO CONFIRMATION OF USAGE RECEIVED BEFORE PUBLICATION 
_____________________________________________________ 
Patalay, Rakesh 
Subject: FW: permission to reproduce 
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From: Patalay, Rakesh 
Sent: 26 March 2013 00:52 
To: 'karsten koenig' 
Subject: permission to reproduce 
 
Dear Karsten, 
I hope that you are well. At Imperial College, Chris and I are just finalising the details to submit my 
PhD thesis. In the thesis I have cited the DermaInspect® Manual and would like to reproduce this 
image. Can I formally ask for your permission to reproduce this adapted figure in my thesis? 
Yours 
Dr Rakesh Patalay 
____________________________________________________________ 
 
E. Karen 2009 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116191089458 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication British Journal of Dermatology 
Licensed content title Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing 
microscopy 
Licensed copyright line © 2009 The Authors. Journal Compilation © 2009 British Association of Dermatologists 
Licensed content author J.K. Karen,D.S. Gareau,S.W. Dusza,M. Tudisco,M. Rajadhyaksha,K.S. Nehal 
Licensed content date Mar 30, 2009 
Start page 1242 End page 1250 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) Figure 1 
Will you be translating? No 
Total 0.00 USD 
F. Koehler 2011 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116171271346 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication Skin Research and Technology 
Licensed content title Keratinocyte morphology of human skin evaluated by in vivo multiphoton laser tomography 
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Licensed copyright line © 2011 John Wiley & Sons A/S 
Licensed content author M. J. Koehler,S. Zimmermann,S. Springer,P. Elsner,K. König,M. Kaatz 
Licensed content date Mar 31, 2011 
Start page 479 End page 486 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) Figure 2 - 3 panels 
Will you be translating? No 
Total 0.00 USD 
G. Krasieva 2013 
___________________________________________ 
From: Tromberg, Bruce <bjtrombe@uci.edu> 
Sent: 02 April 2013 19:57 
To: Patalay, Rakesh 
Subject: Re: Permission to reproduce figure 
Follow Up Flag: Follow up 
Flag Status: Flagged 
 
Hi Rakesh,  
Great to hear from you, I do remember meeting you and talking to you about your work (and 
other topics!). Of course, I am very glad for you to use figure 1 from our JBO paper. If you 
have a chance, send me a pdf of your thesis, we have a skin cancer group here that will be 
very interested in reading it and following your work. How have your patient measurements 
been going? Have you managed to get FLIM from patients in the clinic? Best, Bruce 
 
Bruce J. Tromberg, Ph.D. 
Director, Beckman Laser Institute and Medical Clinic 
Professor, Departments of Biomedical Engineering and Surgery 
Principal Investigator, Laser Microbeam and Medical Program (LAMMP) 
An NIH National Biomedical Technology Research Center 
University of California, Irvine 
949-824-4713, 949-824-8705 
bjtrombe@hs.uci.edu, www.bli.uci.edu 
______________________________________ 
Patalay, Rakesh 
From: Patalay, Rakesh 
Sent: 29 March 2013 00:16 
To: 'bjtrombe@uci.edu' 
Subject: Permission to reproduce figure 
Dear Professor Tromberg, 
My name is Dr Patalay and I am currently a PhD student and doctor working in the optics group of 
Professor Paul French at Imperial College London. I have been researching FLIM applied to skin and 
skin cancer during my thesis and would like to use figure 1 from your recent JBO 2013 paper in my 
thesis. The publishes have granted permission to reproduce the figure but have suggested that I seek 
your permission also – see below 
Yours 
Dr Rakesh Patalay 
_____________________________ 
From: Karen Thomas [mailto:karent@spie.org] 
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Sent: 27 March 2013 18:18 
To: Patalay, Rakesh 
Subject: RE: Reprint 
Dear Dr. Patalay, 
Thank you for seeking permission from SPIE to reprint material from our publications. Publisher's 
permission is hereby granted under the following conditions: 
(1) you obtain permission of one of the authors; 
(2) the material to be used has appeared in our publication without credit or acknowledgment to 
another source; and 
(3) you credit the original SPIE publication. Include the authors' names, title of paper, volume title, 
SPIE volume number, and year of publication in your credit statement. 
 
Sincerely, 
Karen Thomas for 
Eric Pepper, Director of Publications 
SPIE 
P.O. Box 10, Bellingham WA 98227‐0010 USA 
360/676‐3290 (Pacific Time) eric@spie.org 
_____________________________ 
From: Patalay, Rakesh [mailto:r.patalay@imperial.ac.uk] 
Sent: Monday, March 25, 2013 4:36 PM 
To: reprint_permission 
Subject: Reprint 
2 
I would like permission to reproduce the following figure in my PhD thesis 
Krasieva, T. B., C. Stringari, et al. (2013). "Two-photon excited fluorescence lifetime imaging 
and spectroscopy of melanins in vitro and in vivo." Journal of Biomedical Optics 18(3): 
31107.  
Reproduce – Figure 1 – graphs a,b For PhD thesis. Print and electronic copy 
Yours 
Dr Patalay 
____________________________ 
H. Lutz 2012 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116180354597 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content  
Publication International Journal of Cosmetic Science 
Licensed content title Characterization of fibrillar collagen types using multi-dimensional multiphoton laser scanning 
microscopy 
Licensed copyright line © 2012 The Authors. ICS © 2012 Society of Cosmetic Scientists and the Société Française de 
Cosmétologie 
Licensed content author V. Lutz,M. Sattler,S. Gallinat,H. Wenck,R. Poertner,F. Fischer 
Licensed content date Jan 27, 2012 
Start page 209 End page 215 
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Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 2 
Original Wiley figure/table number(s) Figure 4b, Figure 5 
Will you be translating? No 
Total 0.00 USD 
I. Marghoob 2003 
This is a License Agreement between Rakesh Patalay ("You") and Elsevier ("Elsevier") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order 
details, the terms and conditions provided by Elsevier, and the payment terms and 
conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
Supplier Elsevier Limited The Boulevard,Langford Lane Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Rakesh Patalay 
Customer address Optics, Dept of Physics, Blackett Lab London, SW7 2AZ 
License number 3116180772524 
License date Mar 25, 2013 
Licensed content publisher Elsevier 
Licensed content Publication Journal of the American Academy of Dermatology 
Licensed content title Instruments and new technologies for the in vivo diagnosis of melanoma 
Licensed content author Ashfaq A Marghoob,Lucinda D Swindle,Claudia Z.M Moricz,Fitzgeraldo A Sanchez 
Negron,Bill Slue,Allan C Halpern,Alfred W Kopf 
Licensed content date November 2003 
Licensed content volume Number 49 
Licensed content issue 
Number 5 
Number of pages 21 
Start Page 777 End Page 797 
Type of Use reuse in a thesis/dissertation 
Intended publisher of new Work other 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 1 
Format both print and electronic 
Are you the author of this Elsevier article? No 
Will you be translating? No 
Order reference number 
Title of your thesis/dissertation The clinical application of multispectral fluorescence lifetime imaging of human skin 
using multiphoton microscopy 
Expected completion date Apr 2013 
Estimated size (number of pages) 200 
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 GBP 
VAT/Local Sales Tax 0.0 USD / 0.0 GBP 
Total 0.00 GBP 
J. Nosfinger 2001 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
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All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116180970978 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication Photochemistry and Photobiology 
Licensed content title Radiative Relaxation of Sepia Eumelanin is Affected by Aggregation 
Licensed copyright line Copyright © 2007, John Wiley and Sons 
Licensed content author J. Brian Nofsinger,John D. Simon 
Licensed content date May 1, 2007 
Start page 31 End page 37 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 2 
Original Wiley figure/table number(s) Figure 1, Figure 3d 
Will you be translating? No 
Total 0.00 USD 
K. Palero 2007 
This is a License Agreement between Rakesh Patalay ("You") and Elsevier ("Elsevier") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order 
details, the terms and conditions provided by Elsevier, and the payment terms and 
conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
Supplier Elsevier Limited The Boulevard,Langford Lane Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Rakesh Patalay 
Customer address Optics, Dept of Physics, Blackett Lab London, SW7 2AZ 
License number 3116201124618 
License date Mar 25, 2013 
Licensed content publisher Elsevier 
Licensed content Publication Biophysical Journal 
Licensed content title Spectrally Resolved Multiphoton Imaging of In Vivo and Excised Mouse Skin Tissues 
Licensed content author Jonathan A. Palero,Henriëtte S. de Bruijn,Angélique van der Ploeg van den Heuvel,Henricus 
J.C.M. Sterenborg,Hans C. Gerritsen 
Licensed content date 1 August 2007 
Licensed content volume Number 93 
Licensed content issue Number 3 
Number of pages 16 
Start Page 992 End Page 1007 
Type of Use reuse in a thesis/dissertation 
Intended publisher of new Work other 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 1 
Format both print and electronic 
Are you the author of this 
Elsevier article? No 
Will you be translating? No 
Order reference number 
Title of your thesis/dissertation The clinical application of multispectral fluorescence lifetime imaging of human skin 
using multiphoton microscopy 
Expected completion date Apr 2013 
Estimated size (number of pages) 200 
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Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 GBP 
VAT/Local Sales Tax 0.0 USD / 0.0 GBP 
Total 0.00 GBP 
L. Palero 2011 
__________________________________________________________ 
From: prvs=796bea49e=copyright@osa.org on behalf of pubscopyright 
<copyright@osa.org> 
Sent: 01 April 2013 21:19 
To: Patalay, Rakesh 
Subject: RE: permission to reproduce 
Follow Up Flag: Follow up 
Flag Status: Flagged 
Dear Dr. Patalay, 
Thank you for contacting The Optical Society.  
OSA considers your requested use of its copyrighted material to be Fair Use under United States 
Copyright Law. It is requested that a complete citation of the original material be included in any 
publication. Let me know if you have any questions. 
 
Kind Regards, 
Susannah Lehman  
Susannah Lehman 
April 1, 2013 Authorized Agent, The Optical Society 
__________________________________________________________________ 
Patalay, Rakesh 
From: Patalay, Rakesh 
Sent: 26 March 2013 00:04 
To: 'copyright@osa.org' 
Subject: permission to reproduce 
Dear sir, 
RE: 
Palero, J. A., A. N. Bader, et al. (2011). "In vivo monitoring of protein-bound and free NADH 
during ischemia by nonlinear spectral imaging microscopy." Biomedical Optics Express 2(5): 
1030-1039. Figure 5A 
I would like to reproduce this graph in my PhD thesis. This will be completed in print and 
available electronically. 
 
Dr Rakesh Patalay 
Division of Optics, Dept Physics 
Blackett Lab 
Imperial College London 
South Kensington Campus 
London 
SW7 2AZ 
Phone +442075947755 
Fax +44 20 75947714 
______________________________________________ 
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M. Pena 2005 
______________________________________________ 
From: prvs=796bea49e=copyright@osa.org on behalf of pubscopyright 
<copyright@osa.org> 
Sent: 01 April 2013 21:19 
To: Patalay, Rakesh 
Subject: RE: permission to reproduce 
Follow Up Flag: Follow up 
Flag Status: Flagged 
Dear Dr. Patalay, 
 
Thank you for contacting The Optical Society. 
OSA considers your requested use of its copyrighted material to be Fair Use under United States 
Copyright Law. It is requested that a complete citation of the original material be included in any 
publication. Let me know if you have any questions. 
Kind Regards, 
Susannah Lehman 
 
Susannah Lehman 
April 1, 2013 
Authorized Agent, The Optical Society 
__________________________________________________________________ 
Patalay, Rakesh 
From: Patalay, Rakesh 
Sent: 26 March 2013 00:20 
To: 'copyright@osa.org' 
Subject: RE: permission to reproduce 
Dear sir, 
RE: Pena, A., M. Strupler, et al. (2005). "Spectroscopic analysis of keratin endogenous signal 
for skin multiphoton microscopy." Optics Express 13(16): 6268-6274. Figure 2c 
 
I would like to reproduce this graph in my PhD thesis. This will be completed in print and 
available electronically. 
Dr Rakesh Patalay 
Division of Optics, Dept Physics 
Blackett Lab 
Imperial College London 
South Kensington Campus 
London 
SW7 2AZ 
Phone +442075947755 
Fax +44 20 75947714 
_______________________________________________________ 
N. Ratto 
_______________________________________________________ 
Patalay, Rakesh 
From: rattof@ifac.cnr.it 
Sent: 27 March 2013 07:06 
To: Patalay, Rakesh 
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Subject: Re: Gold nanorods 
Follow Up Flag: Follow up 
Flag Status: Flagged 
Sure you can, it is my honor. 
Yours, 
Fulvio 
___________________________________________________________________ 
Quoting "Patalay, Rakesh" <r.patalay@imperial.ac.uk>: 
Dear Fulvio, 
 
My name is Dr Rakesh Patalay and I work with Paul French,  Christopher Dunsby and Clifford Talbot 
at Imperial College London in the Optics department. We have been working on a project studyin  
fluorescence lifetime imaging microscopy (FLIM) of human tissue over the last few years. We have 
also been using samples of gold  nanorods, that your lab has provided us to acquire an IRF for our  
data analysis and Dr Talbot has written a paper about the subject. 
 
 I am currently writing up my PhD thesis of this work and would like  to formally ask for permission 
to use the following EM picture of  the gold nanorods that you provided our group a few years ago. 
 
The image would be used in the thesis , which would be available in  both print form and 
electronically. 
 
I look forward to hearing from you  
 
Yours 
 Dr Rakesh Patala 
_______________________________________________________________________ 
O. Sanchez 2010 
__________________________________________________________________________________________ 
Patalay, Rakesh 
From: Michael Roberts <m.roberts@uq.edu.au> 
Sent: 29 March 2013 02:57 
To: Patalay, Rakesh 
Subject: Re: Permission to use figure 
Hi Rakesh 
I am delighted to also give you permission as you have requested 
Happy Easter 
Mike Roberts 
Sent from my iPhone 
_____________________________________________________ 
 
Patalay, Rakesh 
From: Patalay, Rakesh 
Sent: 29 March 2013 00:11 
To: 'm.roberts@uq.edu.au' 
Subject: Permission to use figure 
Dear Dr Roberts, 
My name is Dr Patalay and I am currently a PhD student and doctor working in the optics group of 
Professor Paul French at Imperial College London. I have been researching FLIM applied to skin and 
skin cancer during my thesis. I would like to use part of figure 3 from your JBO 2010 paper in my 
thesis. 
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The publishes have granted permission to reproduce the figure but have suggested that I seek your 
permission also – see below 
Yours 
Dr Rakesh Patalay 
______________________________________________________________ 
From: Karen Thomas [mailto:karent@spie.org] 
Sent: 27 March 2013 18:21 
To: Patalay, Rakesh 
Subject: RE: Reprint 
Dear Dr. Patalay, 
Thank you for seeking permission from SPIE to reprint material from our publications. Publisher's 
permission is hereby granted under the following conditions: 
(1) you obtain permission of one of the authors; 
(2) the material to be used has appeared in our publication without credit or acknowledgment to 
another source; and 
(3) you credit the original SPIE publication. Include the authors' names, title of paper, volume title, 
SPIE volume number, and year of publication in your credit statement. 
Sincerely, 
Karen Thomas for Eric Pepper, Director of Publications 
SPIE 
P.O. Box 10, Bellingham WA 98227‐0010 USA 
360/676‐3290 (Pacific Time) eric@spie.org 
______________________________________________________________ 
From: Patalay, Rakesh [mailto:r.patalay@imperial.ac.uk] 
Sent: Monday, March 25, 2013 5:24 PM 
To: reprint_permission 
Subject: RE: Reprint 
Dear spie, 
I would like permission to reproduce the following figure in my PhD thesis 
Re : Sanchez, W. Y., T. W. Prow, et al. (2010). "Analysis of the metabolic deterioration of ex 
vivo skin from ischemic necrosis through the imaging of intracellular NAD(P)H by 
multiphoton tomography and fluorescence lifetime imaging microscopy." Journal of 
Biomedical Optics 15(4): 046008-046011. 
Reproduce – Figure 3 - 4 graphs 
For PhD thesis. Print and electronic copy 
Yours 
Dr Rakesh Patalay 
Division of Optics, Dept Physics 
Blackett Lab 
Imperial College London 
South Kensington Campus 
London 
SW7 2AZ 
Phone +442075947755 
Fax +44 20 75947714 
P. Seidenari 2013 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
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license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116200048219 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication Skin Research and Technology 
Licensed content title Diagnosis of BCC by multiphoton laser tomography 
Licensed copyright line © 2012 John Wiley & Sons A/S 
Licensed content author Stefania Seidenari,Federica Arginelli,Sara Bassoli,Jennifer Cautela,Anna Maria 
Cesinaro,Mario Guanti,Davide Guardoli,Cristina Magnoni,Marco Manfredini,Giovanni Ponti,Karsten König 
Licensed content date Jul 8, 2012 
Start page e297 End page e304 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) Figure 3 
Will you be translating? No 
Total 0.00 USD 
Q. Teuchner 1999 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116200231074 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication Photochemistry and Photobiology 
Licensed content title Femtosecond Two-photon Excited Fluorescence of Melanin* 
Licensed copyright line Copyright © 2008, John Wiley and Sons 
Licensed content author Klaus Teuchner,Wolfgang Freyer,Dieter Leupold,Andreas Volkmer,David J. S. Birch,Peter 
Altmeyer,Markus Stucker,Klaus Hoffmann 
Licensed content date Jan 2, 2008 
Start page 146 End page 151 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) Figure 4 
Will you be translating? No 
Total 0.00 USD 
R. Wagnieres 1998 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
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license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116200464210 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication Photochemistry and Photobiology 
Licensed content title In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications 
Licensed copyright line Copyright © 2008, John Wiley and Sons 
Licensed content author Georges A. Wagnieres,Willem M. Star,Brian C. Wilson 
Licensed content date Jan 2, 2008 
Start page 603 End page 632 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) An adaptation of Figure 1A 
Will you be translating? No 
Total 0.00 USD 
S. Wagnieres 1998 
This is a License Agreement between Rakesh Patalay ("You") and John Wiley and 
Sons ("John Wiley and Sons") provided by Copyright Clearance Center ("CCC"). The 
license consists of your order details, the terms and conditions provided by John 
Wiley and Sons, and the payment terms and conditions. 
 
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of 
this form. 
License Number 3116200614223 
License date Mar 25, 2013 
Licensed content publisher John Wiley and Sons 
Licensed content Publication Photochemistry and Photobiology 
Licensed content title In Vivo Fluorescence Spectroscopy and Imaging for Oncological Applications 
Licensed copyright line Copyright © 2008, John Wiley and Sons 
Licensed content author Georges A. Wagnieres,Willem M. Star,Brian C. Wilson 
Licensed content date Jan 2, 2008 
Start page 603 End page 632 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Original Wiley figure/table number(s) Adaptation of Figure 1B 
Will you be translating? No 
Total 0.00 USD 
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